Savitri Krishnamurthy, M.D.

Peer-Reviewed Articles

1. Hu X, Xiong Y, Villodre ES, Zhang H, Longa IR, Song J, Fowlkes N, Krishnamurthy S, Rylander M, Bartholomeusz C, Tripathy D, Woodward WA, Chen J, Debeb BG. Soluble E-cadherin-CXCL1-CXCR2 Axis as a Therapeutic Vulnerability in Inflammatory Breast Cancer Brain Metastasis. Neuro Oncol, 2026. e-Pub 2026. PMID: 41578012.
2. Villodre ES, Song J, Hu X, Gomez K, Cohen EN, Reuben JM, Nasrazadani A, Lim B, Tripathy D, Woodward WA, Krishnamurthy S, Debeb BG. Serum S100A8/S100A9 is associated with increased risk of brain metastasis in patients with inflammatory breast cancer. medRxiv, 2026. e-Pub 2026. PMID: 41646727.
3. Lynce F, Valenza C, Niman SM, Bertucci F, Kai M, Ryan S, Troll E, Layman RM, Fanucci KA, Giordano A, Nasrazadani A, Nakhlis F, Bellon J, Warren L, Block C, Schumer S, Lucci A, Krishnamurthy S, Trapani D, Lerebours F, Dalenc F, Levy C, Petit T, Leheurteur M, Bachelot T, Tredan O, Ribeiro JM, Pistilli B, Zagami P, Ladoire S, Lopez Almeida L, Zemmour C, Carey LA, Tolaney SM, Valero V, Curigliano G, Regan MM, Goncalves A, Woodward WA. Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer. ESMO Open 11(2):106050, 2026. e-Pub 2026. PMID: 41558201.
4. Phi, LH, Cheng, Y, Funakoshi, Y, Bertucci, F, Finetti, P, Van Laere, S, Zou, F, Long, JP, Ogata, S, Krishnamurthy, S, Reuben, JM, Foulks, JM, Warner, SL, Rosenbluth, JM, Sood, AK, Tripathy, D, Ueno, NT, Wang, X. AXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarization. Breast Cancer Research 27(1), 2025. e-Pub 2025. PMID: 40329335.
5. Wang K, Ye R, Bai S, Xiao Z, Yang L, Li J, Tang C, Sei E, Peng J, Casasent AK, Lin SH, Nagi C, Thompson AM, Krishnamurthy S, Navin NE. Coalescing single-cell genomes and transcriptomes to decode breast cancer progression. Cell 188(22):6355-6369.e16, 2025. e-Pub 2025. PMID: 40912251.
6. Ahmed MS, Klippel-Almaraz D, Amin SE, Sura GH, Kundu UR, Yu W, Stewart JM, Gan Q, Krishnamurthy S. Utility of whole-slide imaging for rapid evaluation of thyroid FNA: A multireader prospective study. Cancer Cytopathol 133(9):e70046, 2025. e-Pub 2025. PMID: 40889104.
7. Ferrick-Kiddie EA, Dommaraju S, Yao J, Smith CW, Wang X, Woodward WA, Ueno NT, Krishnamurthy S, Lambowitz AM. High-throughput assay confirmation of a T-cell receptor pre-mRNA fragment as a blood-based inflammatory breast cancer biomarker. medRxiv, 2025. e-Pub 2025. PMID: 40894151.
8. Iwase T, Sridhar N, Kai M, Dong W, Shen Y, Krishnamurthy S, Lucci A, Le-Petross HTC, Nasrazadani A, Saleem S, Layman RM, Valero V, Tripathy D, Woodward WA, Cheng YC, Nakhlis F, Bellon JR, Lynce F, Ueno NT. Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective study. Breast Cancer Res Treat 214(1):69-77, 2025. e-Pub 2025. PMID: 40753318.
9. Lynce F, Niman SM, Kai M, Ma SR, Troll E, Li L, Miller KD, Jagsi R, Mason G, Overmoyer BA, Le-Petross HTC, Nakhlis F, Krishnamurthy S, Harrison BT, Sun SX, Yeh ED, Bellon JR, Warren LE, Stauder MC, Regan MM, Woodward WA. Development of a Multi-Institutional Dataset to Validate a Novel Inflammatory Breast Cancer Diagnostic Score. J Natl Cancer Inst 117(8):1583-1592, 2025. e-Pub 2025. PMID: 40163681.
10. Hu X, Xiong Y, Villodre ES, Zhang H, Song J, Fowlkes N, Krishnamurthy S, Rylander M, Bartholomeusz C, Tripathy D, Woodward WA, Chen J, Debeb BG. Soluble E-cadherin Drives Brain Metastasis in Inflammatory Breast Cancer. bioRxiv, 2025. e-Pub 2025. PMID: 40667060.
11. Mughees M, Tacam MJ, Tan AW, Pitner MK, Iles LR, Hu X, S Villodre E, Debeb BG, Kogawa T, Lim B, Layman RM, Woodward WA, Ueno NT, Tripathy D, Krishnamurthy S, Qi Y, Pusztai L, Wang J, Gandhi V, Bartholomeusz G, Bartholomeusz C. Inhibition of MCL-1 and MEK overcomes MEK inhibitor resistance in triple-negative and inflammatory breast cancers. Mol Cancer Ther 24(9):1453-1465, 2025. e-Pub 2025. PMID: 40358476.
12. Phi LTH, Cheng Y, Funakoshi Y, Bertucci F, Finetti P, Van Laere SJ, Zou F, Long JP, Ogata S, Krishnamurthy S, Reuben JM, Foulks JM, Warner SL, Rosenbluth JM, Sood AK, Tripathy D, Ueno NT, Wang X. AXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarization 27(1):70, 2025. e-Pub 2025. PMID: 40329335.
13. Kuerer HM, Valero V, Smith BD, Krishnamurthy S, Diego EJ, Johnson HM, Lin H, Shen Y, Lucci A, Shaitelman SF, Mitchell MP, Boughey JC, White RL, Hunt KK, Yang WT, Rauch GM. Selective Elimination of Breast Surgery for Invasive Breast Cancer: A Nonrandomized Clinical Trial. JAMA Oncol 11(5):529-534, 2025. e-Pub 2025. PMID: 40152443.
14. Ali H, Bhutani MS, Krishnamurthy S. The Role of Fine-Needle Aspiration in Conjunction With Ancillary Immunophenotyping for Accurate Recognition of a Case of Splenosis in Perirectal Soft Tissue. Diagn Cytopathol 53(5):E92-E97, 2025. e-Pub 2025. PMID: 40012117.
15. Ye Q, Law T, Klippel D, Albarracin C, Chen H, Contreras A, Ding Q, Huo L, Khazai L, Middleton L, Resetkova E, Sahin A, Sun H, Sweeney K, Symmans W, Wu Y, Krishnamurthy S. Prospective and retrospective analysis of whole slide images of sentinel and targeted lymph node frozen sections in breast cancer. Mod Pathol 38(4), 2025. e-Pub 2025. PMID: 39788205.
16. Reddy T, Puri A, Guzman-Rojas L, Thomas C, Qian W, Zhou J, Zhao H, Mahboubi B, Oo A, Cho YJ, Kim B, Thaiparambil J, Rosato R, Martinez KO, Chervo MF, Ayerbe C, Giese N, Wink D, Lockett S, Wong S, Chang J, Krishnamurthy S, Yam C, Moulder S, Piwnica-Worms H, Meric-Bernstam F, Chang J. NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression. Nat Commun 15(1):10737, 2024. e-Pub 2024. PMID: 39737957.
17. Wang, X, Zhao, L, Song, X, Wu, X, Krishnamurthy, S, Semba, T, Shao, SH, Knafl, M, Coffer, LW, Alexander, A, Vines, A, Bopparaju, S, Woodward, W, Chu, RA, Zhang, J, Yam, C, Loo, LW, Nasrazadani, A, Huong, LP, Woodman, SE, Futreal, A, Zhang, S, Zhang, Q, Xu, M, Wistuba, II, Wang, W, Virani, S, Sun, B, Subramanya, S, Song, X, Song, P, Shaw, KR, Prabhakaran, S, Marques-Piubelli, ML, Mohammad, MM, Meric-Bernstam, F, Mendoza, MT, Mallampati, S, Lu, W, Little, L, Lang, W, Kinyua, W, Khanduri, I, Jiang, M, Jacob, J, Jackson, S, Gite, S, Garcia-Prieto, C, Arrechedera, C, Tripathy, D. Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer. npj Precision Oncology 8(1), 2024. e-Pub 2024. PMID: 39558017.
18. Wang, X, Zhao, L, Song, X, Wu, X, Krishnamurthy, S, Semba, T, Shao, SH, Knafl, M, Coffer, LW, Alexander, A, Vines, A, Bopparaju, S, Woodward, W, Chu, RA, Zhang, J, Yam, C, Loo, LW, Nasrazadani, A, Huong, LP, Woodman, SE, Futreal, A, Zhang, S, Zhang, Q, Xu, M, Wistuba, II, Wang, W, Virani, S, Sun, B, Subramanya, S, Song, X, Song, P, Shaw, KR, Prabhakaran, S, Marques-Piubelli, ML, Mohammad, MM, Meric-Bernstam, F, Mendoza, MT, Mallampati, S, Lu, W, Little, L, Lang, W, Kinyua, W, Khanduri, I, Jiang, M, Jacob, J, Jackson, S, Gite, S, Garcia-Prieto, C, Arrechedera, C, Tripathy, D. Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer. npj Precision Oncology 8(1), 2024. e-Pub 2024. PMID: 39558017.
19. Wang X, Zhao L, Song X, Wu X, Krishnamurthy S, Semba T, Shao S, Knafl M, Coffer LW 2nd, Alexander A, Vines A, Bopparaju S, Woodward WA, Chu R, Zhang J, Yam C, Loo LWM, Nasrazadani A, Huong LP, Woodman SE, Futreal A, Tripathy D, Ueno NT. Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer. NPJ Precis Oncol 8(1):265, 2024. e-Pub 2024. PMID: 39558017.
20. Hanna MG, Olson NH, Zarella M, Dash RC, Herrmann MD, Furtado LV, Stram MN, Raciti PM, Hassell L, Mays A, Pantanowitz L, Sirintrapun JS, Krishnamurthy S, Parwani A, Lujan G, Evans A, Glassy EF, Bui MM, Singh R, Souers RJ, de Baca ME, Seheult JN. Recommendations for Performance Evaluation of Machine Learning in Pathology: A Concept Paper From the College of American Pathologists. Arch Pathol Lab Med 148(10):e335-e361, 2024. e-Pub 2023. PMID: 38041522.
21. Krishnamurthy S, Schnitt SJ, Vincent-Salomon A, Canas-Marques R, Colon E, Kantekure K, Maklakovski M, Finck W, Thomassin J, Globerson Y, Bien L, Mallel G, Grinwald M, Linhart C, Sandbank J, Vecsler M. Fully Automated Artificial Intelligence Solution for Human Epidermal Growth Factor Receptor 2 Immunohistochemistry Scoring in Breast Cancer: A Multireader Study. JCO Precis Oncol 8:e2400353, 2024. e-Pub 2024. PMID: 39393036.
22. Snijesh VP, Krishnamurthy S, Bhardwaj V, Punya KM, Niranjana Murthy AS, Almutadares M, Habhab WT, Nasser KK, Banaganapalli B, Shaik NA, Albaqami WF. SHH Signaling as a Key Player in Endometrial Cancer: Unveiling the Correlation with Good Prognosis, Low Proliferation, and Anti-Tumor Immune Milieu. Int J Mol Sci 25(19), 2024. e-Pub 2024. PMID: 39408773.
23. Donthi D, Gan Q, Ding QQ, Krishnamurthy S. Trichorhinophalangeal syndrome 1 expression in breast and nonbreast metastases from Mullerian, lung, gastrointestinal tract, and pancreatic primary tumors by immunohistochemistry with cytology cell block specimens. Cancer Cytopathol 132(12):799-808, 2024. e-Pub 2024. PMID: 39264831.
24. Mitchell MP, Shaitelman SF, Smith BD, Krishnamurthy S, Valero V, Rauch GM, Shen Y, Lin H, Kuerer HM. Feasibility of breast conserving surgery alone in HER2-positive exceptional responders to neoadjuvant systemic therapy. Eur J Surg Oncol 50(12):108613, 2024. e-Pub 2024. PMID: 39243728.
25. Treekitkarnmongkol W, Shah V, Kai K, Katayama H, Wong J, Ladha FA, Nguyen T, Menegaz B, Lu W, Yang F, Mino B, Tang X, Gagea M, Batra H, Raso MG, Wistuba II, Krishnamurthy S, Pinder SE, Sawyer EJ, Thompson AM, Sen S. Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancer. Br J Cancer 131(1):171-183, 2024. e-Pub 2024. PMID: 38760444.
26. Ahmed I, Krishnamurthy S, Bhise R, Vinchurkar K, Kalloli M. Outcomes with optimal treatment in geriatric head and neck cancers - Tertiary cancer centre experience. J Cancer Res Ther 20(5):1384-1389, 2024. e-Pub 2024. PMID: 39412904.
27. Iwase T, Cohen EN, Gao H, Alexander A, Kai M, Chiv V, Wang X, Krishnamurthy S, Liu D, Shen Y, Kida K, Reuben A, Layman R, Ramirez D, Tripathy D, Moulder SL, Yam C, Valero V, Lim B, Reuben JM, Ueno NT. Maintenance pembrolizumab therapy in patients with metastatic HER2-negative breast cancer with prior response to chemotherapy. Clin Cancer Res 30(11):2424-2432, 2024. e-Pub 2024. PMID: 38629963.
28. Wang J, Yoon E, Krishnamurthy S. Concordance between pathologists and between specimen types in detection of HER2-low breast carcinoma by immunohistochemistry. Ann Diagn Pathol 70:152288, 2024. e-Pub 2024. PMID: 38452457.
29. Sun H, Kang EY, Chen H, Sweeney KJ, Suchko M, Wu Y, Wen J, Krishnamurthy S, Albarracin CT, Ding QQ, Foo WC, Sahin AA. Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis. Breast Cancer Res Treat 205(2):403-411, 2024. e-Pub 2024. PMID: 38441847.
30. Tozbikian G, Krishnamurthy S, Bui MM, Feldman M, Hicks DG, Jaffer S, Khoury T, Wei S, Wen H, Pohlmann P. Emerging Landscape of Targeted Therapy of Breast Cancers With Low HER2 Protein Expression. Arch Pathol Lab Med 148(2):242-255, 2024. e-Pub 2024. PMID: 37014972.
31. Guhan M, Crane SM, Valerius LS, Cruz D, Smith BD, Woodward WA, Mitchell MP, Valero V, Rauch GM, Krishnamurthy S, Warnecke CL, Kuerer HM, Shaitelman SF. Patient interest in exploring non-surgical treatment approaches for early stage breast cancer: A qualitative study. Int J Radiat Oncol Biol Phys 118(2):443-454, 2024. e-Pub 2023. PMID: 37802228.
32. Xie X, Chauhan GB, Edupuganti R, Kogawa T, Park J, Tacam M, Tan AW, Mughees M, Vidhu F, Liu DD, Taliaferro JM, Pitner MK, Browning LS, Lee JH, Bertucci F, Shen Y, Wang J, Ueno NT, Krishnamurthy S, Hortobagyi GN, Tripathy D, Van Laere SJ, Bartholomeusz G, Dalby KN, Bartholomeusz C. Correction: Maternal Embryonic Leucine Zipper Kinase Is Associated with Metastasis in Triple-negative Breast Cancer. Cancer Res Commun 4(1):236, 2024. e-Pub 2024. PMID: 38282551.
33. Balema W, Morton J, Larson RA, Li L, Velasquez FC, Fowlkes NW, Krishnamurthy S, Debeb BG, Sevick-Muraca E, Woodward WA. High-fat diet, but not duration of lactation, increases mammary gland lymphatic vessel function and subsequent growth of inflammatory breast cancer cells. J Mammary Gland Biol Neoplasia 28(1):21, 2023. e-Pub 2023. PMID: 37801190.
34. Johnson HM, Lin H, Shen Y, Diego EJ, Krishnamurthy S, Yang WT, Smith BD, Valero V, Lucci A, Sun SX, Shaitelman SF, Mitchell MP, Boughey JC, White RL, Rauch GM, Kuerer HM, Study Group ER. Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy: A Nonrandomized Clinical Trial. JAMA Netw Open 6(9):e2333933, 2023. e-Pub 2023. PMID: 37707811.
35. Johnson HM, Valero V, Yang WT, Smith BD, Krishnamurthy S, Shen Y, Lin H, Lucci A, Rauch GM, Kuerer HM. Eliminating Breast Surgery for Invasive Cancer with Exceptional Response to Neoadjuvant Systemic Therapy: Prospective Multicenter Clinical Trial Planned Initial Feasibility Endpoint. J Am Coll Surg 237(1):101-108, 2023. e-Pub 2023. PMID: 36856291.
36. Nguyen HL, Geukens T, Maetens M, Aparicio S, Bassez A, Borg A, Brock J, Broeks A, Caldas C, Cardoso F, De Schepper M, Delorenzi M, Drukker CA, Glas AM, Green AR, Isnaldi E, Eyfjörð J, Khout H, Knappskog S, Krishnamurthy S, Lakhani SR, Langerod A, Martens JWM, McCart Reed AE, Murphy L, Naulaerts S, Nik-Zainal S, Nevelsteen I, Neven P, Piccart M, Poncet C, Punie K, Purdie C, Rakha EA, Richardson A, Rutgers E, Vincent-Salomon A, Simpson PT, Schmidt MK, Sotiriou C, Span PN, Tan KTB, Thompson A, Tommasi S, Van Baelen K, Van de Vijver M, Van Laere S, Van't Veer L, Viale G, Viari A, Vos H, Witteveen AT, Wildiers H, Floris G, Garg AD, Smeets A, Lambrechts D, Biganzoli E, Richard F, Desmedt C. Obesity-associated changes in molecular biology of primary breast cancer. Nat Commun 14(1):4418, 2023. e-Pub 2023. PMID: 37479706.
37. Maguluri G, Grimble J, Caron A, Zhu G, Krishnamurthy S, McWatters A, Beamer G, Lee SY, Iftimia N. Core Needle Biopsy Guidance Based on Tissue Morphology Assessment with AI-OCT Imaging. Diagnostics (Basel) 13(13), 2023. e-Pub 2023. PMID: 37443670.
38. Engel AJ, Shin K, Adrada BE, Moseley TW, Krishnamurthy S, Whitman GJ. Review of the Sonographic Features of Interpectoral (Rotter) Lymph Nodes in Breast Cancer Staging. Ultrasound Q 39(2):69-73, 2023. e-Pub 2022. PMID: 35439235.
39. Xie, X, Chauhan, GB, Edupuganti, R, Kogawa, T, Park, J, Tacam, MJ, Tan, AW, Mughees, M, Vidhu, F, Liu, D, Taliaferro, JM, Pitner, MK, Browning, LS, Lee, JH, Bertucci, F, Shen, Y, Wang, J, Ueno, NT, Krishnamurthy, S, Hortobagyi, GN, Tripathy, D, Van Laere, S, Bartholomeusz, G, Dalby, KN, Bartholomeusz, C. Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer. Cancer Research Communications 3(6):1078-1092, 2023. e-Pub 2023. PMID: 37377604.
40. Xie X, Chauhan GB, Edupuganti R, Kogawa T, Park J, Tacam M, Tan AW, Mughees M, Vidhu F, Liu DD, Taliaferro JM, Pitner MK, Browning LS, Lee JH, Shen Y, Wang J, Ueno NT, Krishnamurthy S, Hortobagyi GN, Tripathy D, Van Laere SJ, Bartholomeusz G, Dalby KN, Bartholomeusz C. Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer. Cancer Res Commun 3(6):1078-1092, 2023. e-Pub 2023. PMID: 37377604.
41. Wylie D, Wang X, Yao J, Xu H, Ferrick-Kiddie EA, Iwase T, Krishnamurthy S, Ueno NT, Lambowitz AM. Inflammatory breast cancer biomarker identification by simultaneous TGIRT-seq profiling of coding and non-coding RNAs in tumors and blood. medRxiv, 2023. e-Pub 2023. PMID: 37398275.
42. Balamurugan K, Poria DK, Sehareen SW, Krishnamurthy S, Tang W, McKennett L, Padmanaban V, Czarra K, Ewald AJ, Ueno NT, Ambs S, Sharan S, Sterneck E. Stabilization of E-cadherin adhesions by COX-2/GSK3β signaling is a targetable pathway in metastatic breast cancer. JCI Insight 8(6), 2023. e-Pub 2023. PMID: 36757813.
43. Kuerer HM, Smith BD, Krishnamurthy S, Yang WT, Valero V, Shen Y, Lin H, Lucci A, Boughey JC, White RL, Diego EJ, Rauch GM, Trials Group ERC. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial. The lancet oncology 23(12):1517-1524, 2022. e-Pub 2022. PMID: 36306810.
44. Al Abo M, Gearhart-Serna L, Van Laere S, Freedman JA, Patierno SR, Hwang ES, Krishnamurthy S, Williams KP, Devi GR. Adaptive stress response genes associated with breast cancer subtypes and survival outcomes reveal race-related differences. NPJ Breast Cancer 8(1):73, 2022. e-Pub 2022. PMID: 35697736.
45. Wang X, Semba T, Manyam GC, Wang J, Shao S, Bertucci F, Finetti P, Krishnamurthy S, Phi LTH, Pearson T, Van Laere SJ, Burks JK, Cohen EN, Reuben JM, Yang F, Min H, Navin N, Trinh VN, Iwase T, Batra H, Shen Y, Zhang X, Tripathy D, Ueno NT. EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer. Sci Adv 8(50):eabn7983, 2022. e-Pub 2022. PMID: 36525493.
46. Almekinders MM, Bismeijer T, Kumar T, Yang F, Thijssen B, van der Linden R, van Rooijen C, Vonk S, Sun B, Parra Cuentas ER, Wistuba II, Krishnamurthy S, Visser LL, Seignette IM, Hofland I, Sanders J, Broeks A, Love JK, Menegaz B, Wessels L, Thompson AM, de Visser KE, Hooijberg E, Lips E, Futreal A, Wesseling J, PRECISION Consortium GC. Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk. Br J Cancer 127(7):1201-1213, 2022. e-Pub 2022. PMID: 35768550.
47. Wei R, He S, Bai S, Sei E, Hu M, Thompson A, Chen K, Krishnamurthy S, Navin NE. Spatial charting of single-cell transcriptomes in tissues. Nat Biotechnol 40(8):1190-1199, 2022. e-Pub 2022. PMID: 35314812.
48. Yoon EC, Wang G, Parkinson B, Huo L, Peng Y, Wang J, Salisbury T, Wu Y, Chen H, Albarracin CT, Resetkova E, Middleton LP, Krishnamurthy S, Gan Q, Sun H, Huang X, Shen T, Chen W, Parwani AV, Sahin AA, Li Z, Ding Q. TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma. Hum Pathol 125:97-107, 2022. e-Pub 2022. PMID: 35413381.
49. Schlee Villodre E, Hu X, Eckhardt BL, Larson R, Huo L, Yoon EC, Gong Y, Song J, Liu S, Ueno NT, Krishnamurthy S, Pusch S, Tripathy D, Woodward WA, Debeb BG. NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis. J Natl Cancer Inst 114(4):579-591, 2022. e-Pub 2022. PMID: 34893874.
50. Indumathi CK, Jain S, Krishnamurthy S, Alexander B. Utility of RNTCP (NTEP) guidelines in microbiological confirmation of pediatric tuberculosis. Indian J Tuberc 69(2):161-165, 2022. e-Pub 2022. PMID: 35379396.
51. Krishnamurthy S, Ban K. Feasibility of using digital confocal microscopy for cytopathological examination in clinical practice. Mod Pathol 35(3):319-325, 2022. e-Pub 2022. PMID: 34628480.
52. Wang J, Wang WL, Sun H, Huo L, Wu Y, Chen H, Gan Q, Meis JM, Maloney N, Lazar AJ, Yoon EC, Albarracin CT, Krishnamurthy S, Middleton LP, Resetkova E, Yu W, Tan D, Lu W, Solis Soto LM, Wang S, Wistuba II, Parwani AV, Prieto VG, Sahin AA, Li Z, Ding Q. Expression of TRPS1 in phyllodes tumor and sarcoma of the breast. Hum Pathol 121:73-80, 2022. e-Pub 2022. PMID: 35063444.
53. Hou T, Liu Z, Gan Q, Debnam JM, Krishnamurthy S. Clinical and cytopathological features of suspected thyroglossal duct cysts and neoplasms arising from them: A large series from a referral cancer center. Cancer Cytopathol 130(1):72-79, 2022. e-Pub 2022. PMID: 34529338.
54. Masuda H, Harano K, Miura S, Wang Y, Hirota Y, Harada O, Jolly MK, Matsunaga Y, Lim B, Wood AL, Parinyanitikul N, Jin Lee H, Gong G, George JT, Levine H, Lee J, Wang X, Lucci A, Rao A, Schweitzer BL, Lawrence OR, Seitz RS, Morris SW, Hout DR, Nakamura S, Krishnamurthy S, Ueno NT. Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy. JCO Precis Oncol 6:e2000368, 2022. e-Pub 2022. PMID: 35294223.
55. Hu X, Villodre ES, Larson R, Rahal OM, Wang X, Gong Y, Song J, Krishnamurthy S, Ueno NT, Tripathy D, Woodward WA, Debeb BG. Decorin-mediated suppression of tumorigenesis, invasion, and metastasis in inflammatory breast cancer. Commun Biol 4(1):72, 2021. e-Pub 2021. PMID: 33452400.
56. Kai M, Marx AN, Liu DD, Shen Y, Gao H, Reuben JM, Whitman G, Krishnamurthy S, Ross MI, Litton JK, Lim B, Ibrahim N, Kogawa T, Ueno NT. A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer. Sci Rep 11(1):22242, 2021. e-Pub 2021. PMID: 34782633.
57. Fujii Y, Krishnamurthy S, El-Zein R. Ultrastructural Analysis of Inflammatory Breast Cancer Cell Clusters in an Ex Vivo Environment Mechanically Mimicking the Lymph Vascular System. Breast Cancer (Auckl) 15:11782234211056134, 2021. e-Pub 2021. PMID: 34924757.
58. Li X, Kumar S, Harmanci A, Li S, Kitchen RR, Zhang Y, Wali VB, Reddy SM, Woodward WA, Reuben JM, Rozowsky J, Hatzis C, Ueno NT, Krishnamurthy S, Pusztai L, Gerstein M. Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers. Genome Med 13(1):70, 2021. e-Pub 2021. PMID: 33902690.
59. Villodre ES, Hu X, Larson R, Finetti P, Gomez K, Balema W, Stecklein SR, Santiago-Sanchez G, Krishnamurthy S, Song J, Su X, Ueno NT, Tripathy D, Van Laere S, Bertucci F, Vivas-Mejía P, Woodward WA, Debeb BG. Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion. Mol Oncol 15(10):2752-2765, 2021. e-Pub 2021. PMID: 34342930.
60. Park J, Tacam MJ, Chauhan G, Cohen EN, Gagliardi M, Iles LR, Ueno NT, Battula VL, Sohn YK, Wang X, Kim HS, Krishnamurthy S, Fowlkes NW, Green MM, Bartholomeusz GA, Tripathy D, Reuben JM, Bartholomeusz C. Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression. Breast Cancer Res Treat 189(2):333-345, 2021. e-Pub 2021. PMID: 34241740.
61. Simons JM, Scoggins ME, Kuerer HM, Krishnamurthy S, Yang WT, Sahin AA, Shen Y, Lin H, Bedrosian I, Mittendorf EA, Thompson A, Lane DL, Hunt KK, Caudle AS. Prospective Registry Trial Assessing the Use of Magnetic Seeds to Locate Clipped Nodes After Neoadjuvant Chemotherapy for Breast Cancer Patients. Ann Surg Oncol 28(8):4277-4283, 2021. e-Pub 2021. PMID: 33417121.
62. Fang H, Wang SA, Xie W, Tang Z, Hu S, Krishnamurthy S, Medeiros LJ, Wang W. Clinicopathologic Features of Myelodysplastic Syndromes Involving Lymph Nodes. Am J Surg Pathol 45(7):930-938, 2021. e-Pub 2021. PMID: 33739784.
63. van Seijen M, Józwiak K, Pinder SE, Hall A, Krishnamurthy S, Thomas JS, Collins LC, Bijron J, Bart J, Cohen D, Ng W, Bouybayoune I, Stobart H, Hudecek J, Schaapveld M, Thompson A, Lips EH, Wesseling J, PRECISION consortium GC. Variability in grading of ductal carcinoma in situ among an international group of pathologists. J Pathol Clin Res 7(3):233-242, 2021. e-Pub 2021. PMID: 33620141.
64. Thomas C, Karagounis IV, Srivastava RK, Vrettos N, Nikolos F, Francois N, Huang M, Gong S, Long Q, Kumar S, Koumenis C, Krishnamurthy S, Ueno NT, Chakrabarti R, Maity A. Estrogen receptor β-mediated inhibition of actin-based cell migration suppresses metastasis of inflammatory breast cancer. Cancer Res 81(9):2399-2414, 2021. e-Pub 2021. PMID: 33514514.
65. Nia ES, Adrada BE, Whitman GJ, Candelaria RP, Krishnamurthy S, Bassett RL, M Arribas E. MRI features of pseudoangiomatous stromal hyperplasia with histopathological correlation. Breast J 27(3):242-247, 2021. e-Pub 2021. PMID: 33393706.
66. Scimone MT, Krishnamurthy S, Maguluri G, Preda D, Park J, Grimble J, Song M, Ban K, Iftimia N. Assessment of breast cancer surgical margins with multimodal optical microscopy: A feasibility clinical study. PLoS One 16(2):e0245334, 2021. e-Pub 2021. PMID: 33571221.
67. Lim B, Song J, Ibrahim NK, Koenig KB, Chavez-MacGregor M, Ensor JE, Gomez JS, Krishnamurthy S, Caudle AS, Shaitelman SF, Whitman GJ, Valero V. A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast Cancer. Oncologist 26(2):e230-e240, 2021. e-Pub 2021. PMID: 33140515.
68. Bensussan AV, Lin J, Guo C, Katz R, Krishnamurthy S, Cressman E, Eberlin LS. Distinguishing Non-Small Cell Lung Cancer Subtypes in Fine Needle Aspiration Biopsies by Desorption Electrospray Ionization Mass Spectrometry Imaging. Clin Chem 66(11):1424-1433, 2020. e-Pub 2020. PMID: 33141910.
69. Tasoulis MK, Lee HB, Yang W, Pope R, Krishnamurthy S, Kim SY, Cho N, Teoh V, Rauch GM, Smith BD, Valero V, Mohammed K, Han W, MacNeill F, Kuerer HM. Accuracy of Post-Neoadjuvant Chemotherapy Image-Guided Breast Biopsy to Predict Residual Cancer. JAMA Surg:e204103. e-Pub 2020. PMID: 33026457.
70. Kida K, Hess KR, Lim B, Iwase T, Chainitikun S, Valero V, Lucci A, Le-Petross HC, Woodward WA, Krishnamurthy S, Hortobagyi GN, Tripathy D, Ueno NT. Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast Cancer. Cancers (Basel) 12(11), 2020. e-Pub 2020. PMID: 33114311.
71. Su F, Wang X, Pearson T, Lee J, Krishnamurthy S, Ueno NT, Kolonin MG. Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis. Mol Ther Oncolytics 18:579-586, 2020. e-Pub 2020. PMID: 32995482.
72. Gadde M, Phillips C, Ghousifam N, Sorace AG, Wong E, Krishnamurthy S, Syed A, Rahal O, Yankeelov TE, Woodward WA, Rylander MN. In Vitro Vascularized Tumor Platform for Modeling Tumor-Vasculature Interactions of Inflammatory Breast Cancer. Biotechnol Bioeng. e-Pub 2020. PMID: 32648934.
73. Kogawa T, Fujii T, Wu J, Harano K, Fouad TM, Liu DD, Shen Y, Masuda H, Krishnamurthy S, Chavez-MacGregor M, Lim B, Murthy RK, Valero V, Tripathy D, Ueno NT. Prognostic Value of HER2 to CEP17 Ratio on Fluorescence In Situ Hybridization Ratio in Patients with Nonmetastatic HER2-Positive Inflammatory and Noninflammatory Breast Cancer Treated with Neoadjuvant Chemotherapy with or without Trastuzumab. Oncologist 25(6):e909-e919, 2020. e-Pub 2020. PMID: 32003919.
74. Iwase T, Harano K, Masuda H, Kida K, Hess KR, Wang Y, Dirix L, Van Laere SJ, Lucci A, Krishnamurthy S, Woodward WA, Layman RM, Bertucci F, Ueno NT. Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC. BMC Cancer 20(1):430, 2020. e-Pub 2020. PMID: 32423453.
75. Grant SR, Krishnamurthy S, Le-Petross C, Valero V, Teshome M, Woodward WA. An inflammatory imposter: Three cases of Mullerian carcinoma appearing as inflammatory breast cancer. Breast J 26(5):1022-1024, 2020. e-Pub 2020. PMID: 31960546.
76. Golant BT, Velez-Perez A, Krishnamurthy S, Guo M, Mousavi S, Hu MI, Varghese JM, Zafereo ME, Debnam JM. Thyroid carcinoma metastasizing to the submandibular gland: Sonographic findings. J Clin Ultrasound 48(4):227-230, 2020. e-Pub 2020. PMID: 32045024.
77. Krishnamurthy S, Sabir S, Ban K, Wu Y, Sheth R, Tam A, Meric-Bernstam F, Shaw K, Mills G, Bassett R, Hamilton S, Hicks M, Gupta S. Comparison of Real-Time Fluorescence Confocal Digital Microscopy With Hematoxylin-Eosin-Stained Sections of Core-Needle Biopsy Specimens. JAMA Netw Open 3(3):e200476, 2020. e-Pub 2020. PMID: 32134465.
78. Debnam JM, Vu T, Sun J, Wei W, Krishnamurthy S, Zafereo ME, Weitzman SP, Garg N, Ahmed S. Vascular flow on doppler sonography may not be a valid characteristic to distinguish colloid nodules from papillary thyroid carcinoma even when accounting for nodular size. Gland Surg 8(5):461-468, 2019. e-Pub 2019. PMID: 31741876.
79. Gan Q, Edeiken BS, Chen MM, Grubbs EG, Busaidy NL, Zafereo M, Perrier ND, Gule-Monroe MD, Krishnamurthy S. Utility of subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance category in ultrasound-guided thyroid fine-needle aspiration in a large referral cancer center. J Am Soc Cytopathol. e-Pub 2019. PMID: 31526696.
80. Krishnamurthy S, Brown JQ, Iftimia N, Levenson RM, Rajadhyaksha M. Ex Vivo Microscopy: A Promising Next-Generation Digital Microscopy Tool for Surgical Pathology Practice. Arch Pathol Lab Med. e-Pub 2019. PMID: 31295016.
81. Sun S, van la Parra RFD, Rauch GM, Checka C, Tadros AB, Lucci A, Teshome M, Black D, Hwang RF, Smith BD, Krishnamurthy S, Valero V, Yang WT, Kuerer HM. Patient Selection for Clinical Trials Eliminating Surgery for HER2-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy. Ann Surg Oncol. e-Pub 2019. PMID: 31342361.
82. Reddy SM, Reuben A, Barua S, Jiang H, Zhang S, Wang L, Gopalakrishnan V, Hudgens CW, Tetzlaff MT, Reuben JM, Tsujikawa T, Coussens LM, Wani K, He Y, Villareal L, Wood A, Rao A, Woodward WA, Ueno NT, Krishnamurthy S, Wargo JA, Mittendorf, EA. Poor Response to Neoadjuvant Chemotherapy Correlates with Mast Cell Infiltration in Inflammatory Breast Cancer. Cancer Immunol Res 7(6):1025-1035, 2019. e-Pub 2019. PMID: 31043414.
83. Caudle AS, Kuerer HM, Krishnamurthy S, Shin K, Hobbs BP, Ma J, Mittendorf EA, Washington AC, DeSnyder SM, Black DM, Hunt KK, Yang WT. Feasibility of fine-needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study. Cancer 125(3):365-373, 2019. e-Pub 2019. PMID: 30359480.
84. Mathur SC, Fitzmaurice M, Reder NP, Krishnamurthy S, Kennedy M, Tearney GJ, Shevchuk-Chaban MM. Development of Functional Requirements for Ex Vivo Pathology Applications of In Vivo Microscopy System: A Proposal From the In Vivo Microscopy Committee of the College of American Pathologists. Arch Pathol Lab Med. e-Pub 2019. PMID: 30763117.
85. Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, Aure MR, Lingjærde OC, Langerød A, Ringnér M, Ahn SM, Boyault S, Brock JE, Broeks A, Butler A, Desmedt C, Dirix L, Dronov S, Fatima A, Foekens JA, Gerstung M, Hooijer GKJ, Jang SJ, Jones DR, Kim HY, King TA, Krishnamurthy S, Lee HJ, Lee JY, Li Y, McLaren S, Menzies A, Mustonen V, O'Meara S, Pauporté I, Pivot X, Purdie CA, Raine K, Ramakrishnan K, Rodríguez-González FG, Romieu G, Sieuwerts AM, Simpson PT, Shepherd R, Stebbings L, Stefansson OA, Teague J, Tommasi S, Treilleux I, Van den Eynden GG, Vermeulen P, Vincent-Salomon A, Yates L, Caldas C, Van't Veer L, Tutt A, Knappskog S, Tan BKT, Jonkers J, Å B, Ueno NT, Sotiriou C, Viari A, Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE, Thompson AM, Birney E, Stunnenberg HG, van de Vijver MJ, Martens JWM, Børresen-Dale AL, Richardson AL, Kong G, Thomas G, Stratton MR. Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 566(7742):E1, 2019. e-Pub 2019. PMID: 30659290.
86. Ning J, Fouad TM, Lin H, Sahin AA, Lucci A, Woodward WA, Krishnamurthy S, Tripathy D, Ueno NT, Shen Y. The impact of Ki-67 in the context of multidisciplinary care in primary inflammatory breast cancer. J Cancer 10(12):2635-2642, 2019. e-Pub 2019. PMID: 31258771.
87. Wells WA, Thrall M, Sorokina A, Fine J, Krishnamurthy S, Haroon A, Rao B, Shevchuk MM, Wolfsen HC, Tearney GJ, Hariri LP. In Vivo and Ex Vivo Microscopy: Moving Toward the Integration of Optical Imaging Technologies Into Pathology Practice. Arch Pathol Lab Med. e-Pub 2018. PMID: 30525931.
88. Hudspeth TN, Shin K, Babiera GV, Krishnamurthy S, Woodtichartpreecha P, Karbasian N, Whitman GJ. A Pictorial Review of Sonography of Intramammary Lymph Nodes: When to Care and What to Do About It. Ultrasound Q. e-Pub 2018. PMID: 30516732.
89. Krishnamurthy S, Ban K, Shaw K, Mills G, Sheth R, Tam A, Gupta S, Sabir S. Confocal Fluorescence Microscopy Platform Suitable for Rapid Evaluation of Small Fragments of Tissue in Surgical Pathology Practice. Arch Pathol Lab Med. e-Pub 2018. PMID: 30376375.
90. Matsuda N, Wang X, Lim B, Krishnamurthy S, Alvarez RH, Willey JS, Parker CA, Song J, Shen Y, Hu J, Wu W, Li N, Babiera GV, Murray JL, Arun BK, Brewster AM, Reuben JM, Stauder MC, Barnett CM, Woodward WA, Le-Petross HTC, Lucci A, DeSnyder SM, Tripathy D, Valero V, Ueno NT. Safety and Efficacy of Panitumumab Plus Neoadjuvant Chemotherapy in Patients With Primary HER2-Negative Inflammatory Breast Cancer. JAMA Oncol 4(9):1207-1213, 2018. e-Pub 2018. PMID: 29879283.
91. Reddy JP, Atkinson RL, Larson R, Burks JK, Smith D, Debeb BG, Ruffell B, Creighton CJ, Bambhroliya A, Reuben JM, Van Laere SJ, Krishnamurthy S, Symmans WF, Brewster AM, Woodward WA. Mammary stem cell and macrophage markers are enriched in normal tissue adjacent to inflammatory breast cancer. Breast Cancer Res Treat. e-Pub 2018. PMID: 29858753.
92. Rauch GM, Kuerer HM, Adrada B, Santiago L, Moseley T, Candelaria RP, Arribas E, Sun J, Leung JWT, Krishnamurthy S, Yang WT. Biopsy Feasibility Trial for Breast Cancer Pathologic Complete Response Detection after Neoadjuvant Chemotherapy: Imaging Assessment and Correlation Endpoints. Ann Surg Oncol. e-Pub 2018. PMID: 29667115.
93. Ding Q, Wang Y, Zuo Z, Gong Y, Krishnamurthy S, Li CW, Lai YJ, Wei W, Wang J, Manyam GC, Diao L, Zhang X, Lin F, Symmans WF, Sun L, Liu CG, Liu X, Debeb BG, Ueno NT, Harano K, Alvarez RH, Wu Y, Cristofanilli M, Huo L. Decreased expression of microRNA-26b in locally advanced and inflammatory breast cancer. Hum Pathol. e-Pub 2018. PMID: 29689244.
94. Krishnamurthy S, Cortes A, Lopez M, Wallace M, Sabir S, Shaw K, Mills G. Ex Vivo Confocal Fluorescence Microscopy for Rapid Evaluation of Tissues in Surgical Pathology Practice. Arch Pathol Lab Med 142(3):396-401, 2018. e-Pub 2018. PMID: 29266968.
95. Smith AL, Williams MD, Stewart J, Wang WL, Krishnamurthy S, Cabanillas ME, Roy-Chowdhuri S. Utility of the BRAF p.V600E immunoperoxidase stain in FNA direct smears and cell block preparations from patients with thyroid carcinoma. Cancer Cytopathol. e-Pub 2018. PMID: 29579361.
96. Lee J, Geiss GK, Demirkan G, Vellano CP, Filanoski B, Lu Y, Ju Z, Yu S, Guo H, Bogatzki LY, Carter WE, Meredith RK, Krishnamurthy S, Ding Z, Beechem JM, Mills G. Implementation of a Multiplex and Quantitative Proteomics Platform for Assessing Protein Lysates Using DNA-Barcoded Antibodies. Mol Cell Proteomics. e-Pub 2018. PMID: 29531020.
97. Kalambo M, Adrada BE, Adeyefa MM, Krishnamurthy S, Hess K, Carkaci S, Whitman GJ. Phyllodes Tumor of the Breast: Ultrasound-Pathology Correlation. AJR Am J Roentgenol:W1-W7. e-Pub 2018. PMID: 29412020.
98. van la Parra RFD, Tadros AB, Checka CM, Rauch GM, Jr LA, Smith BD, Krishnamurthy S, Valero V, Yang WT, Kuerer HM. Baseline factors predicting a response to neoadjuvant chemotherapy with implications for non-surgical management of triple-negative breast cancer. Br J Surg. e-Pub 2018. PMID: 29465744.
99. Iftimia N, Park J, Maguluri G, Krishnamurthy S, McWatters A, Sabir SH. Investigation of tissue cellularity at the tip of the core biopsy needle with optical coherence tomography. Biomed Opt Express 9(2):694-704, 2018. e-Pub 2018. PMID: 29552405.
100. Yamauchi T, Espinosa Fernandez JR, Imamura CK, Yamauchi H, Jinno H, Takahashi M, Kitagawa Y, Nakamura S, Lim B, Krishnamurthy S, Reuben JM, Liu D, Tripathy D, Chen H, Takebe N, Saya H, Ueno NT. Dynamic changes in CD44v-positive cells after preoperative anti-HER2 therapy and its correlation with pathologic complete response in HER2-positive breast cancer. Oncotarget 9(6):6872-6882, 2018. e-Pub 2018. PMID: 29467936.
101. Fouad TM, Ueno NT, Yu RK, Ensor JE, Alvarez RH, Krishnamurthy S, Lucci A, Reuben JM, Yang W, Willey JS, Valero V, Bondy ML, Cristofinalli M, Shete S, Woodward WA, El-Zein R. Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Center. PLoS One 13(9):e0204372, 2018. e-Pub 2018. PMID: 30248155.
102. Harano K, Wang Y, Lim B, Seitz RS, Morris SW, Bailey DB, Hout DR, Skelton RL, Ring BZ, Masuda H, Rao AUK, Laere SV, Bertucci F, Woodward WA, Reuben JM, Krishnamurthy S, Ueno NT. Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype. PLoS One 13(10):e0204513, 2018. e-Pub 2018. PMID: 30312311.
103. Ueno NT, Espinosa Fernandez JR, Cristofanilli M, Overmoyer B, Rea D, Berdichevski F, El-Shinawi M, Bellon J, Le-Petross HT, Lucci A, Babiera G, DeSnyder SM, Teshome M, Chang E, Lim B, Krishnamurthy S, Stauder MC, Parmar S, Mohamed MM, Alexander A, Valero V, Woodward WA. International Consensus on the Clinical Management of Inflammatory Breast Cancer from the Morgan Welch Inflammatory Breast Cancer Research Program 10th Anniversary Conference. J Cancer 9(8):1437-1447, 2018. e-Pub 2018. PMID: 29721054.
104. Kuerer HM, Krishnamurthy S, Rauch GM, Yang WT, Smith BD, Valero V. Optimal Selection of Breast Cancer Patients for Elimination of Surgery Following Neoadjuvant Systemic Therapy. Ann Surg. e-Pub 2017. PMID: 29064904.
105. Candelaria RP, Krishnamurthy S, Huang ML, Santiago L, Adrada BE. Imaging and pathological findings in a case of invasive squamous cell carcinoma of the breast. Breast J. e-Pub 2017. PMID: 28727282.
106. Tadros AB, Smith BD, Shen Y, Lin H, Krishnamurthy S, Lucci A, Barcenas CH, Hwang RF, Rauch G, Santiago L, Strom EA, DeSnyder SM, Yang WT, Black DM, Albarracin CT, Chavez-MacGregor M, Hunt KK, Kuerer HM. Ductal Carcinoma In Situ and Margins <2?mm: Contemporary Outcomes With Breast Conservation. Ann Surg. e-Pub 2017. PMID: 28742682.
107. Bado I, Nikolos F, Rajapaksa G, Wu W, Castaneda J, Krishnamurthy S, Webb P, JÅ G, Thomas C. Somatic loss of estrogen receptor beta and p53 synergize to induce breast tumorigenesis. Breast Cancer Res 19(1):79, 2017. e-Pub 2017. PMID: 28673316.
108. DeSnyder SM, Mittendorf EA, Le-Petross C, Krishnamurthy S, Whitman GJ, Ueno NT, Woodward WA, Kuerer HM, Akay CL, Babiera GV, Yang W, Lucci A. Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer. Clin Breast Cancer. e-Pub 2017. PMID: 28755879.
109. Ruiz-Cordero R, Jorgensen JL, Krishnamurthy S, Landon G. A common complication of myelofibrosis presenting as a rare finding in cerebrospinal fluid cytology. Diagn Cytopathol. e-Pub 2017. PMID: 28603913.
110. Weston BR, Ross WA, Bhutani MS, Lee JH, Pande M, Sholl AB, Krishnamurthy S. Prospective randomized comparison of a 22G core needle using standard versus capillary suction for EUS-guided sampling of solid pancreatic masses. Endosc Int Open 5(6):E505-E512, 2017. e-Pub 2017. PMID: 28596983.
111. Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Black DM, Santiago L, Hobbs BP, Lucci A, Gilcrease M, Hwang RF, Candelaria RP, Chavez-MacGregor M, Smith BD, Arribas E, Moseley T, Teshome M, Miggins MV, Valero V, Hunt KK, Yang WT. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg. e-Pub 2017. PMID: 28549010.
112. Harao M, Forget MA, Roszik J, Gao H, Babiera GV, Krishnamurthy S, Chacon JA, Li S, Mittendorf EA, DeSnyder SM, Rockwood KF, Bernatchez C, Ueno NT, Radvanyi LG, Vence L, Haymaker C, Reuben JM. 4-1BB-enhanced expansion of CD8+ TIL from triple-negative breast cancer unveils mutation-specific CD8+ T cells. Cancer Immunol Res. e-Pub 2017. PMID: 28473315.
113. Tadros AB, Yang WT, Krishnamurthy S, Rauch GM, Smith BD, Valero V, Black DM, Lucci A, Caudle AS, DeSnyder SM, Teshome M, Barcenas CH, Miggins M, Adrada BE, Moseley T, Hwang RF, Hunt KK, Kuerer HM. Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery. JAMA Surg. e-Pub 2017. PMID: 28423171.
114. Reyes ME, Fujii T, Branstetter D, Krishnamurthy S, Masuda H, Wang X, Reuben JM, Woodward WA, Edwards BJ, Hortobagyi GN, Tripathy D, Dougall WC, Eckhardt BL, Ueno NT. Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression. Breast Cancer Res Treat. e-Pub 2017. PMID: 28417335.
115. Matsuda N, Lim B, Wang Y, Krishnamurthy S, Woodward W, Alvarez RH, Lucci A, Valero V, Reuben JM, Meric-Bernstam F, Ueno NT. Identification of frequent somatic mutations in inflammatory breast cancer. Breast Cancer Res Treat. e-Pub 2017. PMID: 28243898.
116. Lih CJ, Harrington RD, Sims DJ, Harper KN, Bouk CH, Datta V, Yau J, Singh RR, Routbort MJ, Luthra R, Patel KP, Mantha GS, Krishnamurthy S, Ronski K, Walther Z, Finberg KE, Canosa S, Robinson H, Raymond A, Le LP, McShane LM, Polley EC, Conley BA, Doroshow JH, Iafrate AJ, Sklar JL, Hamilton SR, Williams PM. Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial: Molecular Analysis for Therapy Choice Clinical Trial. J Mol Diagn. e-Pub 2017. PMID: 28188106.
117. Roy-Chowdhuri S, Chen H, Singh RR, Krishnamurthy S, Patel KP, Routbort MJ, Manekia J, Barkoh BA, Yao H, Sabir S, Broaddus RR, Medeiros LJ, Staerkel G, Stewart J, Luthra R. Concurrent fine needle aspirations and core needle biopsies: a comparative study of substrates for next-generation sequencing in solid organ malignancies. Mod Pathol. e-Pub 2017. PMID: 28084342.
118. Alexander A, Karakas C, Chen X, Carey JP, Yi M, Bondy M, Thompson P, Cheung KL, Ellis IO, Gong Y, Krishnamurthy S, Alvarez RH, Ueno NT, Hunt KK, Keyomarsi K. Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer. Oncotarget. e-Pub 2017. PMID: 28107181.
119. Woodward WA, Cristofanilli M, Merajver SD, Van Laere S, Pusztai L, Bertucci F, Berditchevski F, Polyak K, Overmoyer B, Devi GR, Sterneck E, Schneider R, Debeb BG, Wang X, van Golen KL, El-Zein R, Rahal OM, Alexander A, Reuben JM, Krishnamurthy S, Lucci A, Ueno NT. Scientific Summary from the Morgan Welch MD Anderson Cancer Center Inflammatory Breast Cancer (IBC) Program 10th Anniversary Conference. J Cancer 8(17):3607-3614, 2017. e-Pub 2017. PMID: 29667990.
120. Sabir SH, Krishnamurthy S, Gupta S, Mills GB, Wei W, Cortes AC, Mills Shaw KR, Luthra R, Wallace MJ. Characteristics of percutaneous core biopsies adequate for next generation genomic sequencing. PLoS One 12(12):e0189651, 2017. e-Pub 2017. PMID: 29281680.
121. Debnam JM, Kwon M, Fornage BD, Krishnamurthy S, Clayman GL, Edeiken-Monroe BS. Sonographic Evaluation of Intrathyroid Metastases. J Ultrasound Med. e-Pub 2016. PMID: 27925648.
122. Krishnamurthy S, Bevers T, Kuerer HM, Smith B, Yang WT. Paradigm Shifts in Breast Care Delivery: Impact of Imaging in a Multidisciplinary Environment. AJR Am J Roentgenol:1-8. e-Pub 2016. PMID: 27929664.
123. Dobroff AS, D'Angelo S, Eckhardt BL, Ferrara F, Staquicini DI, Cardó-Vila M, Staquicini FI, Nunes DN, Kim K, Driessen WH, Hajitou A, Lomo LC, Barry M, Krishnamurthy S, Sahin A, Woodward WA, Prossnitz ER, Anderson RL, Dias-Neto E, Brown-Glaberman UA, Royce ME, Ueno NT, Cristofanilli M, Hortobagyi GN, Marchiò S, Gelovani JG, Sidman RL, Arap W, Pasqualini R. Towards a transcriptome-based theranostic platform for unfavorable breast cancer phenotypes. Proc Natl Acad Sci U S A. e-Pub 2016. PMID: 27791177.
124. Shin K, Caudle AS, Kuerer HM, Santiago L, Candelaria RP, Dogan B, Leung J, Krishnamurthy S, Yang W. Radiologic Mapping for Targeted Axillary Dissection: Needle Biopsy to Excision. AJR Am J Roentgenol:1-8. e-Pub 2016. PMID: 27726422.
125. Dobbs JL, Shin D, Krishnamurthy S, Kuerer H, Yang W, Richards-Kortum R. Confocal fluorescence microscopy to evaluate changes in adipocytes in the tumor microenvironment associated with invasive ductal carcinoma and ductal carcinoma in situ. Int J Cancer 139(5):1140-9, 2016. e-Pub 2016. PMID: 27116366.
126. Debeb BG, Lacerda L, Anfossi S, Diagaradjane P, Chu K, Bambhroliya A, Huo L, Wei C, Larson RA, Wolfe AR, Xu W, Smith DL, Li L, Ivan C, Allen PK, Wu W, Calin GA, Krishnamurthy S, Zhang XH, Buchholz TA, Ueno NT, Reuben JM, Woodward WA. miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer. J Natl Cancer Inst 108(8), 2016. e-Pub 2016. PMID: 27075851.
127. Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M, Brinkman AB, Morganella S, Aure MR, Lingjærde OC, Langerød A, Ringnér M, Ahn SM, Boyault S, Brock JE, Broeks A, Butler A, Desmedt C, Dirix L, Dronov S, Fatima A, Foekens JA, Gerstung M, Hooijer GK, Jang SJ, Jones DR, Kim HY, King TA, Krishnamurthy S, Lee HJ, Lee JY, Li Y, McLaren S, Menzies A, Mustonen V, O'Meara S, Pauporté I, Pivot X, Purdie CA, Raine K, Ramakrishnan K, Rodríguez-González FG, Romieu G, Sieuwerts AM, Simpson PT, Shepherd R, Stebbings L, Stefansson OA, Teague J, Tommasi S, Treilleux I, Van den Eynden GG, Vermeulen P, Vincent-Salomon A, Yates L, Caldas C, Veer LV, Tutt A, Knappskog S, Tan BK, Jonkers J, Å B, Ueno NT, Sotiriou C, Viari A, Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE, Thompson AM, Birney E, Stunnenberg HG, van de Vijver MJ, Martens JW, Børresen-Dale AL, Richardson AL, Kong G, Thomas G, Stratton MR. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. e-Pub 2016. PMID: 27135926.
128. Raj SD, Amer AM, Garg N, Krishnamurthy S, Hess KR, Park YM, Moseley T, Whitman GJ. Incidental Suspicious Regional Lymph Nodes on Breast Sonography: Is Sampling Necessary?. Curr Probl Diagn Radiol. e-Pub 2016. PMID: 27338308.
129. Debeb BG, Lacerda L, Larson R, Wolfe AR, Krishnamurthy S, Reuben JM, Ueno NT, Gilcrease M, Woodward WA. Histone deacetylase inhibitor-induced cancer stem cells exhibit high pentose phosphate pathway metabolism. Oncotarget. e-Pub 2016. PMID: 27078845.
130. Kuerer HM, Yang WT, Krishnamurthy S. Comment on 'Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques'. Br J Cancer. e-Pub 2016. PMID: 27092783.
131. Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, Bedrosian I, Hobbs BP, DeSnyder SM, Hwang RF, Adrada BE, Shaitelman SF, Chavez-MacGregor M, Smith BD, Candelaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Kuerer HM. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol 34(10):1072-8, 2016. e-Pub 2016. PMID: 26811528.
132. Huo L, Wang Y, Gong Y, Krishnamurthy S, Wang J, Diao L, Liu CG, Liu X, Lin F, Symmans WF, Wei W, Zhang X, Sun L, Alvarez RH, Ueno NT, Fouad TM, Harano K, Debeb BG, Wu Y, Reuben J, Cristofanilli M, Zuo Z. MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. Mod Pathol 29(4):330-46, 2016. e-Pub 2016. PMID: 26916073.
133. Krishnamurthy, S. Current status of clinical genomics in patients with metastatic breast cancer. Breast Diseases: A Year Book Quarterly 27(3):182-186, 2016. e-Pub 2016.
134. Raghav K, French JT, Ueno NT, Lei X, Krishnamurthy S, Reuben JM, Valero V, Ibrahim NK. Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction. PLoS One 11(1):e0145534, 2016. e-Pub 2016. PMID: 26752563.
135. Roy-Chowdhuri S, Chow CW, Kane MK, Yao H, Wistuba II, Krishnamurthy S, Stewart J, Staerkel G. Optimizing the DNA yield for molecular analysis from cytologic preparations. Cancer Cytopathol. e-Pub 2015. PMID: 26630358.
136. Hall CS, Karhade M, Laubacher BA, Kuerer HM, Krishnamurthy S, DeSnyder S, Anderson AE, Valero V, Ueno NT, Yisheng L, Xiao S, Lucci A. Circulating Tumor Cells and Recurrence After Primary Systemic Therapy in Stage III Inflammatory Breast Cancer. J Natl Cancer Inst 107(11), 2015. e-Pub 2015. PMID: 26374427.
137. Dogan BE, Dryden MJ, Wei W, Fornage BD, Buchholz TA, Smith B, Hunt K, Krishnamurthy S, Yang WT. Sonography and Sonographically Guided Needle Biopsy of Internal Mammary Nodes in Staging of Patients With Breast Cancer. AJR Am J Roentgenol 205(4):905-911, 2015. e-Pub 2015. PMID: 26397343.
138. Rauch GM, Hobbs BP, Kuerer HM, Scoggins ME, Benveniste AP, Park YM, Caudle AS, Fox PS, Smith BD, Adrada BE, Krishnamurthy S, Yang WT. Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence. Ann Surg Oncol. e-Pub 2015. PMID: 26416712.
139. Shaitelman SF, Tereffe W, Dogan BE, Hess KR, Caudle AS, Valero V, Stauder MC, Krishnamurthy S, Candelaria RP, Strom EA, Woodward WA, Hunt KK, Buchholz TA, Whitman GJ. Role of Ultrasonography of Regional Nodal Basins in Staging Triple-Negative Breast Cancer and Implications For Local-Regional Treatment. Int J Radiat Oncol Biol Phys 93(1):102-10, 2015. e-Pub 2015. PMID: 26279028.
140. Fouad TM, Kogawa T, Liu DD, Shen Y, Masuda H, El-Zein R, Woodward WA, Chavez-MacGregor M, Alvarez RH, Arun B, Lucci A, Krishnamurthy S, Babiera G, Buchholz TA, Valero V, Ueno NT. Erratum to: Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis. Breast Cancer Res Treat 152(2):417, 2015. e-Pub 2015. PMID: 26092296.
141. Fouad TM, Kogawa T, Liu DD, Shen Y, Masuda H, El-Zein R, Woodward WA, Chavez-MacGregor M, Alvarez RH, Arun B, Lucci A, Krishnamurthy S, Babiera G, Buchholz TA, Valero V, Ueno NT. Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis. Breast Cancer Res Treat. e-Pub 2015. PMID: 26017070.
142. Huang SY, Ahrar K, Gupta S, Wallace MJ, Ensor JE, Krishnamurthy S, Matin SF. Safety and Diagnostic Accuracy of Percutaneous Biopsy in Upper Tract Urothelial Carcinoma. BJU Int 115(4):625-32, 2015. e-Pub 2015. PMID: 24905868.
143. Scoggins ME, Fox PS, Kuerer HM, Rauch GM, Benveniste AP, Park YM, Lari SA, Krishnamurthy S, Yang WT. Correlation between sonographic findings and clinicopathologic and biologic features of pure ductal carcinoma in situ in 691 patients. AJR Am J Roentgenol 204(4):878-88, 2015. e-Pub 2015. PMID: 25794082.
144. Francis AM, Haugen CE, Grimes LM, Crow JR, Yi M, Mittendorf EA, Bedrosian I, Caudle AS, Babiera GV, Krishnamurthy S, Kuerer HM, Hunt KK. Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?. Ann Surg Oncol. e-Pub 2015. PMID: 25905585.
145. Krishnamurthy S. Biospecimen repositories and cytopathology. Cancer Cytopathol 123(3):152-61, 2015. e-Pub 2015. PMID: 25524469.
146. Gonzalez-Angulo AM, Lei X, Alvarez RH, Green MC, Murray JL, Valero V, Koenig KB, Ibrahim NK, Litton JK, Nair L, Krishnamurthy S, Hortobagyi GN, Meric-Bernstam F. Phase II Randomized Study of Ixabepilone Versus Observation in Patients With Significant Residual Disease After Neoadjuvant Systemic Therapy for HER2-Negative Breast Cancer. Clin Breast Cancer. e-Pub 2015. PMID: 25913905.
147. Caudle AS, Yang WT, Mittendorf EA, Black DM, Hwang R, Hobbs B, Hunt KK, Krishnamurthy S, Kuerer HM. Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial. JAMA Surg 150(2):137-43, 2015. e-Pub 2015. PMID: 25517573.
148. Dobbs J, Krishnamurthy S, Kyrish M, Benveniste AP, Yang W, Richards-Kortum R. Confocal fluorescence microscopy for rapid evaluation of invasive tumor cellularity of inflammatory breast carcinoma core needle biopsies. Breast Cancer Res Treat 149(1):303-10, 2015. e-Pub 2015. PMID: 25417171.
149. Lacerda L, Debeb BG, Smith D, Larson R, Solley T, Xu W, Krishnamurthy S, Gong Y, Levy LB, Buchholz T, Ueno NT, Klopp A, Woodward WA. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model. Breast Cancer Res 17(1):42, 2015. e-Pub 2015. PMID: 25887413.
150. Dobbs JL, Mueller JL, Krishnamurthy S, Shin D, Kuerer H, Yang W, Ramanujam N, Richards-Kortum R. Micro-anatomical quantitative optical imaging: toward automated assessment of breast tissues. Breast Cancer Res 17:105, 2015. e-Pub 2015. PMID: 26290094.
151. Cohen EN, Gao H, Anfossi S, Mego M, Reddy NG, Debeb B, Giordano A, Tin S, Wu Q, Garza RJ, Cristofanilli M, Mani SA, Croix DA, Ueno NT, Woodward WA, Luthra R, Krishnamurthy S, Reuben JM. Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition in Inflammatory Breast Cancer Cells. PLoS One 10(7):e0132710, 2015. e-Pub 2015. PMID: 26207636.
152. Wilbur DC, Brachtel EF, Gilbertson JR, Jones NC, Vallone JG, Krishnamurthy S. Whole slide imaging for human epidermal growth factor receptor 2 immunohistochemistry interpretation: Accuracy, Precision, and reproducibility studies for digital manual and paired glass slide manual interpretation. J Pathol Inform 6:22, 2015. e-Pub 2015. PMID: 26110090.
153. Adrada BE, Krishnamurthy S, Carkaci S, Posleman-Monetto FE, Ewere A, Whitman GJ. Unusual Benign Tumors of the Breast. J Clin Imaging Sci 5:27, 2015. e-Pub 2015. PMID: 26085959.
154. Malowany JI, Kundu U, Santiago L, Krishnamurthy S. Fine-needle aspiration detects primary neuroendocrine carcinoma of the breast in a patient with breast implants. Cytojournal 12:1, 2015. e-Pub 2015. PMID: 25685170.
155. Roy-Chowdhuri S, Krishnamurthy S. The role of cytology in the era of HPV-related head and neck carcinoma. Semin Diagn Pathol. e-Pub 2014. PMID: 25638437.
156. Caudle AS, Kuerer HM, Le-Petross HT, Yang W, Yi M, Bedrosian I, Krishnamurthy S, Fornage BD, Hunt KK, Mittendorf EA. Predicting the extent of nodal disease in early-stage breast cancer. Ann Surg Oncol 21(11):3440-7, 2014. e-Pub 2014. PMID: 24859939.
157. Mosalpuria K, Hall C, Krishnamurthy S, Lodhi A, Hallman DM, Baraniuk MS, Bhattacharyya A, Lucci A. Cyclooxygenase-2 expression in non-metastatic triple-negative breast cancer patients. Mol Clin Oncol 2(5):845-850, 2014. e-Pub 2014. PMID: 25054056.
158. Karhade M, Hall C, Mishra P, Anderson A, Kuerer H, Bedrosian I, Krishnamurthy S, Lucci A. Circulating tumor cells in non-metastatic triple-negative breast cancer. Breast Cancer Res Treat 147(2):325-33, 2014. e-Pub 2014. PMID: 25164970.
159. Mittendorf EA, Caudle AS, Yang W, Krishnamurthy S, Shaitelman S, Chavez-MacGregor M, Woodward WA, Bedrosian I, Kuerer HM, Hunt KK. Implementation of the american college of surgeons oncology group Z1071 trial data in clinical practice: Is there a way forward for sentinel lymph node dissection in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy?. Ann Surg Oncol 21(8):2468-73, 2014. e-Pub 2014. PMID: 24841348.
160. Meric-Bernstam F, Akcakanat A, Chen H, Sahin A, Tarco E, Carkaci S, Adrada BE, Singh G, Do KA, Garces ZM, Mittendorf E, Babiera G, Bedrosian I, Hwang R, Krishnamurthy S, Symmans WF, Gonzalez-Angulo AM, Mills GB. Influence of biospecimen variables on proteomic biomarkers in breast cancer. Clin Cancer Res 20(14):3870-83, 2014. e-Pub 2014. PMID: 24895461.
161. Kunda U, Weston B, Lee J, Hofstetter W, Krishnamurthy S. Evolving role of endoscopic ultrasonography–guided fine-needle aspiration in tumor staging and treatment of patients with carcinomas of the upper gastrointestinal tract. Journal of the American Society of Cytopathology 3(1):29-36, 2014. e-Pub 2014.
162. Woodward WA, Krishnamurthy S, Lodhi A, Xiao L, Gong Y, Cristofanilli M, Buchholz TA, Lucci A. Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cells. J Cancer 5(5):360-7, 2014. e-Pub 2014. PMID: 24799954.
163. Fitzsullivan E, Lari SA, Smith B, Caudle AS, Krishnamurthy S, Lucci A, Mittendorf EA, Babiera GV, Black DM, Wagner JL, Bedrosian I, Woodward W, Gainer SM, Hwang R, Meric-Bernstam F, Hunt KK, Kuerer HM. Incidence and Consequence of Close Margins in Patients with Ductal Carcinoma in Situ Treated with Mastectomy: Is Further Therapy Warranted?. Ann Surg Oncol 20(13):4103-12, 2013. e-Pub 2013. PMID: 23975313.
164. Meric-Bernstam F, Rasmussen JC, Krishnamurthy S, Tan IC, Zhu B, Wagner JL, Babiera GV, Mittendorf EA, Sevick-Muraca EM. Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agents. Biomed Opt Express 5(1):183-96, 2013. e-Pub 2013. PMID: 24466486.
165. Bertucci F, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM, Marsan M, Iwamoto T, Krishnamurthy S, Masuda H, Van Dam P, Woodward WA, Cristofanilli M, Reuben JM, Dirix L, Viens P, Symmans WF, Birnbaum D, Van Laere SJ. Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival. Ann Oncol. e-Pub 2013. PMID: 24299959.
166. Masuda H, Baggerly KA, Wang Y, Iwamoto T, Brewer T, Pusztai L, Kai K, Kogawa T, Finetti P, Birnbaum D, Dirix L, Woodward WA, Reuben JM, Krishnamurthy S, Symmans WF, Van Laere SJ, Bertucci F, Hortobagyi GN, Ueno NT. Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers. Breast Cancer Res 15(6):R112. e-Pub 2013. PMID: 24274653.
167. Krishnamurthy S, Mathews K, McClure S, Murray M, Gilcrease M, Albarracin C, Spinosa J, Chang B, Ho J, Holt J, Cohen A, Giri D, Garg K, Bassett RL, Liang K. Multi-Institutional Comparison of Whole Slide Digital Imaging and Optical Microscopy for Interpretation of Hematoxylin-Eosin-Stained Breast Tissue Sections. Arch Pathol Lab Med. e-Pub 2013. PMID: 23947655.
168. Van Laere SJ, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM, Marsan M, Iwamoto T, Krishnamurthy S, Masuda H, van Dam P, Woodward WA, Viens P, Cristofanilli M, Birnbaum D, Dirix L, Reuben JM, Bertucci F. Uncovering the molecular secrets of Inflammatory Breast Cancer biology: An integrated analysis of three distinct Affymetrix gene expression data sets. Clin Cancer Res. e-Pub 2013. PMID: 23396049.
169. Lee S, Skelton TS, Zheng F, Schwartz KA, Perrier ND, Lee JE, Bassett RL, Ahmed S, Krishnamurthy S, Busaidy NL, Grubbs EG. The biopsy-proven benign thyroid nodule: Is long-term follow-up necessary?. J Am Coll Surg 217(1):81-8, 2013. e-Pub 2013. PMID: 23659946.
170. Rauch GM, Kuerer HM, Scoggins ME, Fox PS, Benveniste AP, Park YM, Lari SA, Hobbs BP, Adrada BE, Krishnamurthy S, Yang WT. Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status. Breast Cancer Res Treat 139(3):639-47, 2013. e-Pub 2013. PMID: 23774990.
171. Giordano A, Gao H, Cohen EN, Anfossi S, Khoury J, Hess K, Krishnamurthy S, Tin S, Cristofanilli M, Hortobagyi GN, Woodward WA, Lucci A, Reuben JM. Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients. Ann Oncol. e-Pub 2013. PMID: 23798614.
172. Tsai CJ, Li J, Gonzalez-Angulo AM, Allen PK, Woodward WA, Ueno NT, Lucci A, Krishnamurthy S, Gong Y, Yang W, Cristofanilli M, Valero V, Buchholz TA. Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy. Am J Clin Oncol. e-Pub 2013. PMID: 23648437.
173. Krishnamurthy S, Bischoff F, Ann Mayer J, Wong K, Pham T, Kuerer H, Lodhi A, Bhattacharyya A, Hall C, Lucci A. Discordance in HER2 gene amplification in circulating and disseminated tumor cells in patients with operable breast cancer. Cancer Med 2(2):226-33, 2013. e-Pub 2013. PMID: 23634290.
174. Woodward WA, Krishnamurthy S, Yamauchi H, El-Zein R, Ogura D, Kitadai E, Niwa S, Cristofanilli M, Vermeulen P, Dirix L, Viens P, van Laere S, Bertucci F, Reuben JM, Ueno NT. Genomic and expression analysis of microdissected inflammatory breast cancer. Breast Cancer Res Treat 138(3):761-72, 2013. e-Pub 2013. PMID: 23568481.
175. Scoggins M, Krishnamurthy S, Santiago L, Yang W. Lobular carcinoma in situ of the breast: clinical, radiological, and pathological correlation. Acad Radiol 20(4):463-70, 2013. e-Pub 2013. PMID: 23498988.
176. Dobbs JL, Ding H, Benveniste AP, Kuerer HM, Krishnamurthy S, Yang W, Richards-Kortum R. Feasibility of confocal fluorescence microscopy for real-time evaluation of neoplasia in fresh human breast tissue. J Biomed Opt 18(10):106016, 2013. e-Pub 2013. PMID: 24165742.
177. Xu W, Lacerda L, Debeb BG, Atkinson RL, Solley TN, Li L, Orton D, McMurray JS, Hang BI, Lee E, Klopp AH, Ueno NT, Reuben JM, Krishnamurthy S, Woodward WA. The antihelmintic drug pyrvinium pamoate targets aggressive breast cancer. PLoS One 8(8):e71508, 2013. e-Pub 2013. PMID: 24013655.
178. Krishnamurthy S, Woodward W, Yang W, Reuben JM, Tepperberg J, Ogura D, Niwa S, Huo L, Gong Y, El-Zein R, Gonzalez-Angulo AM, Chavez-Macgregor M, Alvarez R, Lucci A, Valero V, Ueno NT. Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma. Springerplus 2:409, 2013. e-Pub 2013. PMID: 24156086.
179. Thomas C, Rajapaksa G, Nikolos F, Hao R, Katchy A, McCollum CW, Bondesson M, Quinlan P, Thompson A, Krishnamurthy S, Esteva FJ, Gustafsson JA. ERβ1 represses basal-like breast cancer epithelial to mesenchymal transition by destabilizing EGFR. Breast Cancer Res 14(6):R148. e-Pub 2012. PMID: 23158001.
180. Dhillon J, Mohanty SK, Krishnamurthy S. Cytologic diagnosis of thyroid-like follicular carcinoma of the kidney: A case report. Diagn Cytopathol. e-Pub 2012. PMID: 23166108.
181. Debeb BG, Lacerda L, Xu W, Larson R, Solley T, Atkinson R, Sulman EP, Ueno NT, Krishnamurthy S, Reuben JM, Buchholz TA, Woodward WA. Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/β-catenin signaling. Stem Cells 30(11):2366-77, 2012. e-Pub 2012. PMID: 22961641.
182. Krishnamurthy S, Bhattacharyya A, Lodhi A, Hall CS, Bedrosian I, Kuerer HM, Lucci A. Use of disseminated tumor cells to predict outcome in patients with stage I-III breast cancer. J Clin Oncol 30(27_suppl):119, 2012. e-Pub 2012. PMID: 28146711.
183. Gainer SM, Lodhi AK, Bhattacharyya A, Krishnamurthy S, Kuerer HM, Lucci A. Invasive lobular carcinoma predicts micrometastasis in breast cancer. J Surg Res 177(1):93-6, 2012. e-Pub 2012. PMID: 22482764.
184. Lucci A, Hall CS, Lodhi AK, Bhattacharyya A, Anderson AE, Xiao L, Bedrosian I, Kuerer HM, Krishnamurthy S. Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol 13(7):688-95, 2012. e-Pub 2012. PMID: 22677156.
185. Bartholomeusz C, Oishi T, Saso H, Akar U, Liu P, Kondo K, Kazansky A, Krishnamurthy S, Lee J, Esteva FJ, Kigawa J, Ueno NT. MEK1/2 inhibitor selumetinib (AZD6244) inhibits growth of ovarian clear cell carcinoma in a PEA-15-dependent manner in a mouse xenograft model. Mol Cancer Ther 11(2):360-9, 2012. e-Pub 2012. PMID: 22144664.
186. Baltzell K, Buehring GC, Krishnamurthy S, Kuerer H, Shen HM, Sison JD. Epstein-Barr virus is seldom found in mammary epithelium of breast cancer tissue using in situ molecular methods. Breast Cancer Res Treat 132(1):267-74, 2012. e-Pub 2012. PMID: 22042367.
187. Lee J, Bartholomeusz C, Krishnamurthy S, Liu P, Saso H, Lafortune TA, Hortobagyi GN, Ueno NT. PEA-15 unphosphorylated at both serine 104 and serine 116 inhibits ovarian cancer cell tumorigenicity and progression through blocking β-catenin. Oncogenesis 1:e22, 2012. e-Pub 2012. PMID: 23552738.
188. Kelly CM, Bernard PS, Krishnamurthy S, Wang B, Ebbert MT, Bastien RR, Boucher KM, Young E, Iwamoto T, Pusztai L. Agreement in risk prediction between the 21-gene recurrence score assay (Oncotype DX®) and the PAM50 breast cancer intrinsic Classifier™ in early-stage estrogen receptor-positive breast cancer. Oncologist 17(4):492-8, 2012. e-Pub 2012. PMID: 22418568.
189. Le-Petross HT, Cristofanilli M, Carkaci S, Krishnamurthy S, Jackson EF, Harrell RK, Reed BJ, Yang WT. MRI features of inflammatory breast cancer. AJR Am J Roentgenol 197(4):W769-76, 2011. e-Pub 2011. PMID: 21940550.
190. Wagner JL, Fearmonti R, Hunt KK, Hwang RF, Meric-Bernstam F, Kuerer HM, Bedrosian I, Crosby MA, Baumann DP, Ross MI, Feig BW, Krishnamurthy S, Hernandez M, Babiera GV. Prospective Evaluation of the Nipple-Areola Complex Sparing Mastectomy for Risk Reduction and for Early-Stage Breast Cancer. Ann Surg Oncol, 2011. e-Pub 2011. PMID: 21979111.
191. Baltzell K, Buehring GC, Krishnamurthy S, Kuerer H, Shen HM, Sison JD. Limited evidence of human papillomavirus on breast tissue using molecular in situ methods. Cancer, 2011. e-Pub 2011. PMID: 21823105.
192. Kundu UR, S K. Use of the momoclonal antibody MOC-31 as an immunomarker for detecting metastatic adenocarcinoma in effusion cytology. Cancer Cytopathol 119(4):272-8, 2011. e-Pub 2011. PMID: 21732548.
193. Feldman S, Krishnamurthy S, Gillanders W, Gittleman M, Beitsch PD, Young PR, Streck CJ, Whitworth PW, Levine EA, Boolbol S, Han LK, Hermann R, Hoon DS, Giuliano AE, Meric-Bernstam F, Group US. A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes. Cancer 117(12):2599-607, 2011. e-Pub 2011. PMID: 21226034.
194. Hall C, Krishnamurthy S, Lodhi A, Bhattacharyya A, Anderson A, Kuerer H, Bedrosian I, Singh B, Lucci A. Disseminated tumor cells predict survival after neoadjuvant therapy in primary breast cancer. Cancer, 2011. e-Pub 2011. PMID: 21717428.
195. Krishnamurthy S, Bischoff FZ, Mayer JA, Wong K, Mikolajczyk S, Pham T, Kuerer HM, Lodhi A, Bhattacharyya A, Hall C, Lucci A. Detection of HER2 status of circulating tumor cells and disseminated tumor cells using a microfluidic platform (cell enrichment and extraction technology [CEE]). J Clin Oncol 29(15_suppl):613, 2011. e-Pub 2011. PMID: 28020641.
196. Hall C, Krishnamurthy S, Lodhi A, Bhattacharyya A, Anderson A, Kuerer HM, Bedrosian I, Lucci A. An evaluation of bone marrow stromal-derived growth factor-1 and interleukin-8 levels in patients with stage I-III breast cancer with disseminated tumor cells. J Clin Oncol 29(15_suppl):10610, 2011. e-Pub 2011. PMID: 28022917.
197. Bastien RR, Ebbert MT, Boucher KM, Kelly CM, Wang B, Iwamoto T, Krishnamurthy S, Pusztai L, Bernard PS. Using the PAM50 breast cancer intrinsic classifier to assess risk in ER+ breast cancers: A direct comparison to Oncotype DX. J Clin Oncol 29(15_suppl):503, 2011. e-Pub 2011. PMID: 28021372.
198. Bhattacharyya A, Krishnamurthy S, Lodhi A, Hall C, Anderson A, Kuerer HM, Bedrosian I, Alvarez RH, Ueno NT, Jackson S, Singh B, Lucci A. Use of HER2 amplification in the primary tumor to predict presence of circulating tumor cells in inflammatory breast cancer. J Clin Oncol 29(15_suppl):e11133, 2011. e-Pub 2011. PMID: 28023839.
199. Andreopoulou E, Yang LY, Rangel KM, Reuben JM, Hsu L, Krishnamurthy S, Valero V, Fritsche HA, Cristofanilli M. Comparison of assay methods for detection of circulating tumor cells (CTCs) in metastatic breast cancer (MBC): AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system. Int J Cancer 10:26111. e-Pub 2011. PMID: 21469140.
200. Reuben JM, Lee BN, Gao H, Cohen EN, Mego M, Giordano A, Wang X, Lodhi A, Krishnamurthy S, Hortobagyi GN, Cristofanilli M, Lucci A, Woodward WA. Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44(+)CD24(lo) cancer stem cell phenotype. Eur J Cancer 47(10). e-Pub 2011. PMID: 21334874.
201. Iwamoto T, Bianchini G, Qi Y, Cristofanilli M, Lucci A, Woodward WA, Reuben JM, Matsuoka J, Gong Y, Krishnamurthy S, Valero V, Hortobagyi GN, Robertson F, Symmans WF, Pusztai L, Ueno NT. Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer. Breast Cancer Res Treat 125(3):785-95, 2011. e-Pub 2011. PMID: 21153052.
202. Li J, Gonzalez-Angulo AM, Allen PK, Yu TK, Woodward WA, Ueno NT, Lucci A, Krishnamurthy S, Gong Y, Bondy ML, Yang W, Willey JS, Cristofanilli M, Valero V, Buchholz TA. Triple-negative subtype predicts poor overall survival and high locoregional relapse in inflammatory breast cancer. Oncologist 16(12):1675-83, 2011. e-Pub 2011. PMID: 22147002.
203. Robertson FM, Bondy M, Yang W, Yamauchi H, Wiggins S, Kamrudin S, Krishnamurthy S, Le-Petross H, Bidaut L, Player AN, Barsky SH, Woodward WA, Buchholz T, Lucci A, Ueno N, Cristofanilli M. Inflammatory Breast Cancer: The Disease, the Biology, the Treatment. CA Cancer J Clin 60(6):351-75, 2010. e-Pub 2010. PMID: 20959401.
204. Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M. International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol. e-Pub 2010. PMID: 20603440.
205. Klopp AH, Lacerda L, Gupta A, Debeb BG, Solley T, LI L, Spaeth E, Xu W, Zhang X, Lewis MT, Reuben JM, Krishnamurthy S, Ferrari M, Gaspar R, Buchholz TA, Cristofanilli M, Marini F, Andreeff M, Woodward WA. Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells. PLoS One 8(5), 2010. e-Pub 2010.
206. Dhillon J, Krishnamurthy S, Fuller GN. Papillary tumour of the pineal region: diagnosis by cytology smear. Cytopathology 21(4):267-9, 2010. e-Pub 2010. PMID: 19832879.
207. Krishnamurthy S, Cristofanilli M, Singh B, Reuben J, Gao H, Cohen EN, Andreopoulou E, Hall CS, Lodhi A, Jackson S, Lucci A. Detection of minimal residual disease in blood and bone marrow in early stage breast cancer. Cancer 116(14):3330-7, 2010. e-Pub 2010. PMID: 20564098.
208. Kelly CM, Krishnamurthy S, Bianchini G, Litton JK, Gonzalez-Angulo AM, Hortobagyi GN, Pusztai L. Utility of oncotype DX risk estimates in clinically intermediate risk hormone receptor-positive, HER2-normal, grade II, lymph node-negative breast cancers. Cancer 116(22):5161-7. e-Pub 2010. PMID: 20665886.
209. Gupta S, Sultenfuss M, Romaguera JE, Ensor J, Krishnamurthy S, Wallace MJ, Ahrar K, Madoff DC, Murthy R, Hicks ME. CT-guided percutaneous lung biopsies in patients with haematologic malignancies and undiagnosed pulmonary lesions. Hematol Oncol 28(2):75-81, 2010. e-Pub 2010. PMID: 19728397.
210. Hall C, Krishnamurthy S, Lodhi A, Mosalpuria K, Kuerer HM, Meric-Bernstam F, Bedrosian I, Hunt KK, Lucci A. Disseminated Tumor Cells in Biologic Subtypes of Stage I-III Breast Cancer Patients. Ann Surg Oncol 17(12):3252-8. e-Pub 2010. PMID: 20559739.
211. Bedrosian I, Babiera GV, Mittendorf EA, Kuerer HM, Pantoja L, Hunt KK, Krishnamurthy S, Meric-Bernstam F. A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients. Cancer 116(11):2543-8, 2010. e-Pub 2010. PMID: 20336790.
212. Reuben JM, Lee BN, Li C, Gao H, Broglio KR, Valero V, Jackson SA, Ueno NT, Krishnamurthy S, Hortobagyi GN, Cristofanilli M. Circulating tumor cells and biomarkers: implications for personalized targeted treatments for metastatic breast cancer. Breast J 16(3):327-30, 2010. e-Pub 2010. PMID: 20408820.
213. Sharma R, Bedrosian I, Lucci A, Hwang RF, Rourke LL, Qiao W, Buchholz TA, Kronowitz SJ, Krishnamurthy S, Babiera GV, Gonzalez-Angulo AM, Meric-Bernstam F, Mittendorf EA, Hunt KK, Kuerer HM. Present-Day Locoregional Control in Patients with T1 or T2 Breast Cancer with 0 and 1 to 3 Positive Lymph Nodes After Mastectomy Without Radiotherapy. Ann Surg Oncol 17(11):2899-908. e-Pub 2010. PMID: 20443145.
214. Avritscher R, Krishnamurthy S, Ensor J, Gupta S, Tam A, Madoff DC, Murthy R, Hicks ME, Wallace MJ. Accuracy and sensitivity of computed tomography-guided percutaneous needle biopsy of pulmonary hilar lymph nodes. Cancer 116(8):1974-80, 2010. e-Pub 2010. PMID: 20151422.
215. Singh B, Cook KR, Martin C, Huang EH, Mosalpuria K, Krishnamurthy S, Cristofanilli M, Lucci A. Evaluation of a CXCR4 antagonist in a xenograft mouse model of inflammatory breast cancer. Clin Exp Metastasis 27(4):233-40, 2010. e-Pub 2010. PMID: 20229045.
216. Bartholomeusz C, Gonzalez-Angulo AM, Kazansky A, Krishnamurthy S, Liu P, Yuan LX, Yamasaki F, Liu S, Hayashi N, Zhang D, Esteva FJ, Hortobagyi GN, Ueno NT. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase. Clin Cancer Res 16(6):1802-11, 2010. e-Pub 2010. PMID: 20215547.
217. Albarracin C, Edgerton ME, Gilcrease MZ, Huo L, Krishnamurthy S, Middleton LP, Resetkova E, Sahin AA, Sneige N, Fraser WS, Wu Y. Is it too soon to start reporting HER2 genetic heterogeneity?. Arch Pathol Lab Med 134(2):162-3; author reply 163, 2010. e-Pub 2010. PMID: 20121597.
218. Debeb BG, Zhang X, Krishnamurthy S, Gao H, Cohen E, Li L, Rodriguez AA, Landis MD, Lucci A, Ueno NT, Robertson F, Xu W, Lacerda L, Buchholz TA, Cristofanilli M, Reuben JM, Lewis MT, Woodward WA. Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Mol Cancer 9:180, 2010. e-Pub 2010. PMID: 20615238.
219. Krishnamurthy S. Current applications and future prospects of fine needle aspiration of locoregional lymph nodes in breast cancer. Cancer Cytophathol 6(117):451-62, 2009. e-Pub 2009.
220. Zhang D, LaFortune TA, Krishnamurthy S, Esteva FJ, Cristofanilli M, Liu P, Lucci A, Singh B, Hung MC, Hortobagyi GN, Ueno NT. EGFR Tyrosine Kinare inhibitor reverses mesaehymal to epitheiral phenotype and inhibits metastasis in inflammatory breast cancer. Clinical cancer research 21(15):6639-48, 2009. e-Pub 2009.
221. Reuben JM, Lee B, Lucci A, Gao H, Cohen EN, Li C, Krishnamurthy S, Hortobagyi GN, Woodward WA, Cristofanilli M. Disseminated tumor cells in primary breast cancer: Evaluation of the percentage of breast cancer stem cells in bone marrow aspirates of patients receiving neoadjuvant chemotherapy. J Clin Oncol 27(15_suppl):505, 2009. e-Pub 2009. PMID: 27960787.
222. Lu J, Steeg PS, Price JE, Krishnamurthy S, Mani SA, Reuben J, Cristofanilli M, Dontu G, Bidaut L, Valero V, Hortobagyi GN, Yu D. Breast cancer metastasis: challenges and opportunities. Cancer Res 69(12):4951-3. e-Pub 2009. PMID: 19470768.
223. Hennessy BT, Gonzalez-Angulo AM, Stemke-Hale K, Gilcrease MZ, Krishnamurthy S, Lee JS, Fridlyand J, Sahin A, Agarwal R, Joy C, Liu W, Stivers D, Baggerly K, Carey M, Lluch A, Monteagudo C, He X, Weigman V, Fan C, Palazzo J, Hortobagyi GN, Nolden LK, Wang NJ, Valero V, Gray JW, Perou CM, Mills GB. Characterization of a naturally occuring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res 69(10):4116-24, 2009. e-Pub 2009. PMID: 19435916.
224. Taboada JL, Stephens TW, Krishnamurthy S, Brandt KR, Whitman GJ. The many faces of fat necrosis in the breast. American Journal of Roentgenology 192(3):815-825, 2009. e-Pub 2009. PMID: 19234281.
225. Krishnamurthy S, Meric-Bernstam F, Lucci A, Hwang RF, Kuerer HM, Babiera G, Ames FC, Feig BW, Ross MI, Singletary E, Hunt KK, Bedrosian I. A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Cancer 115(7):1555-1562, 2009. e-Pub 2009. PMID: 19195040.
226. Kuerer HM, Albarracin CT, Yang WT, Cardiff RD, Brewster AM, Symmans WF, Hylton NM, Middleton LP, Krishnamurthy S, Perkins GH, Babiera G, Edgerton ME, Czerniecki BJ, Arun BK, Hortobagyi GN. Ductal carcinoma in situ: state of the science and roadmap to advance the field. Journal of Clinical Oncology 27(2):279-288, 2009. e-Pub 2009. PMID: 19064970.
227. Cristofanilli M, Krishnamurthy S, Das CM, Reuben JM, Spohn W, Noshari J, Becker F, Gascoyne PR. Dielectric cell separation of fine needle aspirates from tumor xenografts. Journal of Separation Science 31(21):3732-3739, 2008. e-Pub 2008. PMID: 18958846.
228. Cristofanilli M, Morandi P, Krishnamurthy S, Reuben, Lee BM, Francis D, Booser D, Green M, Arum B, Puszatai L, Poroglio K, Islam R, Valero V, Hortobagyi GN. Imatinib mesylate (Gleevec) in advanced breast cancer expressing C-kit or PDGFR-B: Clinical activity and biological commentations 19(10):1713-1719, 2008. e-Pub 2008.
229. Kocjan G, Bourgain C, Fassina A, Hagmar B, Herbert A, Kapila K, Kardum-Skelin I, Kloboves-Prevodnik V, Krishnamurthy S, Koutselini H, Majak B, Olszewski W, Onal B, Pohar-Marinsek Z, Shabalova I, Smith J, Tani E, Vielh P, Wiener H, Schenck U, Schmitt F. The role of breast FNAC in diagnosis and clinical management: a survey of current practice. Cytopathology 19(5):271-278, 2008. e-Pub 2008. PMID: 18821945.
230. Bedi DG, Krishnamurthy R, Krishnamurthy S, Edeiken BS, Le-Petross H, Fornage BD, Bassett RL, Hunt KK. Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study. AJR Am J Roentgenol 191(3):646-52, 2008. e-Pub 2008. PMID: 18716089.
231. Akkiprik M, Feng Y, Wang H, Chen K, Hu L, Sahin A, Krishnamurthy S, Ozer A, Hao X, Zhang W. Multifunctional roles of insulin-like growth factor binding protein 5 in breast cancer. Breast Cancer Res 10(4):212, 2008. e-Pub 2008. PMID: 18710598.
232. Mazouni C, arum B, Andre F, Ayers M, Krishnamurthy S, wary B, Hurtobagyi GN, Buzdar AV, Pusztai L. Collagen IV levels are elevated in the serum of patients with primary breast cancer compared to healthy volunteers. BJC, 2008. e-Pub 2008.
233. Lucci A, Krishnamurthy S, Singh B, Bedrosian I, Meri-Bernstam F, Rueben J, Broglio K, Mosalpuria K, Lodhi A, Vencent L, Cristofanilli M. Cylooxygenase=2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow. Breast Cancer Res Treat. e-Pub 2008.
234. Roshni R, Keurer HM, Cristofanilli M, Shukla S, Rao M, Poroglio K, Krishnamurthy S. Breast cancer presentation, treatment and outcome in Asian-American women. Breast J, 2008. e-Pub 2008.
235. Lucci A, Krishnamurthy S, Mosalpuria K, Bedrosian I, Meric-Bernstam F, Reuben JM, Singh B, Woodward WA, Cristofanilli M. Global evaluation of minimal residual disease in primary breast cancer patients. J Clin Oncol 26(15_suppl):1020, 2008. e-Pub 2008. PMID: 27951330.
236. Yi M, S K, Kuerer HM, Meric-Bernstam F, Bedrosian I, Ross MI, Ames FC, Lucci A, Hwang RF, Hunt KK. Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with carcinoma in situ or microinvasive breast cancer. Am J Surg, 2008. e-Pub 2008. PMID: 18436181.
237. Miyahara N, Shoda J, Ishige K, Kawamoto T, Ueda T, Taki R, Ohkohchi N, Hyodo I, Thomas MB, Krishnamurthy S, Carraway KL, Irimura T. MUC4 interacts with ErbB2 in human gallbladder carcinoma: Potential pathobiological implications. Eur J Cancer, 2008. e-Pub 2008. PMID: 18397823.
238. Lang JE, Mosalpuria K, Cristofanilli M, Krishnamurthy S, Reuben J, Singh B, Bedrosian I, Meric-Bernstam F, Lucci A. HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer. Breast Cancer Res Treat, 2008. e-Pub 2008. PMID: 18327638.
239. Tam A, Krishnamurthy S, Pillsbury EP, Ensor JE, Gupta S, Murthy R, Ahrar K, Wallace MJ, Hicks ME, Madoff DC. Percutaneous image-guided splenic biopsy in the oncology patient: an audit of 156 consecutive cases. Journal of Vascular and Interventional Radiology 19(1):80-87, 2008. e-Pub 2008. PMID: 18192471.
240. Kraeft SK, Honig M, Krishnamurthy S. Emperipolesis in the cerebrospinal fluid from a patient with Rosai-Dorfman disease. Diagn Cytopathol. e-Pub 2008. PMID: 18064697.
241. Yamasaki F, Johansen MJ, Zhang D, Krishnamurthy S, Felix E, Bartholomeusz C, Aguilar RJ, Kurisu K, Mills GB, Hortobagyi GN, Ueno NT. Acquired Resistance to Erlotinib in A-431 Epidermoid Cancer Cells Requires Down-regulation of MMAC1/PTEN and UP-regulation of Phosphorylated Akt. Cancer Res 67(12):5779-5799, 2007. e-Pub 2007.
242. Yang WT, Hennessy BT, Dryden MJ, Valero V, Hunt KK, Krishnamurthy S. Mammary angiosarcomas: imaging findings in 24 patients. Radiology 242(3):725-34, 2007. e-Pub 2007.
243. Baruch AC, Wang H, Staerkel GA, Evans DB, Hwang RF, Krishnamurthy S. Immunocytochemical study of the expression of mesothelin in fine-needle aspiration biopsy specimens of pancreatic adenocarcinoma. Diagn Cytopathol 242(3):725-34, 2007. e-Pub 2007.
244. Krishnamurthy S. Applications of molecular techniques to fine-needle aspiration biopsy. Cancer 25(111):106-22, 2007. e-Pub 2007.
245. Gonzales-Angulo AM, Sahin A, Krishnamurthy S, Yang Y, Kau SW, Hortobagyi GN, Cristofanilli M. Biologic markers in axillary node-negative breast cancer; differential expression in invasive ductal carcinoma versus invasive lobular carcinoma. Clin Breast Cancer 7(5):396-400, 2006. e-Pub 2006.
246. Kobayashi K, Gupta S, Trent JC, Vauthey JN, Krishnamurthy S, Ensor J, Ahrar K, Wallace MJ, Madoff DC, Murthy R, McRae SE. Hepatic artery chembolization for 110 gastrointestinal stromal tumors response, survival, and prognostic factors. Cancer 107(12):2833-41, 2006. e-Pub 2006.
247. Jeruss JS, Hunt KK, Xing Y, Krishamurthy S, Meric-Bernstam F, Cantor SB, Ross MI, Cormier JN. Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective?. Cancer 107(10):2328-2336, 2006. e-Pub 2006.
248. Cristofanilli M, Krishnamurthy S, Guerra L, Broglio K, Arun B, Booser DJ, Menander K, Van Wart Hood J, Valero V, Hortobagyi GN. A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: safety, efficacy, and biologic activity of a novel gene-therapy approach. Cancer 107(5):935-44, 2006. e-Pub 2006.
249. Uzquiano MC, Kuruvilla S, Fischer CP, Liu J, Krishnamurthy S, Adler DG. An unusual solid pseudopapillary tumor of the pancreas. Pancreas 33(1):103-4, 2006. e-Pub 2006.
250. Yang CH, Gonzalez-Angulo AM, Reuben JM, Booser DJ, Pusztai L, Krishnamurthy S, Esseltine D, Stec J, Broglio KR, Islam R, Hortobagyi GN, Cristofanilli M. Bortezomib (VELCADE(R) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits. Ann Oncol 17(5):813-7, 2006. e-Pub 2006.
251. Lambert LA, Ayers GD, Hwang RF, Hunt KK, Ross MI, Kuerer HM, Singletary SE, Babiera GV, Ames FC, Feig B, Lucci A, Krishnamurthy S, Meric-Bernstam F. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastasis after a positive sentinel node biopsy. Ann Surg Oncol 13(3):310-20, 2006. e-Pub 2006.
252. Pawlik TM, Hawke DH, Liu Y, Krishnamurthy S, Fritsche H, Hunt KK, Kuerer HM. Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. BMC Cancer 16(6):68, 2006. e-Pub 2006.
253. Dimashkieh H, Krishnamurthy S. Ultrasound guided fine-needle aspiration biopsy of parathyroid gland and lesions. Cytojournal 28(3):6, 2006. e-Pub 2006.
254. Hennessy BT, Krishnamurthy S, Giordano S, Buchholz TA, Kau SW, Duan Z, Valero V, Hortobagyi GN. Squamous cell carcinoma of the breast. J Clin Oncol 23(31):7827-35, 2005. e-Pub 2005. PMID: 16258085.
255. Jalali M, Krishnamurthy S. Comparison of immunomarkers for the identification of adrenocortical cells in cytology specimens. Diagn Cytopathol 33(2):78-82, 2005. e-Pub 2005. PMID: 16007649.
256. Cristofanilli M, Yamamura Y, Kau SW, Bevers T, Strom S, Patangan M, Hsu L, Krishnamurthy S, Theriault RL, Hortobagyi GN. Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer 103(6):1122-8, 2005. e-Pub 2005. PMID: 15712375.
257. Gong Y, Krishnamurthy S. Fine-needle aspiration of an unusual case of poorly differentiated insular carcinoma of the thyroid. Diagn Cytopathol 32(2):103-7, 2005. e-Pub 2005. PMID: 15637672.
258. Gupta S, Krishnamurthy S, Broemeling LD, Morello FA, Jr, Wallace MJ, Ahrar K, Madoff DC, Murthy R, Hicks ME. Small
259. Li J, Zhao J, Yu X, Lange J, Kuerer H, Krishnamurthy S, Schilling E, Khan SA, Sukumar S, Chan DW. Identification of biomarkers for beast cancer in nipple aspiration and ductal lavage fluid. Clin Cancer Res 11(23):8321-20, 2005. e-Pub 2005.
260. Pawlik TM, Fritsche H, Coombes KR, Xiao L, Krishnamurthy S, Hunt KK, Pusztai L, Chen JN, Clarke CH, Arun B, Hung MC, Kuerer HM. Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry. Breast Cancer Res Treat 89(2):149-57, 2005. e-Pub 2005. PMID: 15692757.
261. Kuerer HM, Coombes KR, Chen JN, Xiao L, Clarke C, Fritsche H, Krishnamurthy S, Marcy S, Hung MC, Hunt KK. Association between ductal fluid proteomic expression profiles and the presence of lymph node metastases in women with breast cancer. Surgery 136(5):1061-9, 2004. e-Pub 2004. PMID: 15523402.
262. Krishnamurthy S, Zhao L, Hayes K, Glassman AB, Cristofanilli M, Singletary SE, Hunt KK, Kuerer HM, Sneige N. Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary study. Cancer 102(5):322-7, 2004. e-Pub 2004. PMID: 15376199.
263. Shen J, Hunt KK, Mirza NQ, Krishnamurthy S, Singletary SE, Kuerer HM, Meric-Bernstam F, Feig B, Ross MI, Ames FC, Babiera GV. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma. Cancer 101(6):1330-7, 2004. e-Pub 2004. PMID: 15316905.
264. Cabioglu N, Krishnamurthy S, Kuerer HM, Hunt KK, Singletary SE, Meric-Bernstam F, Ross MI, Feig BW, Ames FC, Babiera GV. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge. Cancer 101(3):508-17, 2004. e-Pub 2004. PMID: 15274063.
265. Shen J, Hunt KK, Mirza NQ, Krishnamurthy S, Singletary SE, Kuerer HM, Meric-Bernstam F, Feig B, Ross MI, Babiera GV. Intramammary lymph node metastases are an independent predictor in breast cancer outcomes. J Clin Oncol 22(14_suppl):615, 2004. e-Pub 2004. PMID: 28016715.
266. Gonzalez-Angulo AM, Krishnamurthy S, Yamamura Y, Broglio KR, Pusztai L, Buzdar AU, Hortobagyi GN, Esteva FJ. Lack of association between amplification of her-2 and response to preoperative taxanes in patients with breast carcinoma. Cancer 101(2):258-63, 2004. e-Pub 2004. PMID: 15241821.
267. Chagpar A, Evelegh M, Fritsche HA, Jr, Krishnamurthy S, Hunt KK, Kuerer HM. Prospective evaluation of a novel approach for the use of a quantitative galactose oxidase-Schiff reaction in ductal fluid samples from women with breast carcinoma. Cancer 100(12):2549-54, 2004. e-Pub 2004. PMID: 15197795.
268. Recine M, Kaw M, Evans DB, Krishnamurthy S. Fine-needle aspiration cytology of mucinous tumors of the pancreas. Cancer 102(2):92-9, 2004. e-Pub 2004. PMID: 15098253.
269. Gonzalez-Angulo, AM, Krishnamurthy S, Yamamura Y, Broglio K, Pusztai L, Buzdar AU, Hortobagyi GN, Esteva FJ. Correlation between Response to Primary Chemotherapy with single Agent Taxanes and Her-2 Gene amplification in Patients with Breast Carcinoma. Cancer 15((2)):258-63, 2004. e-Pub 2004.
270. Gong, Y, Symmans WF, Krishnamurthy S, Patel S, Sneige N. Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma. Cancer:102(1):143-8; discussion 148-9, 2004. e-Pub 2004.
271. Krishnamurthy S, Dimashkieh H, Patel S, Sneige N. Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears. Diagn Cytopathol 29(6):309-14, 2003. e-Pub 2003. PMID: 14648786.
272. Bedrosian I, Bedi D, Kuerer HM, Fornage BD, Harker L, Ross MI, Ames FC, Krishnamurthy S, Edeiken-Monroe BS, Meric F, Feig BW, Akins J, Singletary SE, Mirza NQ, Hunt KK. Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol 10(9):1025-30, 2003. e-Pub 2003. PMID: 14597440.
273. Madigan MN, Dempsey PJ, Krishnamurthy S. Ultrasound-guided fine needle aspiration cytodiagnosis of leiomyosarcoma metastatic to the breast. A case report. Acta Cytol 47(5):783-6, 2003. e-Pub 2003. PMID: 14526679.
274. Symmans WF, Ayers M, Clark EA, Stec J, Hess KR, Sneige N, Buchholz TA, Krishnamurthy S, Ibrahim NK, Buzdar AU, Theriault RL, Rosales MF, Thomas ES, Gwyn KM, Green MC, Syed AR, Hortobagyi GN, Pusztai L. Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma. Cancer 97(12):2960-71, 2003. e-Pub 2003. PMID: 12784330.
275. Hristova EN, Krishnamurthy S, Ro JY, Ayala AG. Pulmonary epithelioid hemangioendothelioma with prominent signet ring cell features mimicking metastatic adenocarcinoma. Ann Diagn Pathol 7(3):160-4, 2003. e-Pub 2003. PMID: 12808567.
276. Hwang RF, Krishnamurthy S, Hunt KK, Mirza N, Ames FC, Feig B, Kuerer HM, Singletary SE, Babiera G, Meric F, Akins JS, Neely J, Ross MI. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10(3):248-54, 2003. e-Pub 2003. PMID: 12679309.
277. Krishnamurthy S, Sneige N, Thompson PA, Marcy SM, Singletary SE, Cristofanilli M, Hunt KK, Kuerer HM. Nipple aspirate fluid cytology in breast carcinoma. Cancer 99(2):97-104, 2003. e-Pub 2003. PMID: 12704689.
278. Diaz LK, Hunt K, Ames F, Meric F, Kuerer H, Babiera G, Ross M, Singletary E, Middleton LP, Symmans WF, Krishnamurthy S, Sahin A, Sneige N, Gilcrease MZ. Histologic localization of sentinel lymph node metastases in breast cancer. Am J Surg Pathol 27(3):385-9, 2003. e-Pub 2003. PMID: 12604895.
279. Kuerer HM, Thompson PA, Krishnamurthy S, Fritsche HA, Marcy SM, Babiera GV, Singletary SE, Cristofanilli M, Sneige N, Hunt KK. High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer. Clin Cancer Res 9(2):601-5, 2003. e-Pub 2003. PMID: 12576424.
280. Meric F, Mirza NQ, Vlastos G, Buchholz TA, Kuerer HM, Babiera GV, Singletary SE, Ross MI, Ames FC, Feig BW, Krishnamurthy S, Perkins GH, McNeese MD, Strom EA, Valero V, Hunt KK. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 97(4):926-33, 2003. e-Pub 2003. PMID: 12569592.
281. Sneige N, Lim SC, Whitman GJ, Krishnamurthy S, Sahin AA, Smith TL, Stelling CB. Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision. Am J Clin Pathol 119(2):248-53, 2003. e-Pub 2003. PMID: 12579995.
282. Tabatabai ZL, Krishnamurthy S. Radiation-induced atypical glandular cells mimicking recurrent adenocarcinoma in a posthysterectomy vaginal smear. Acta Cytol 47(1):106-7, 2003. e-Pub 2003. PMID: 12585042.
283. Pusztai, L, Krishnamurthy S, Cardona TP, Sneige N, Esteva FJ, Volchenok M, Breitenfelder P, Kau SW, Takayama S, Krajewski S, Reed JC, Hortobagyi GN, Bast RC. Expression of BAG-1 and BCL-2 proteins before and after neoadjuvant chemotherapy of locally advanced breast cancer. Cancer investigation, 2003. e-Pub 2003.
284. Kuerer HM, Goldknopf IL, Fritsche H, Krishnamurthy S, Sheta EA, Hunt KK. Identification of distinct protein expression patterns in bilateral matched pair breast ductal fluid specimens from women with unilateral invasive breast carcinoma. High-throughput biomarker discovery. Cancer 95(11):2276-82, 2002. e-Pub 2002. PMID: 12436432.
285. Wallace MJ, Krishnamurthy S, Broemeling LD, Gupta S, Ahrar K, Morello FA, Jr, Hicks ME. CT-guided percutaneous fine-needle aspiration biopsy of small (< or =1-cm) pulmonary lesions. Radiology 225(3):823-8, 2002. e-Pub 2002. PMID: 12461267.
286. Krishnamurthy S, Sneige N, Ordonez NG, Hunt KK, Kuerer HM. Characterization of foam cells in nipple aspirate fluid. Diagn Cytopathol 27(5):261-4; discussion 265, 2002. e-Pub 2002. PMID: 12411988.
287. Huang E, Buchholz TA, Meric F, Krishnamurthy S, Mirza NQ, Ames FC, Feig BW, Kuerer HM, Ross MI, Singletary SE, McNeese MD, Strom EA, Hunt KK. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 95(10):2059-67, 2002. e-Pub 2002. PMID: 12412158.
288. Sneige N, Wang J, Baker BA, Krishnamurthy S, Middleton LP. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 15(10):1044-50, 2002. e-Pub 2002. PMID: 12379750.
289. Krishnamurthy S, Sneige N, Bedi DG, Edieken BS, Fornage BD, Kuerer HM, Singletary SE, Hunt KK. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 95(5):982-8, 2002. e-Pub 2002. PMID: 12209680.
290. Lee A, S K, Sahin A, Symmans WF, Hunt K, Sneige N. Intraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients. Cancer 96(4):225-31, 2002. e-Pub 2002. PMID: 12209664.
291. Kuerer HM, Krishnamurthy S, Kronowitz SJ. Important technical considerations for skin-sparing mastectomy with sentinel lymph node dissection. Arch Surg 137(6):747, 2002. e-Pub 2002. PMID: 12049553.
292. Krishnamurthy S, Kuerer HM. Foam cells in nipple aspiration fluid. Cytopathology 13:64, 2002. e-Pub 2002.
293. Stewart JMM, Krishnamurthy S. Fine-needle aspiration cytology of a case of HIV-associated anaplastic myeloma. Diagn Cytopathol 27(4):218-222, 2002. e-Pub 2002.
294. Krishnamurthy S, Bedi DG, Caraway NP. Ultrasound-guided fine-needle aspiration biopsy of the thyroid bed. Cancer 93(3):199-205, 2001. e-Pub 2001. PMID: 11391607.
295. Krishnamurthy S, Katz RL, Shumate A, Strohlein K, Khanna A, Tucker SL, Raijman I, Lahoti S. DNA image analysis combined with routine cytology improves diagnostic sensitivity of common bile duct brushing. Cancer 93(3):229-35, 2001. e-Pub 2001. PMID: 11391612.
296. Krishnamurthy S. Application of Molecular Pathology in Diagnostic Surgical Pathology and Cytopathology: Current Practice and future prospects. Proceedings of the Sixth International CME & Update in Surgical Pathology:55-58, 2001. e-Pub 2001.
297. Krishnamurthy S, Ashfaq R, Shin HJ, Sneige N. Distinction of phyllodes tumor from fibroadenoma: a reappraisal of an old problem. Cancer 90(6):342-9, 2000. e-Pub 2000. PMID: 11156517.
298. Krishnamurthy S, Ordonez NG, Shelton TO, Ayala AG, Sneige N. Fine-needle aspiration cytology of a case of oncocytic adrenocortical carcinoma. Diagn Cytopathol 22(5):299-303, 2000. e-Pub 2000. PMID: 10790237.
299. Bedrosian, I, Bedi D, Kuerer H, Harker L, Ross M, Ames F, Krishnamurthy S, Edeiken-Monroe B, Singletary E, Mirza N, Hunt K. Concordance of Axillary Ultrasound with Nodal Pathology in Patients with Early Stage Breast Cancer. American Journal of Surgical Oncology, 2000. e-Pub 2000.
300. Freeman RB, Jr, Tran CL, Mattoli J, Patel K, Supran S, Basile FG, Krishnamurthy S, Aihara R. Tumor necrosis factor genetic polymorphisms correlate with infections after liver transplantation. NEMC TNF Study Group. New England Medical Center Tumor Necrosis Factor. Transplantation 67(7):1005-10, 1999. e-Pub 1999. PMID: 10221485.
301. Krishnamurthy S, Jungbluth AA, Busam KJ, Rosai J. Uterine tumors resembling ovarian sex-cord tumors have an immunophenotype consistent with true sex-cord differentiation. Am J Surg Pathol 22(9):1078-82, 1998. e-Pub 1998. PMID: 9737240.
302. Krishnamurthy S, Integlia MJ, Grand RJ, Dayal Y. Pancreatic acinar cell clusters in pediatric gastric mucosa. Am J Surg Pathol 22(1):100-5, 1998. e-Pub 1998. PMID: 9422322.
303. Krishnamurthy S, Dayal Y. Parietal cell protrusions in gastric ulcer disease. Hum Pathol 28(10):1126-30, 1997. e-Pub 1997. PMID: 9343318.
304. Integlia MJ, Krishnamurthy S, Berhane R, Grand RJ, Dayal Y. Pancreatic metaplasia of the gastric mucosa in pediatric patients. Am J Gastroenterol 92(9):1553-6, 1997. e-Pub 1997. PMID: 9317086.
305. Krishnamurthy S, Dayal Y. Immunohistochemical expression of transforming growth factor alpha and epidermal growth factor receptor in gastrointestinal carcinoids. Am J Surg Pathol 21(3):327-33, 1997. e-Pub 1997. PMID: 9060603.
306. Alexander, J, Krishnamurthy S, Kovacs D, Dayal Y. Cytokeratin profile of extrahepatic pancreaticobiliary epithelia and their carcinomas. Applied Immunohistochemistry 5((4)):216-222, 1997. e-Pub 1997.
307. Krishnamurthy S, Dayal Y. Pancreatic metaplasia in Barrett's esophagus. An immunohistochemical study. Am J Surg Pathol 19(10):1172-80, 1995. e-Pub 1995. PMID: 7573675.
308. Krishnamurthy S, Sehgal S, Datta BN, Chugh KS. Class specific antinuclear antibodies in systemic lupus erythematosus. Indian J Med Res 98:27-29, 1993. e-Pub 1993.
309. Jolly, BB, Krishnamurthy S, Vaidhyanathan S. Zoons balanitis. Uro Int 50:182-184, 1993. e-Pub 1993.
310. Sarode, VR, Krishnamurthy S, Banerjee CK, Narasimharao KL, Khajhuria A. Primary extra renal Wilms Tumor: Identification of a putative precursor lesion. Histopathology 21:76-78, 1992. e-Pub 1992.
311. Nijhawan, R, Dey P, Krishnamurthy S, Gupta SK. Fine needle aspiration cytology of malignant sertoli cell tumor of the testis. Acta Cytologica 36((4)):563-565, 1992. e-Pub 1992.
312. Sarode VR, Datta BN, Krishnamurthy S, Singh K, Bhasin D. Kaposis sarcoma of spleen with unusual clinical and histologic features. Arch Pathol Lab Med 115:1042-1046, 1991. e-Pub 1991.

Invited Articles

1. Gerstung, M, Jolly, C, Leshchiner, I, Dentro, SC, Gonzalez, S, Rosebrock, D, Mitchell, TJ, Rubanova, Y, Anur, P, Yu, K, Tarabichi, M, Deshwar, A, Wintersinger, J, Kleinheinz, K, Vázquez-García, I, Haase, K, Jerman, L, Sengupta, S, Macintyre, G, Malikic, S, Donmez, N, Livitz, DG, Cmero, M, Demeulemeester, J, Schumacher, S, Fan, Y, Zhu, H, Wang, W, Van Loo, P, Fan, Y, Akbani, R, Akdemir, KC, Aldape, KD, Cao, S, Chakravarty, D, Chen, Y, Czerniak, BA, Eils, R, El-Naggar, AK, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Lazar, A, Lichter, P, Mills, GB, Sood, AK, Wang, L, Weinstein, JN. Author Correction. Nature 614(7948):E42, 2023. e-Pub 2023. PMID: 36697833.
2. Yoon E, Wang G, Wu Y, Chen H, Albarracin C, Resetkova E, Krishnamurthy S, Salisbury T, Sahin A, Ding Q. Expression of TRPS1, SOX10 and GATA3 in Triple Negative Invasive Ductal and Lobular Carcinomas, 2022. e-Pub 2022.
3. Krishnamurthy, S. Commentary on "Nerve fibers in breast cancer tissues indicate aggressive tumor progression". Breast Diseases: A Year Book Quarterly 27:38-39, 2016. e-Pub 2016.
4. Krishnamurthy, S. Commentary on "A new clinical cut-off of cytokeratin 19 mRNA copy number in sentinel lymph node better identifies patients eligible for axillary lymph node dissection in breast cancer". Breast Diseases: A Year Book Quarterly 26(3):702-706, 2015. e-Pub 2015.
5. Krishnamurthy, S. Commentary on "The prognostic significance of tumour–stroma ratio in oestrogen receptor-positive breast cancer". Breast Diseases: A Year Book Quarterly 26:53:55, 2015. e-Pub 2015.
6. Krishnamurthy, S. Commentary on "Cdc20 and securin overexpression predict short-term breast cancer survival". Breast Diseases: A Year Book Quarterly 26(2):140:142, 2014. e-Pub 2014.
7. Krishnamurthy S. Commentary on "Clinicopathologic factors of the recurrent tumor predict outcome in patients with ipsilateral breast tumor recurrence". Breast Diseases: A Year Book Quarterly 23:198-199, 2012. e-Pub 2012.
8. Krishnamurthy, S. Commentary on "P53 as a marker of prognosis in African-American women with breast cancer". Breast Diseases: A Year Book Quarterly 22(3), 2011. e-Pub 2011.
9. Krishnamurthy S. Micrometastases in Sentinel lymph nodes in breast cancer. Breast Diseases, A Yearbook Quaterly, 2010. e-Pub 2010.
10. Krishnamurthy S. Commentary on "Clinical validation of a molecular assay for intra-operative detection of metastases in breast sentinel lymph nodes in. Breast Diseases: A Year Book Quarterly, 2008. e-Pub 2008.
11. Krishnamurthy S. Commentary on "The Value of intraoperative frozen section enaminate of sentinel Lymph nodes in Breast Cancer. Breast Diseases: A Year Book Quarterly, 2008. e-Pub 2008.
12. Krishnamurthy S. Commentary on "A prospective blinded trail of touch prep analysis verses frozen section for intraoperation evaluation of sentinel lymph nodes in breast cancer" in. Breast Diseases: A Year Book Quarterly, 2008. e-Pub 2008.
13. Reuben JM, Krishnamurthy S, Woodward W, Cristofanilli M. The role of circulating tumor cells in breast cancer diagnosis and prediction of therapy responses. Expert Opinion Medical Diagnosis 2(4):339-348, 2008. e-Pub 2008.
14. Krishnamurthy S. Commentary on "Sentinel lymph node staging for breast cancer. Intraoperative molecular pathology overcomes conventional histologic sampling errors". Breast Diseases a Year Book Quarterly, 2008. e-Pub 2008.
15. Krishnamurthy S. Commentary on "Prognostic markers in triple negative breast cancer". Breast Diseases a Year Book Quarterly, 2008. e-Pub 2008.
16. Krishnamurthy S. Commentary on "Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometasteses and isolated tumor cells: Analysis of 174 patients after SLN biopsy.". Breast Diseases: A Year Book Quarterly, 2007. e-Pub 2007.
17. Krishnamurthy S. Commentary on "Intraoperative evaluation of axillary sentinel lymph nodes in breast cancer.". Breast Diseases: A Year Book Quarterly, 2007. e-Pub 2007.
18. Krishnamurthy S. Commentary on "Identification of a basal-like subtype of breast ductal carcinoma in situ.". Breast Diseases: A Year Book Quarterly, 2006. e-Pub 2006.
19. Krishnamurthy S. Commentary on "Solid papillary ductal carcinoma in situ versus ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin.". Breast Diseases: A Year Book Quarterly, 2006. e-Pub 2006.
20. Krishnamurthy S. Prognostic markers in triple-negative breast cancer. Breast Diseases: A Year Book Quarterly, 2006. e-Pub 2006.
21. Krishnamurthy S. Commentary on "A rapid, fully automated molecular-based assay accurately analyzes sentinel lymph nodes for the presence of metastatic breast cancer.". Breast Diseases: A Year Book Quarterly, 2006. e-Pub 2006.
22. Krishnamurthy S. Commentary on "Intracystic papillary carcinoma of breast: A re-evaluation using a panel of myoepithlial cell markers.". Breast Diseases: A Year Book Quarterly, 2006. e-Pub 2006.
23. Krishnamurthy S. Commentary on "Breast fine needle aspiration specimens with scant celularity are clinically useful.". Breast Diseases A Year Book Quarterly, 2006. e-Pub 2006.
24. Krishnamurthy S. Commentary on "Identification and characterization of optimal gene expression markers for detection of breast cancer metastasis.". Breast Diseases A Year Book Quarterly, 2006. e-Pub 2006.
25. Krishnamurthy S. Commentary on "Meta-analysis of sentinel lymph node imprint cytology in breast cancer.". Breast Diseases: A Year Book Quarterly, 2006. e-Pub 2006.
26. Krishnamurthy S. Commentary on "Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: Results of a multi-institutional prospective cohort study.". Breast Diseases: A Year Book Quarterly, 2006. e-Pub 2006.
27. Krishnamurthy S. Commentary on "Nipple aspirate fluid basic fibroblast growth factor in patients with breast cancer.". Breast Diseases A Year Book Quarterly, 2006. e-Pub 2006.
28. Krishnamurthy S. Commentary on "Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract.". Breast Diseases: A Year Book Quarterly, 2005. e-Pub 2005.
29. Krishnamurthy S. Commentary on "Effect of core-biopsy vs. fine needle aspiration of pathologic measurement of tumor size in breast cancer.". Breast Diseases: A Year Book Quarterly, 2005. e-Pub 2005.
30. Krishnamurthy S. Commentary on "Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast.". Breast Diseases: A Year Book Quarterly, 2005. e-Pub 2005.
31. Krishnamurthy S. Commentary on "Association of breast with papillary lesions identified at percutaneous image guided breast biopsies.". Breast Diseases: A Year Book Quarterly, 2005. e-Pub 2005.
32. Krishnamurthy S. Commentary on "Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.", 2005. e-Pub 2005.
33. Krishnamurthy S. Commentary on "Cytokeratin staining for intraoperative evaluation of sentinel lymph nodes in patients with invasive lobular carcinoma.". Breast Diseases: Year Book Quarterly, 2005. e-Pub 2005.
34. Krishnamurthy S. Commentary on "Automated quantitative analysis of E-cadherin expression in lymph node metastasis is predicitve of survival in invasive breast cancer.". Breast Diseases: A Year Book Quarterly, 2005. e-Pub 2005.
35. Krishnamurthy S. Commentary on "Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract.". Breast Diseases: A Year Book Quarterly, 2005. e-Pub 2005.
36. Krishnamurthy S. Commentary on "Imprint cytology of the sentinel lymph node in the assessment of axillary node status in breast carcinoma.". Breast Diseases: A Year Book Quarterly, 2004. e-Pub 2004.
37. Krishnamurthy S. Commentary on "Touch Imprint of Axillary Lymph Nodes after Neoadjuvant Chemotherapy in Patients with Breast Carcinoma.". Breast Diseases: A Year Book Quarterly, 2004. e-Pub 2004.
38. Krishnamurthy S. Commentary on "Primary Non-Phyllodes Breast Sarcomas.". Breast Diseases: A Year Book Quarterly, 2004. e-Pub 2004.
39. Krishnamurthy S. Commentary on "Intraoperative Imprint Cytologic Evaluation of Sentinel lymphNodes for Lobular Carcinoma of the Breast.". Breast Diseases: A Year Book Quarterly, 2004. e-Pub 2004.
40. Krishnamurthy S. Commentary on "Adenoid cystic carcinoma of the breast: molecular markers, treatment and clinical outcome.". Breast Diseases: A Year Book Quarterly 14, 2003. e-Pub 2003.
41. Krishnamurthy S. Commentary on "Detection of Chromosomal Aneusomy by Fluorescence in situ hybridization for patients with nipple discharge.". Breast Diseases: A Year Book Quarterly 14, 2003. e-Pub 2003.
42. Krishnamurthy S. Commentary on "Accuracy of 11-gauge vacuum-assisted core biopsy of mammographic breast lesions.". Breast Diseases: A Year Book Quarterly 14, 2003. e-Pub 2003.
43. Krishnamurthy S. Commentary on "Can true papillary neoplasms of breast and their mimickers be accurately classified by cytology?". Diseases: A Year Book Quarterly 13, 2003. e-Pub 2003.
44. Krishnamurthy S. Commentary on "Image-Guided core needle biopsy analysis of papillary lesions of the breast.". Breast Diseases: A Year Book Quarterly 14, 2003. e-Pub 2003.
45. Krishnamurthy S. Commentary on "Does the level of E-Cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastsis.". Breast Diseases: A Year Book Quarterly 14, 2003. e-Pub 2003.
46. Krishnamurthy S. Commentary on "Diagnosis and subclassification of breast carcinoma by fine-needle aspiration biopsy.". Breast Diseases: A Year Book Quarterly 14, 2003. e-Pub 2003.
47. Krishnamurthy S. Commentary on "Keratin immunohistochemistry detects clinical significant metastases in bone marrow biopsy specimens in women with lobular breast carcinoma.". Breast Diseases: A Year Book Quarterly 13, 2003. e-Pub 2003.
48. Krishnamurthy S. Commentary on "Mammary lesions diagnosed as Papillary by aspiration biopsy: 70 cases with follow-up.". Breast Diseases: A Year Book Quarterly (In press), 2003. e-Pub 2003.
49. Krishnamurthy S. Commentary on "Evaluation of Fine Needle Aspiration Cytology of Breast Masses in Males.". Breast Diseases: A Year Book Quarterly 13, 2003. e-Pub 2003.
50. Krishnamurthy S, Sneige N. Molecular and biologic markers of premalignant lesions of human breast. Adv Anat Pathol 9(3):185-97, 2002. e-Pub 2002. PMID: 11981114.

Review Articles

1. Krishnamurthy S. Current landscape and emerging opportunities for using telecytology for rapid on-site assessment in cytopathology. Cancer Cytopathol 133(7):e70027, 2025. e-Pub 2025. PMID: 40522771.
2. Tozbikian G, Bui MM, Hicks DG, Jaffer S, Khoury T, Wen HY, Krishnamurthy S, Wei S. Best practices for achieving consensus in HER2-low expression in breast cancer: current perspectives from practising pathologists. Histopathology 85(3):489-502, 2024. e-Pub 2024. PMID: 38973387.
3. Shin J, Kapoor M, Patel M, Krishnamurthy S, Whitman GJ. Comparing Breast Hemangiomas to Breast Angiosarcomas: An Imaging Based Review. Curr Probl Diagn Radiol 52(3):212-219, 2023. e-Pub 2023. PMID: 36804401.
4. Sheth RA, Sabir S, Krishnamurthy S, Avery RK, Zhang YS, Khademhosseini A, Oklu R. Endovascular Embolization by Transcatheter Delivery of Particles: Past, Present, and Future. J Funct Biomater 8(2), 2017. e-Pub 2017. PMID: 28368345.
5. Kuerer HM, Smith BD, Chavez-MacGregor M, Albarracin C, Barcenas CH, Santiago L, Edgerton ME, Rauch GM, Giordano SH, Sahin A, Krishnamurthy S, Woodward W, Tripathy D, Yang WT, Hunt KK. DCIS Margins and Breast Conservation: MD Anderson Cancer Center Multidisciplinary Practice Guidelines and Outcomes. J Cancer 8(14):2653-2662, 2017. e-Pub 2017. PMID: 28928852.
6. Krishnamurthy S. The emerging role of circulating tumor cells in breast cancer. Cancer Cytopathol 120(3):161-6, 2012. e-Pub 2012. PMID: 22275137.
7. Krishnamurthy S, Bevers T, Kuerer H, Yang WT. Multidisciplinary considerations in the management of high-risk breast lesions. AJR Am J Roentgenol 198(2):W132-40, 2012. e-Pub 2012. PMID: 22268202.
8. Yamauchi H, Woodward WA, Valero V, Alvarez RH, Lucci A, Buchholz TA, Iwamoto T, Krishnamurthy S, Yang W, Reuben JM, Hortobágyi GN, Ueno NT. Inflammatory breast cancer: what we know and what we need to learn. Oncologist 17(7):891-9, 2012. e-Pub 2012. PMID: 22584436.
9. Krishnamurthy S, Sneige N. Molecular and biologic markers of premalignant lesions of human breast. Adv Anat Pathol 9(3):185-97, 2002. e-Pub 2002. PMID: 11981114.

Professional Educational Materials

1. Krishnamurthy S. E-Journal Club. American Society of Cytopathology, 2008.
2. Krishnamurthy S. Video on Pathology of Inflammatory Breast Cancer.

Other Articles

1. Rodriguez-Martin, B, Alvarez, EG, Baez-Ortega, A, Zamora, J, Supek, F, Demeulemeester, J, Santamarina, M, Ju, YS, Temes, J, Garcia-Souto, D, Detering, H, Li, Y, Rodriguez-Castro, J, Dueso-Barroso, A, Bruzos, AL, Dentro, SC, Blanco, MG, Contino, G, Ardeljan, D, Tojo, M, Roberts, ND, Zumalave, S, Edwards, PA, Weischenfeldt, J, Puiggròs, M, Chong, Z, Chen, K, Lee, EA, Wala, JA, Van Loo, P, Akbani, R, Akdemir, KC, Aldape, KD, Cao, S, Chakravarty, D, Chen, Y, Czerniak, BA, Eils, R, Fan, Y, Han, L, von Kalle, C, Krishnamurthy, S, Langerod, A, Lichter, P, Mills, GB, Myklebost, O, Thompson, A, Wang, L, Weinstein, JN, Yuan, Y Author Correction. Nature Genetics 55(6):1080, 2023. PMID: 36944736.
2. Yuan, Y, Ju, YS, Kim, Y, Li, J, Wang, Y, Yoon, CJ, Yang, Y, Martincorena, I, Creighton, CJ, Weinstein, JN, Xu, Y, Han, L, Kim, HL, Nakagawa, H, Park, K, Campbell, PJ, Liang, H, Aaltonen, LA, Abascal, F, Abeshouse, A, Aburatani, H, Adams, DJ, Agrawal, N, Ahn, KS, Ahn, SM, Aikata, H, Akbani, R, Akdemir, KC, Aldape, KD, Cao, S, Chakravarty, D, Chen, Y, Czerniak, BA, Eils, R, El-Naggar, AK, Fan, Y, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Langerod, A, Lazar, A, Lichter, P, Mills, GB, Myklebost, O, Sood, AK, Thompson, A, Van Loo, P, Wang, L Author Correction. Nature Genetics 55(6):1078, 2023. PMID: 36944732.
3. Cortés-Ciriano, I, Lee, JK, Xi, R, Jain, D, Jung, YL, Yang, L, Gordenin, D, Klimczak, LJ, Zhang, CZ, Pellman, D, Akdemir, KC, Alvarez, EG, Baez-Ortega, A, Beroukhim, R, Boutros, PC, Bowtell, DD, Brors, B, Burns, KH, Campbell, PJ, Chan, K, Chen, K, Cortés-Ciriano, I, Dueso-Barroso, A, Akbani, R, Akdemir, KC, Aldape, KD, Cao, S, Chakravarty, D, Chen, Y, Czerniak, BA, Eils, R, El-Naggar, AK, Fan, Y, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Langerod, A, Lazar, A, Lichter, P, Mills, GB, Myklebost, O, Sood, AK, Thompson, A, Van Loo, P, Wang, L, Weinstein, JN, Yuan, Y, Zhu, H Author Correction. Nature Genetics 55(6):1076, 2023. PMID: 36944733.
4. Akdemir, KC, Le, VT, Chandran, S, Li, Y, Verhaak, R, Beroukhim, R, Campbell, PJ, Chin, L, Dixon, JR, Futreal, A, Akdemir, KC, Alvarez, EG, Baez-Ortega, A, Boutros, PC, Bowtell, DD, Brors, B, Burns, KH, Campbell, PJ, Chan, K, Chen, KS, Cortés-Ciriano, I, Dueso-Barroso, A, Dunford, AJ, Akbani, R, Aldape, KD, Cao, S, Chakravarty, D, Chen, Y, Czerniak, BA, Eils, R, El-Naggar, AK, Fan, Y, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Langerod, A, Lazar, A, Li, J, Lichter, P, Mills, GB, Myklebost, O, Sood, AK, Thompson, A, Van Loo, P, Wang, L, Weinstein, JN, Yuan, Y, Zhu, H Author Correction. Nature Genetics 55(6):1079, 2023. PMID: 36944735.
5. Yakneen, S, Waszak, SM, Aminou, B, Bartolome, J, Boroevich, KA, Boyce, R, Brooks, AN, Buchanan, A, Buchhalter, I, Butler, A, Byrne, NJ, Cafferkey, A, Campbell, PJ, Chen, Z, Cho, S, Choi, W, Clapham, P, Davis-Dusenbery, BN, De La Vega, FM, Eils, R, Akbani, R, Akdemir, KC, Cao, S, Chakravarty, D, Chen, K, Chen, Y, Chong, Z, Czerniak, BA, El-Naggar, AK, Fan, Y, Futreal, A, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Lazar, A, Wang, L, Li, J, Liang, H, Lu, Y, Mills, GB, Park, K, Sood, AK, Su, X, Ueno, NT, Wang, L, Wang, W, Weinstein, JN, Yuan, Y Author Correction. Nature biotechnology 41(4):577, 2023. PMID: 36944844.
6. Alexandrov, LB, Kim, J, Haradhvala, NJ, Huang, MN, Tian Ng, AW, Wu, Y, Boot, A, Covington, KR, Gordenin, DA, Bergstrom, EN, Islam, SM, Lopez-Bigas, N, Klimczak, LJ, McPherson, JR, Morganella, S, Sabarinathan, R, Wheeler, DA, Mustonen, V, Alexandrov, LB, Akbani, R, Akdemir, KC, Cao, S, Chakravarty, D, Chen, K, Chen, Y, Chong, Z, Czerniak, BA, Eils, R, El-Naggar, AK, Fan, Y, Futreal, A, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Lazar, A, Wang, L, Li, J, Liang, H, Lu, Y, Mills, GB, Park, K, Sood, AK, Su, X, Ueno, NT, Wang, W, Weinstein, JN, Yuan, Y, Zhu, H Author Correction. Nature 614(7948):E41, 2023. PMID: 36697836.
7. Aaltonen, LA, Abascal, F, Abeshouse, A, Aburatani, H, Adams, D, Agrawal, N, Ahn, KS, Ahn, SM, Aikata, H, Akbani, R, Akdemir, KC, Al Ahmadie, H, Al-Sedairy, ST, Al-Shahrour, F, Alawi, M, Aldape, KD, Plass, C, Broaddus, R, Langerod, A, Cao, S, Chakravarty, D, Chen, K, Chen, Y, Chong, Z, Czerniak, BA, Eils, R, El-Naggar, AK, Fan, Y, Futreal, A, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Lazar, A, Li, J, Liang, H, Lichter, P, Lu, Y, Mills, GB, Park, K, Sood, AK, Su, X, Thompson, A, Ueno, NT, Van Loo, P, Wang, L, Weinstein, JN, Yuan, Y, Zhu, H Author Correction. Nature 614(7948):E39, 2023. PMID: 36697834.
8. Li, Y, Roberts, ND, Wala, JA, Shapira, O, Schumacher, SE, Kumar, K, Khurana, E, Waszak, S, Korbel, JO, Haber, JE, Imielinski, MB, Akdemir, KC, Alvarez, EG, Baez-Ortega, A, Beroukhim, R, Boutros, PC, Bowtell, DD, Brors, B, Burns, KH, Campbell, PJ, Chan, K, Chen, K, Cortés-Ciriano, I, Dueso-Barroso, A, Dunford, A, Edwards, PA, Estivill, X, Etemadmoghadam, D, Feuerbach, L, Fink, JL, Frenkel-Morgenstern, M, Garsed, DW, Chakravarty, D, Chong, Z, El-Naggar, AK, Fan, Y, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Langerod, A, Lazar, A, Lichter, P, Mills, GB, Park, K, Sood, AK, Thompson, A, Van Loo, P, Weinstein, JN Author Correction. Nature 614(7948):E38, 2023. PMID: 36697835.
9. Paczkowska, M, Barenboim, J, Sintupisut, N, Fox, NS, Zhu, H, Abd-Rabbo, D, Mee, MW, Boutros, PC, Abascal, F, Amin, S, Bader, GD, Beroukhim, R, Bertl, J, Boroevich, KA, Chakravarty, D, Chen, K, Park, K, Akbani, R, Akdemir, KC, Aldape, KD, Cao, S, Chakravarty, D, Chen, Y, Chong, Z, Czerniak, BA, Eils, R, El-Naggar, AK, Fan, Y, Futreal, A, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Lazar, A, Li, J, Liang, H, Lichter, P, Lu, Y, Mills, GB, Sood, AK, Su, X, Thompson, A, Ueno, NT, Van Loo, P, Wang, L, Wang, W, Weinstein, JN, Yuan, Y, Zhu, H Author Correction. Nature communications 13(1), 2022. PMID: 36481658.
10. Reyna, MA, Haan, D, Paczkowska, M, Verbeke, LP, Vazquez, M, Kahraman, A, Pulido-Tamayo, S, Barenboim, J, Wadi, L, Dhingra, P, Shrestha, R, Getz, G, Lawrence, MS, Pedersen, JS, Chakravarty, D, Chen, K, Park, K, Akbani, R, Akdemir, KC, Aldape, KD, Cao, S, Chakravarty, D, Chen, Y, Chong, Z, Czerniak, BA, Eils, R, El-Naggar, AK, Fan, Y, Futreal, A, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Lazar, A, Li, J, Liang, H, Lichter, P, Lu, Y, Mills, GB, Sood, AK, Su, X, Thompson, A, Ueno, NT, Van Loo, P, Wang, L, Wang, W, Weinstein, JN, Yuan, Y, Zhu, H Author Correction. Nature communications 13(1), 2022. PMID: 36481610.
11. Rubanova, Y, Shi, R, Harrigan, CF, Li, R, Wintersinger, J, Sahin, N, Deshwar, AG, Dentro, SC, Leshchiner, I, Gerstung, M, Jolly, C, Haase, K, Tarabichi, M, Eils, R, Plass, C, Broaddus, R, Cao, S, Wang, W, Van Loo, P, Akbani, R, Akdemir, KC, Aldape, KD, Chakravarty, D, Chen, K, Chen, Y, Chong, Z, Czerniak, BA, El-Naggar, AK, Fan, Y, Futreal, A, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Lazar, A, Li, J, Liang, H, Lichter, P, Lu, Y, Mills, GB, Park, K, Sood, AK, Su, X, Thompson, A, Ueno, NT, Wang, L, Weinstein, JN, Yuan, Y, Zhu, H Author Correction. Nature communications 13(1), 2022. PMID: 36482170.
12. Bhandari, V, Li, CH, Bristow, RG, Boutros, PC, Aaltonen, LA, Abascal, F, Abeshouse, A, Aburatani, H, Adams, D, Agrawal, N, Ahn, KS, Ahn, SM, Aikata, H, Akbani, R, Akdemir, KC, Plass, C, Broaddus, R, Aldape, KD, Cao, S, Chakravarty, D, Chen, K, Chen, Y, Chong, Z, Czerniak, BA, Eils, R, El-Naggar, AK, Fan, Y, Futreal, A, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Lazar, A, Li, J, Liang, H, Lichter, P, Lu, Y, Mills, GB, Park, K, Sood, AK, Su, X, Thompson, A, Ueno, NT, Van Loo, P, Wang, L, Wang, W, Weinstein, JN, Yuan, Y, Zhu, H Author Correction. Nature communications 13(1), 2022. PMID: 36481612.
13. Shuai, S, Abascal, F, Amin, S, Bader, GD, Bandopadhayay, P, Barenboim, J, Beroukhim, R, Bertl, J, Boroevich, KA, Brunak, S, Campbell, PJ, Carlevaro-Fita, J, Chakravarty, D, Chan, CY, Chen, K, Choi, JK, Park, K, Akbani, R, Akdemir, KC, Aldape, KD, Cao, S, Chakravarty, D, Chen, Y, Chong, Z, Czerniak, BA, Eils, R, El-Naggar, AK, Fan, Y, Futreal, A, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Lazar, A, Li, J, Liang, H, Lichter, P, Lu, Y, Mills, GB, Sood, AK, Su, X, Thompson, A, Ueno, NT, Van Loo, P, Wang, L, Wang, W, Weinstein, JN, Yuan, Y, Zhu, H Author Correction. Nature communications 13(1), 2022. PMID: 36481739.
14. Cmero, M, Yuan, K, Ong, CS, Schröder, J, Adams, DJ, Anur, P, Beroukhim, R, Boutros, PC, Bowtell, DD, Campbell, PJ, Cao, S, Christie, EL, Cun, Y, Eils, R, Plass, C, Broaddus, R, Deshwar, AG, Fan, Y, Van Loo, P, Wang, W, Akbani, R, Akdemir, KC, Aldape, KD, Chakravarty, D, Chen, K, Chen, Y, Chong, Z, Czerniak, BA, El-Naggar, AK, Futreal, A, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Lazar, A, Li, J, Liang, H, Lichter, P, Lu, Y, Mills, GB, Park, K, Sood, AK, Su, X, Thompson, A, Ueno, NT, Wang, L, Weinstein, JN, Yuan, Y, Zhu, H Author Correction. Nature communications 13(1), 2022. PMID: 36481724.
15. Jiao, W, Atwal, G, Polak, P, Karlic, R, Cuppen, E, Al-Shahrour, F, Atwal, G, Bailey, PJ, Biankin, AV, Boutros, PC, Campbell, PJ, Chang, DK, Cooke, SL, Desphande, V, Faltas, B, Lazar, A, Akbani, R, Akdemir, KC, Aldape, KD, Cao, S, Chakravarty, D, Chen, K, Chen, Y, Chong, Z, Czerniak, BA, Eils, R, El-Naggar, AK, Fan, Y, Futreal, A, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Li, J, Liang, H, Lichter, P, Lu, Y, Mills, GB, Park, K, Sood, AK, Su, X, Thompson, A, Ueno, NT, Van Loo, P, Wang, L, Wang, W, Weinstein, JN, Yuan, Y, Zhu, H Author Correction. Nature communications 13(1), 2022. PMID: 36481665.
16. Sieverling, L, Hong, C, Koser, S, Ginsbach, P, Kleinheinz, K, Hutter, B, Braun, DM, Cortés-Ciriano, I, Xi, R, Kabbe, R, Park, PJ, Eils, R, Schlesner, M, Akdemir, KC, Alvarez, EG, Baez-Ortega, A, Beroukhim, R, Chen, K, Akbani, R, Aldape, KD, Cao, S, Chakravarty, D, Chen, Y, Chong, Z, Czerniak, BA, El-Naggar, AK, Fan, Y, Futreal, A, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Lazar, A, Li, J, Liang, H, Lichter, P, Lu, Y, Mills, GB, Park, K, Sood, AK, Su, X, Thompson, A, Ueno, NT, Van Loo, P, Wang, L, Wang, W, Weinstein, JN, Yuan, Y, Zhu, H Author Correction. Nature communications 13(1), 2022. PMID: 36481818.
17. Zhang, Y, Chen, F, Fonseca, NA, He, Y, Fujita, M, Nakagawa, H, Zhang, Z, Brazma, A, Amin, SB, Awadalla, P, Bailey, PJ, Brazma, A, Brooks, AN, Plass, C, Broaddus, R, Akbani, R, Akdemir, KC, Aldape, KD, Cao, S, Chakravarty, D, Chen, K, Chen, Y, Chong, Z, Czerniak, BA, Eils, R, El-Naggar, AK, Fan, Y, Futreal, A, Gershenwald, JE, Han, L, Huse, J, von Kalle, C, Krishnamurthy, S, Lazar, A, Li, J, Liang, H, Lichter, P, Lu, Y, Mills, GB, Park, K, Sood, AK, Su, X, Thompson, A, Ueno, NT, Van Loo, P, Wang, L, Wang, W, Weinstein, JN, Yuan, Y, Zhu, H Author Correction. Nature communications 13(1), 2022. PMID: 36481652.
18. Su F, Wang X, Pearson T, Lee J, Krishnamurthy S, Ueno NT, Kolonin MG Erratum: Ablation of Stromal Cells with a Targeted Proapoptotic Peptide Suppresses Cancer Chemotherapy Resistance and Metastasis. Mol Ther Oncolytics 25:305-306, 2022. PMID: 35663226.
19. Balema W, Larson R, Whye RV, Ye R, Ning J, Rahal O, Stecklein S, Krishnamurthy S, El-Zein R, Woodward W Modeling limited breastfeeding and diet on IBC like tumor progression. San Antonio Breast Cancer Symposium 80(4_Suppl), 2020.

Editorials

1. S|\b K. Relevance and impact of the International Academy of Cytology Yokohama System for standardized reporting of breast fine-needle aspiration biopsy cytology. J Am Soc Cytopathol 9(2):63-66, 2020. PMID: 32033919.
2. Krishnamurthy S. Current status of clinical genomics in patients with metastatic breast cancer. Breast Diseases: A Year Book Quarterly 27(3):182-186, 2016.
3. Krishnamurthy S. Emerging role of circulating tumor cells in breast cancer. Cancer Cytopathology, 2012.
4. Krishnamurthy S. Current applications and future prospects of fine needle aspiration biopsy of axillary lymph nodes in breast cancer. Cancer Cytopathology, 2009.
5. Krishnamurthy S. Intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Breast Diseases: A Year Book Quarterly, 2008.
6. Krishnamurthy, S. Applications of molecular techniques in fine needle aspiration biopsy. Cancer Cytopathology, 2007.

Abstracts

1. Ye, Q, Klippel, D, Albarracin, C, Chen, H, Contreras, A, Ding, Q, Huo, L, Khazai, L, Middleton, L, Resetkova, E, Sahin, A, Sun, H, Sweeney, K, Symmans, W, Wu, Y, Krishnamurthy, S. A Prospective Study of Real Time Whole Slide Imaging of Frozen Sections for Intraoperative Evaluation of Axillary Sentinel Lymph Nodes in Breast Cancer. USCAP 113th Annual Meeting, 2024. e-Pub 2024.
2. Ahmed, M, Klippel, D, Amin, S, Sura, G, Kundu, U, Y, Wendong, Stewart, J, Gan, Q, Krishnamurthy, S. Utility of Whole Slide Imaging for Evaluation of Thyroid Fine Needle Aspiration: A Multi-reader Prospective Study, 2024. e-Pub 2024.
3. Iwase T, Alexander A, Cohen EN, Gao H, Chiv VY, Kai M, Kida K, Krishnamurthy S, Liu D, Shen Y, Ramirez DL, Reuben A, Tripathy D, Booser DJ, Moulder SL, Yam C, Valero V, Lim B, Reuben JM, Ueno NT. Biomarker analysis of phase II pembrolizumab maintenance treatment after chemotherapy response in patients with HER2-negative inflammatory breast cancer and triple-negative breast cancer. ASCO Annual Meeting 41(16_Suppl), 2023. e-Pub 2023.
4. Wang K, Xiao Z, Lin Y, Wei R, Ye J, Ye R, Hu M, Bai S, Sei E, Thennavan A, Lim B, Futreal A, Thompson A, Krishnamurthy S, Navin N. Reprogramming of the preinvasive breast microenvironment identified by spatial nucleus barcoding. AACR Annual Meeting 83(7_Suppl), 2023. e-Pub 2023.
5. Phi L, Semba T, Trinh NV, Zou F, Foulks JM, Warner SL, Krishnamurthy S, Long JP, Reuben JM, Tripathy D, Ueno NT, Wang X. TBK1 inhibition potentiates the efficacy of AXL-targeted therapy by modulating tumor microenvironment in aggressive breast cancers. AACR Annual Meeting 83(7_Suppl), 2023. e-Pub 2023.
6. Wang X, Zhao L, Semba T, Song X, Knafl M, Krishnamurthy S, Shao S, Coffer LW, II, Alexander A, Wood A, Bopparaju S, Woodward WA, Chu R, Zhang J, Woodman S, Futreal A, Yam C, Tripathy D, Ueno NT. Genomic and transcriptomic analyses identify distinct features of triple-negative inflammatory breast cancer. AACR Annual Meeting 83(7_Suppl), 2023. e-Pub 2023.
7. Krishnamurthy S, Jain P, Tripathy D, Basset R, Randhawa R, Muhammad H, Huang W, Yang H, Kummar S, Wilding G, Roy R. Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network-Based Artificial Intelligence Tool. JCO Clinical Cancer Informatics 7, 2023. e-Pub 2023. PMID: 36961981.
8. Balema W, Krishnamurthy S, Lawrence A, Rodriguez M, Larson R, Fowlkes N, Ueno NT, Woodward W. CCR7 expression in Inflammatory breast cancer. San Antonio Breast Cancer Symposium 83(5_Suppl), 2023. e-Pub 2023.
9. Krishnamurthy S, Jain P, Tripathy D, Muhammad H, huang W, Yang H, Kummar S, Wilding G, Roy R, Randhawa R. Predicting response of triple negative breast cancer to neoadjuvant chemotherapy using a deep convolutional neural network-based artificial intelligence tool. San Antonio Breast Cancer Symposium 83(5_Suppl), 2023. e-Pub 2023.
10. Hu X, Xiong Y, Villodre ES, Song J, Manyam GC, Tacam MJ, Wang J, Bartholomeusz C, Tripathy D, Ueno NT, Woodward W, Krishnamurthy S, Chen J, Debeb B. Soluble E-cadherin: a novel prognostic biomarker and driver of brain metastasis in inflammatory breast cancer. San Antonio Breast Cancer Symposium 83(5_Suppl), 2023. e-Pub 2023.
11. Villodre ES, Hu X, Song J, Gomez K, Su X, Reuben J, Ueno NT, Tripathy D, Krishnamurthy S, Debeb B. Serum S100A8/S100A9 levels are associated with increased risk of brain metastasis in patients with aggressive breast cancer. San Antonio Breast Cancer Symposium 83(5_Suppl), 2023. e-Pub 2023.
12. Iwase T, Alexander A, Chiv V, Kai M, Kida K, Parker C, Marx AN, Cohen E, Gao H, Reuben J, Wang X, Krishnamurthy S, Liu D, Shen Y, Ramirez D, Tripathy D, Booser D, Yam C, Valero V, Lim B, Ueno NT, Willey JS. Phase II study of Pembrolizumab Maintenance treatment in patients with HER2-negative inflammatory breast cancer (IBC) and triple-negative breast cancer (TNBC) after response to chemotherapy. San Antonio Breast Cancer Symposium 83(5_Suppl), 2023. e-Pub 2023.
13. Rempel D, Berkeley A, Thompson A, Krishnamurthy S, Augustine B, Hunt K, Jatoi I, Nazarullah A, Nagi C, Levy Y. Development and validation of a convolutional neural network to identify ductal carcinoma in situ in lumpectomy margins using wide field optical coherence tomography. AACR Annual Meeting 15(12_Suppl_1), 2022. e-Pub 2022.
14. Wei R, He S, Bai S, Sei E, Hu M, Nagi C, Menegaz B, Javaid H, Wesseling J, Futreal A, Thompson A, Krishnamurthy S, Navin N. A single-cell and spatial investigation of tumor and TME for DCIS. AACR Annual Meeting 15(12_Suppl_1), 2022. e-Pub 2022.
15. Treekitkarnmongkol W, Shah V, Kai K, Katayama H, Wong JW, Ladha FA, Menegaz B, Pinder SE, Lu W, Yang F, Tang X, Krishnamurthy S, Wistuba II, Sawyer EJ, Thompson AM, Sen S. Epigenetic activation of SOX11 is associated with recurrence and progression of DCIS to invasive breast cancer. AACR Annual Meeting 15(12_Suppl_1), 2022. e-Pub 2022.
16. Rempel D, Berkeley A, Nagi C, Pekar V, Burns M, Augustine B, Nazarullah A, Jatoi I, Hunt KK, Thompson A, Krishnamurthy S. Development and validation of convolutional neural network to identify regions of interest in lumpectomy margins using optical coherence tomography. AACR Annual Meeting 82(12_Suppl), 2022. e-Pub 2022.
17. Guhan M, Crane S, Valerius L, La Cruz DD, Smith BD, Woodward WA, Valero V, Rauch GM, Krishnamurthy S, Warneke CL, Kuerer HM, Shaitelman SF. Patient interest in exploring nonsurgical treatment approaches for early-stage breast cancer: A qualitative study. ASCO Annual Meeting 40(16_Suppl), 2022. e-Pub 2022.
18. Wei R, He S, Bai S, Sei E, Hu M, Thompson A, Chen K, Krishnamurthy S, Navin N. Spatial charting of single cell transcriptomes in tissues. AACR Annual Meeting 82(12_Suppl), 2022. e-Pub 2022.
19. Yoon E, Wang G, Wu Y, Chen H, Albarracin C, Resetkova E, S <, Salisbury T, Sahin A, Ding Q. Expression of TRPS1, SOX10 and GATA3 in Triple Negative Invasive Ductal and Lobular Carcinomas, 2022. e-Pub 2022.
20. Xie X, Chauhan GB, Edupuganti R, Kogawa T, Park J, Tacam MT, Vidhu F, Liu DD, Taliaferro JM, Pitner MK, Shen Y, Ueno NT, Krishnamurthy S, Hortobagyi GN, Tripathy D, Van Laere SJ, Bartholomeusz G, Dalby K, Bartholomeusz C. Maternal embryonic leucine zipper kinase is associated with metastasis in triple-negative breast cancer. San Antonio Breast Cancer Symposium 82(4_Suppl), 2022. e-Pub 2022.
21. Phi L, Semba T, Foulks J, Warner S, Bearss D, Krishnamurthy S, Long J, Reuben J, Tripathy D, Ueno N, Wang X. TBK1 inhibition potentiates the efficacy of AXL-targeted therapy in aggressive breast cancer preclinical models. San Antonio Breast Cancer Symposium 82(4_Suppl), 2022. e-Pub 2022.
22. Wang X, Semba T, Manyam GC, Wang J, Shao S, Bertucci F, Finetti P, Krishnamurthy S, Phi LT, Pearson T, Burks JK, Cohen EN, Reuben JM, Yang F, Min H, Navin N, Iwase T, Shen Y, Zhang X, Tripathy D, Ueno NT. Remodeling the inflammatory breast cancer tumor microenvironment to enhance immunotherapy: Novel therapeutic development. San Antonio Breast Cancer Symposium 82(4_Suppl), 2022. e-Pub 2022.
23. Abo MA, Gearhart-Serna L, Laere SV, Freedman J, Patierno S, Hwang E, Krishnamurthy S, Williams K, Devi G. Adaptive stress response genes associated with breast cancer subtypes and survival outcomes reveal race-related differences. San Antonio Breast Cancer Symposium 82(4_Suppl), 2022. e-Pub 2022.
24. Balamurugan K, Sehareen S, Krishnamurthy S, Sharan S, Tang W, Ueno N, Ambs S, Poria D, Sterneck E. Promotion of E-cadherin-mediated tumor cell adhesion by COX-2/GSK3β signaling is a targetable mechanism of metastatic breast cancer. San Antonio Breast Cancer Symposium 82(4_Suppl), 2022. e-Pub 2022.
25. Nguyen H, Geukens T, Maetens M, Baelen KV, Schepper MD, Leduc S, Isnaldi E, Aparicio S, Borg A, Brock J, Broeks A, Caldas C, Green A, Khout H, Jórunn E, Knappskog S, Krishnamurthy S, Lakhani S, Langerod A, Martens JW, Murphy L, Nik-Zainal S, Purdie C, Rakha E, Richardson A, Salomon A, Simpson P, Sotiriou C, Span P, Tan BK, Thompson A, Tommasi S, de Vijver MV, Laere SV, Viari A, Floris G, Biganzoli E, Richard F, Desmedt C. The association between genomic alterations and body mass index in patients with early breast cancer. San Antonio Breast Cancer Symposium 82(4_Suppl), 2022. e-Pub 2022.
26. Wylie DC, Wang X, Yao J, Xu H, Iwase T, Krishnamurthy S, Ueno NT, Lambowitz AM. Disease classification modeling of inflammatory breast cancer based on simultaneous profiling of coding and non-coding RNAs in tumor and blood samples by TGIRT-sequencing. San Antonio Breast Cancer Symposium 82(4_Suppl), 2022. e-Pub 2022.
27. Kuppusamy B, Sehareen S, Krishnamurthy S, Sharana S, Tang W, Ueno NT, Ambs S, Poria DK, Sternecka E. Promotion of E-cadherin-mediated tumor cell adhesion by COX-2/GSK3b signaling is a targetable mechanism of metastatic breast cancer. AACR Annual Meeting 20(12_Suppl), 2021. e-Pub 2021.
28. Devi GR, Abo MA, Gearhart-Serna L, Geradts J, McCall SJ, Krishnamurthy S. Identification of a tumor cell adaptive stress response signaling pathway, which drives aggressive breast cancer phenotype and therapeutic resistance, in African American patients with locally advanced breast cancer subtypes. AACR Annual Meeting 29(6_Suppl_2), 2020. e-Pub 2020.
29. Kida K, Hess KR, Lim B, Iwase T, Chainitikun S, Sapon ME, Valero V, Lucci A, Le-Petross C, Woodward WA, Krishnamurthy S, Hortobagyi GN, Tripathy D, Ueno NT. Validation of prognostic stage and anatomic stage in the American joint committee on cancer 8th edition for inflammatory breast cancer. San Antonio Breast Cancer Symposium 80(4_Suppl), 2020. e-Pub 2020.
30. Hu X, Villodre ES, Larson R, Rahal OM, Wang X, Krishnamurthy S, Tripathy D, Ueno NT, Woodward WA, Debeb BG. Decorin-mediated suppression of tumorigenesis and skin invasion in inflammatory breast cancer via inhibition of the E-cadherin/EGFR axis. San Antonio Breast Cancer Symposium 80(4_Suppl), 2020. e-Pub 2020.
31. Villodre ES, Hu X, Larson R, Eckhardt BL, Gong Y, Huo L, Song J, Krishnamurthy S, Ibrahim N, Ueno NT, Tripathy D, Woodward WA, Debeb BG. Ndrg1-egfr axis in inflammatory breast cancer tumorigenesis and brain metastasis. San Antonio Breast Cancer Symposium 80(4_Suppl), 2020. e-Pub 2020.
32. Seijen MV, Jóźwiak K, Pinder SE, Hall A, Krishnamurthy S, Thomas JS, Collins LC, Bijron J, Bart J, Cohen D, Ng W, Bouybayoune I, Stobart H, Hudecek J, Schaapveld M, Thompson A, Lips EH, Wesseling J, PRECISION consortium GC. Variability in ductal carcinoma in situ grading among an international group of pathologists. San Antonio Breast Cancer Symposium 80(4_Suppl), 2020. e-Pub 2020.
33. Tasoulis MK, Lee H, Yang W, Pope R, Krishnamurthy S, Kim S, Cho N, Teoh V, Rauch GM, Smith BD, Valero V, Han W, Royal Marsden Hospital MDT, MacNeill F, Kuerer HM. Accuracy of post-neoadjuvant chemotherapy image-guided breast biopsy to predict the presence of residual cancer: A multi-institutional pooled analysis. AACR Annual Meeting 80(4_Suppl), 2020. e-Pub 2020.
34. Thomas C, Karagounis I, Srivastava R, Kumar S, Francois N, Nikolos F, Bado I, Chao H, Koumenis C, Krishnamurthy S, Ueno NT, Chakrabarti R, Maity A. Estrogen receptor β suppresses metastasis of inflammatory breast cancer by regulating signaling that promotes cytoskeleton remodeling. San Antonio Breast Cancer Symposium 80(4_Suppl), 2020. e-Pub 2020.
35. Patel LR, Mitsch J, Figueredo GP, Quinlan P, Jordan LB, Purdie CA, Krishnamurthy S, Barton MC, Thompson AM. Cytosolic TRIM24 characterizes an aggressive subset of ER- PR- and TP53 mutant breast cancer. AACR Annual Meeting 78(13_Suppl), 2018. e-Pub 2018.
36. Matsuda N, Wang X, Krishnamurthy S, Alvarez RH, Willey Jie JS, Lim B, Parker CA, Babiera G, Booser DJ, Murray JL, Arun B, Brewster AM, Reuben JM, Stauder MC, Woodward WA, Lucci A, DeSnyder SM, Tripathy D, Valero V, Ueno NT. Phase II study of panitumumab, nab-paclitaxel, and carboplatin followed by FEC neoadjuvant chemotherapy for patients with primary HER2-negative inflammatory breast cancer. Journal of Clinical Oncology 34, 2016. e-Pub 2016.
37. Huo L, Wang Y, Gong Y, Krishnamurthy, S Wang J, Diao L, Liu CG, Xiuping L, Lin F, Symmans W, Wei W, Zhang X, Sun L, Alvarez R, Ueno N, Fouad T, Harano K, Debeb B, Wu Y, Reuben J, Cristofanilli M, Zuo Z. MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancer. Modern Pathology 29:330–346, 2016. e-Pub 2016.
38. Landon G, Krishnamurthy S, Caraway N. Axillary lymph node FNA findings after gel tissue marker placement-rcognition and avoidance of potential pitfalls. Journal of the American Society of Cytopathology 4(6), 2015. e-Pub 2015.
39. Matsuda N, Alvarez RH, Krishnamurthy S, Willey JS, Wang X, Lim B, Parker CA, Marx A, Babiera G, Booser DJ, Murray JL, Arun B, Brewster AM, Reuben JM, Woodward WA, Lucci A, Gainer SM, Tripathy D, Valero V, Ueno NT. Phase II study of panitumumab, nab-paclitaxel, and carboplatin followed by FEC neoadjuvant chemotherapy for patients with primary HER-2 negative inflammatory breast cancer. Journal of Clinical Oncology 33, 2015. e-Pub 2015.
40. Krishnamurthy S, Nelles, N. Current Role of Fine needle aspiration of ancillary lymph nodes in the management of patients with early stage breast cancer. United States and Canadian Academy of Pathology, 2015. e-Pub 2015.
41. Khanna A, Tasto A, Feng J, Cortes A, Guo M, Krishnamurthy S. The utility of cervista human papillomavirus assay in necrotic fine-needle aspiration specimens of metastatic squamous cell carcinoma from neck lymph nodes. Journal of the American Society of Cytopathology 4(6), 2015. e-Pub 2015.
42. Nelles N, Krishnamurthy S. Current Role of Fine-Needle Aspiration of Axillary Lymph Nodes in the management of early-stage breast cancer. Modern Pathology 28:81-115, 2015. e-Pub 2015.
43. Landon G, Krishnamurthy S, Caraway N. Axillary Llmph node FNA findings after gel tissue marker placement - recognition and avoidance of potential pitfalls. Journal of the American Society of Cytopathology 4(6), 2015. e-Pub 2015.
44. Kundu U, Krishnamurthy S. The accuracy of endoscopic ultrasound-guided fine needle aspiration in the diagnosis of pancreatic mucinous cystic neoplasms. Journal of the American Society of Cytopathology 4(6), 2015. e-Pub 2015.
45. Krishnamurthy S, Cortes AC, Wallace MJ. Relative advantages of interventional radiology (IR) guided fine needle aspiration (FNA) performed in conjunction with core needle biopsy of solid tumors. 62nd Annual Scientific Meeting, Journal of the American Society of Cytopathology, 2014. e-Pub 2014.
46. Aapro MS, Demidchik Y, Bondarenko I, Siedakov I, Sakaeva D, Krishnamurthy S, Roman L, Lebedeva L, Mefti F, Ponomarova O, Bachelot TD, Lytvyn I, Delaloge S, Kupp A, y K, Bougnoux P, Campone M, Martin M. Vinflunine plus capecitabine for advanced breast cancer previously treated with or resistant to anthracycline and resistant to taxane: A phase III study versus capecitabine. Journal of Clinical Oncology 32, 2014. e-Pub 2014.
47. Singh C, Krishnamurthy S, Cortes A, Wallace MJ. Image-Guided fine needle aspiration (FNA) versus core needle biopsy (CNB) of malignant neoplasms: a comparative study of tumor cell yield for ancillary molecular testing. Modern Pathology 27(95-129), 2014. e-Pub 2014.
48. Lott-Limbach A, Edeiken-Monroe B, Krishnamurthy S. The predictive value of ultrasound guided fine needle aspiration in the initial staging of neck lymph nodes in patients with papillary thyroid carcinoma. Journal of the American Society of Cytopathology 3(5), 2014. e-Pub 2014.
49. Charanjeet S, Krishnamurthy S, Cortes A, Wallace M. Relative advantage of fine needle aspiration biopsy for molecular testing. Modern Pathology, 2014. e-Pub 2014.
50. Krishnamurthy S, Cortes A, Wallace M. Relative advantages of interventional radiology - guided fine needle aspiration performed in conjunction with core needle biopsy of solid tumors. Journal of the American Society of Cytopathology 3(5), 2014. e-Pub 2014.
51. Cohen EN, Gao H, Anfossi S, Giordano A, Tin S, Wu Q, B-N L, Luthra R, Krishnamurthy S, Hortobagyi GN, Ueno NT, Woodward WA, Reuben JM. Immune-induced epithelial to mesenchymal transition in inflammatory breast cancer induces unique increases in E-cadherin, adhesion and migration through TNF-a, IL-6 and TGF-b. Cancer Research 73, 2013. e-Pub 2013.
52. Fouad TM, Kogawa T, Liu DD, Shen Y, Masuda H, El-Zein R, Woodward WA, Arun B, Chavez-Macgregor M, Alvarez RH, Lucci A, Krishnamurthy S, Hortobagyi GN, Valero V, Ueno NT. Survival differences between patients with metastatic inflammatory and non-inflammatory breast cancer, 2013. e-Pub 2013.
53. Masuda H, Chavez-Mac Gregor M, Liu DD, Alvarez RH, Krishnamurthy S, Lucci A, Woodward W, Gildy B, Mittendorf EA, DeSnyder SM, Shen Y, Willey JS, Hortobagyi GN, Valero V, Ueno NT. Predictors of poor clinical outcome among patients with inflammatory breast cancer (IBC) who did and did not achieve pathological complete response (pCR) after neoadjuvant systemic chemotherapy, 2013. e-Pub 2013.
54. Cohen EN, Gao H, Anfossi S, Giordano A, Tin S, Wu Q, B-N L, Luthra R, Krishnamurthy S, Hortobagyi GN, Ueno NT, Woodward WA, Reuben JM. Immune-induced epithelial to mesenchymal transition in inflammatory breast cancer induces unique increases in E-cadherin, adhesion and migration through TNF-α, IL-6 and TGF-β, 2013. e-Pub 2013.
55. Masuda H, Chavez-Mac Gregor M, Liu DD, Alvarez RH, Krishnamurthy S, Lucci A, Woodward W, Gildy B, Mittendorf EA, DeSnyder SM, Shen Y, Willey JS, Hortobagyi GN, Valero V, Ueno NT. Predictors of poor clinical outcome among patients with inflammatory breast cancer (IBC) who did and did not achieve pathological complete response (pCR) after neoadjuvant systemic chemotherapy. Cancer Research 73(24 Suppl), 2013. e-Pub 2013.
56. Fouad TM, Kogawa T, Liu DD, Shen Y, Masuda H, El-Zein R, Woodward WA, Arun B, Chavez-Macgregor M, Alvarez RH, Lucci A, Krishnamurthy S, Hortobagyi GN, Valero V, Ueno NT. Survival differences between patients with metastatic inflammatory and non-inflammatory breast cancer. Cancer Research 73(24 Suppl), 2013. e-Pub 2013.
57. Krishnamurthy S, Sholl AB, Weston BR, Kundu U, Ross WA, Bhutani MS, Lee JH. Emerging utility of a dual-use 22-gauge (Vook EchoTip ProCore HD) needle for endoscopic ultrasound-guided cytologic and histologic sampling of solid pancreatic lesions. 61st Annual Scientific Meeting, Journal of the American Society of Cytopathology 2(1 Supp):S6, 2013. e-Pub 2013.
58. Kundu U, Krishnamurthy S. Sonographic characteristics of locoregional lymph nodes that can predict the presence of metastatic carcinoma by endoscopic ultrasound-guided fine needle aspiration in patients with carcinomas of gastrointestinal and pancreaticobiliary tra. 61st Annual Scientific Meeting, Journal of the American Society of Cytopathology 2(1):S18-S19, 2013. e-Pub 2013.
59. Caudle AS, Kuerer HM, Le-Petross HT, Yang WT, Bedrosian I, Krishnamurthy S, Lucci A, Hunt, Mittendorf EA. Predicting the extent of nodal disease in early breast cancer. Journal of Clinical Oncology, Breast Cancer Symposium 31(26):Supplement, 2013. e-Pub 2013.
60. Krishnamurthy S, Sholl A, Weston B, Kundu U, Ross W, Bhutani M, Lee J. Emerging utility of a dual-use 22-gauge (cook EchoTtp ProCore HD) needle for endoscopic ultrasound-guided cytologic and histologic sampling of solid pancreatic lesions. Journal of the American Society of Cytopathology 2(1), 2013. e-Pub 2013.
61. Kundu U, Weston B, Lee J, Hofstetter W, Krishnamurthy S. Evolving role of endoscopic ultrasonography–guided fine-needle aspiration in tumor staging and treatment of patients with carcinomas of the upper gastrointestinal tract. Journal of the American Society of Cytopathology 3(1):29-36, 2013. e-Pub 2013.
62. Eckhardt BL, Miao RY, Cao Y, Driessen WH, Krishnamurthy S, Arap W, Ueno N, Anderson RL, Pasqualini R. Peptide-based molecular targeting of inflammatory breast cancer. Cancer Research 72(24 Suppl), 2012. e-Pub 2012.
63. Meric-Bernstam F, Akcakanat A, Chen H, Sahin A, Tarco E, Carkaci S, Adrada B, Singh G, Anh-Do K, Garces Z, Mittendorf EA, Babiera G, Wagner J, Bedrosian I, Krishnamurthy S, Symmans WF, Gonzalez-Angulo AM, Mills G. Effect of biospecimen variables on proteomic biomarker assessment in breast cancer. Cancer Research 72(24 Suppl), 2012. e-Pub 2012.
64. Cohen EN, Gao H, Anfossi S, Giordano A, Tin S, Wu, Q, B-N L, Luthra R, Krishnamurthy S, Hortobagyi GN, Ueno NT, Woodward WA, Reuben JM. Soluble factors from activated immune cells induce epithelial mesenchymal transition in inflammatory breast cancer cells. Cancer Research 72(24 Suppl), 2012. e-Pub 2012.
65. Giordano A, Gao H, Cohen EN, Anfossi S, Hess KR, Krishnamurthy S, Tin S, Cristofanilli M, Hortobagyi GN, Woodward WA, Ueno NT, Lucci A, Reuben JM. Identification of cancer stem cells (CD44+CD24-/lo) in bone marrow as a prognostic factor in early breast cancer patients. Cancer Research 72(24 Suppl), 2012. e-Pub 2012.
66. Debeb BG, Larson RA, Lacerda L, Xu W, Smith DL, Ueno NT, Reuben JM, Gilcrease M, Krishnamurthy S, Buchholz TA, Woodward WA. Histone deacetylase (HDAC)-inhibitor mediated reprogramming drives cancer cells to the pentose phosphate metabolic pathway. Cancer Research 72(24 Suppl), 2012. e-Pub 2012.
67. Krishnamurthy S, Woodward W, Reuben JM, Tepperberg J, Ogura D, Niwa S, Ueno NT. Status of anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma. Cancer Research 72(24 Suppl), 2012. e-Pub 2012.
68. Atkinson RL, Sexton KR, Ueno NT, El-Zein R, Brewster AM, Krishnamurthy S, Woodward WA. Epidemiological risk factors and normal breast tissue markers in inflammatory breast cancer. Cancer Research 72(24 Suppl), 2012. e-Pub 2012.
69. Siddiqui S, Keyomarsi K, Krishnamurthy S. Utility of collodion technique for creating cell blocks of breast cancer cell lines. 60th Annual Scientific Meeting, Journal of the American Society of Cytopathology 1(1):S12, 2012. e-Pub 2012.
70. Uma K, Krishnamurthy S. The utility of endoscopic ultrasonography guided fine needle aspiration in the staging and management of carcinomas of upper gastrointestinal tract. 60th Annual Scientific Meeting, Journal of the American Society of Cytopathology 1(1):S97, 2012. e-Pub 2012.
71. Krishnamurthy S, Bischoff, FZ, Mayer JA, Kuerer HM, Lodhi A, Bhattacharyya A, Hall CS, Wong K, Pham T, Pircher TJ, Lucci A. Detection of discordant HER2 status by FISH in circulating tumor cells and disseminated tumor cells in early-stage breast cancer using a microfluidic-based cell enrichment and extraction platform (OncoCEE). Journal of Clinical Oncology, ASCO Annual Meeting 30(15):Supplement, 2012. e-Pub 2012.
72. Robertson FM, Ye Z, Chu K, Luo AZ, Wright MC, Jin J, Barsky SH, Cristofanilli M, Krishnamurthy S. Secretory leukocyte protease inhibitor as a differential diagnostic biomarker of tumor emboli in inflammatory breast cancer. Cancer Research 71(24 Suppl), 2012. e-Pub 2012.
73. Thomas C, Gayani R, Nikolos F, Hao R, Katchy A, McCollum C, Williams C, Bondesson M, Krishnamurthy S, Esteva F, J-A G. Estrogen receptor beta inhibits breast cancer EMT by regulating the expression of miR-200. Cancer Research 71(24 Suppl), 2012. e-Pub 2012.
74. Gainer S, Krishnamurthy S, Bhattacharyya A, Lodhi A, Hall C, Kuerer H, Bedrosian I, Anderson A, Singh B, Lucci A. Circulating tumor cells after neoadjuvant therapy predict outcome in stage I to III breast cancer. Cancer Research 71(24 Suppl), 2012. e-Pub 2012.
75. Krishnamurthy, Bischoff FZ, Mayer JA, Wong K, Pham T, Kuerer HM, Lodhi AK, Bhattacharyya A, Hall CS, Lucci A. Detection of HER2 gene amplification in circulating tumor cells and disseminated tumor cells by fluorescence in situ hybridization using OncoCEE&trade. Cancer Research 71(24 Suppl), 2012. e-Pub 2012.
76. Bhattacharyya A, Krishnamurthy S, Lodhi A, Hall C, Anderson A, Jackson S, Ueno N, Bedrosian I, Kuerer H, Lucci A. HER2 amplification in primary tumor: a potential marker for presence of circulating tumor cells in inflammatory breast cancer patients. Cancer Research 71(24 Suppl), 2012. e-Pub 2012.
77. Lucci A, Krishnamurthy S, Lodhi A, Bhattacharyya A, Hall C, Anderson A, Bedrosian I, Singh B, Kuerer H. Microscopic disease in blood and bone marrow predicts survival in early stage breast cancer. Cancer Research 71(24 Suppl), 2012. e-Pub 2012.
78. Lucci A, Krishnamurthy S, Bhattacharyya A, Lodhi A, Hall C, Singh B, Anderson A, i B, Kuerer H. Circulating tumor cells predict survival in non-metastatic breast cancer. Cancer Research 71(24 Suppl), 2012. e-Pub 2012.
79. Burch-Smith RA, Payne L, Bhattacharyya A, Valencia K, Quinones J, Deavers M, Krishnamurthy S. Comparison of estrogen receptor immunostaining in papanicolaou-stained direct smears and matched cell block sections. Mod Pathol, 2012. e-Pub 2012.
80. Khanna A, Cortes A, El-Zein R, S|| |. Preparation of cold cell blocks of cytologic specimens. Journal of the American Society of Cytopathology, 2012. e-Pub 2012.
81. Krishnamurthy S, Mathews K, McClure S, Murray M, Visscher D. Whole-Slide digital imaging versus optical microscopy for primary diagnosis of hematoxylin-and-Eosin-stained breast tissue sections. Mod Pathol, 2012. e-Pub 2012.
82. Hall C, Krishnamurthy S, Lodhi A, Bhattacharyya A, Anderson A, Kuerer HM, Bedrosian I, Lucci A. An evaluation of bone marrow stromal-derived growth factor-1 and interleukin-8 levels in patients with stage I-III breast cancer with disseminated tumor cells. Journal of Clinical Oncology, ASCO Annual Meeting 29(15):Supplement, 2011. e-Pub 2011.
83. Bhattacharyya A, Krishnamurthy S, Lodhi A, Hall C, Anderson A, Kuerer HM, Bedrosian I, Alvarez RH, Ueno NT, Jackson S, Singh B, Lucci A. Use of HER2 amplification in the primary tumor to predict presence of circulating tumor cells in inflammatory breast cancer. Journal of Clinical Oncology, ASCO Annual Meeting 29(15):Supplement, 2011. e-Pub 2011.
84. Krishnamurthy S, Bischoff FZ, Mayer JA, Wong K, Mikolajczyk S, Pham T, Kuerer HM, Lodhi A, Bhattacharyya A, Hall C, Lucci A. Detection of HER2 status of circulating tumor cells and disseminated tumor cells using a microfluidic platform (cell enrichment and extraction technology [CEE]). Journal of Clinical Oncology, ASCO Annual Meeting 29(15):Supplement, 2011. e-Pub 2011.
85. Bastien RRL, Ebbert MTW, Boucher KM, Kelly CM, Wang B, Iwamoto T, Krishnamurthy S, Pusztai L, Bernard PS. Using the PAM50 breast cancer intrinsic classifier to assess risk in ER+ breast cancers: A direct comparison to Oncotype Dx. Journal of Clinical Oncology, ASCO Annual Meeting 29(15):Supplement, 2011. e-Pub 2011.
86. Dhillon J, Dawlett M, Gupta S, Ahrar K, Wallace M, Lodhi A, Krishnamurthy S. Relative utilization of interventional radiology guided fine needle aspiration biopsy and core needle biopsy for the investigation of renal masses. Mod Pathol, 2011. e-Pub 2011.
87. Dhillon J, Dawlett M, Gupta S, Ahrar K, Wallace M, Hodhi A, Krishnamurthy S. Relative utilization of interventional radiology guided fine needle aspiration biopsy and core needle biopsy for the investigation of lung lesions. Mod Pathol, 2011. e-Pub 2011.
88. Burch-Smith R, Babiera G, Fearmonti R, Wagner J, Krishnamurthy S. Pathologic evaluation of nipple-aeolar complex sparing mastectomy specimens. Mod Pathol, 2011. e-Pub 2011.
89. Lodhi, AK, Krishnamurthy S, Bhattacharyya, Hall A, S C, Anderson AE, Singh B, Lucci A. Is ethnicity a predictor of micrometastatic disease in early stage breast cancer patients?, 2010. e-Pub 2010.
90. Krishnamurthy, S, Guerra, L, Valero, V, Cristofanilli, M. Pathologic changes following adenoviral 53 gene (advexin) therapy for locally advanced breast cancer, 2010. e-Pub 2010.
91. Krishnamurthy, S. Comparison of image guided fine needle aspiration biopsy and core needle biopsy for the evaluation of deep seated lesions in a quaternary care center, 2010. e-Pub 2010.
92. Lodhi, AK, Krishnamurthy, S, Bhattacharyya, A, Hall, S C, Anderson, AE, Singh, B, Lucci, A. Influence of Body Mass Index on Presence of Disseminated Tumor Cells in Clinical Stage I-III Breast Cancer Patients, 2010. e-Pub 2010.
93. Mayer, JA, Pham, T, Wong, K, Lucci, A, Bischoff, FZ, Krishnamurthy, S. Comparison of fluorescence in situ hybridization of estrogen receptor genetic locus with protein expression in invasive breast carcinoma. AACR, 2010. e-Pub 2010.
94. Bendre, M, Yang, W, Krishnamurthy, S. The Emerging Role of Fine Needle Aspiration of Satellite Lesions Around Index Lesions Newly Diagnosed as Breast Cancer: A Study of 203 Patients, 2010. e-Pub 2010.
95. Payne, L, Wright, M, Lodhi, A, Narra, Umadevi, Ramirez, RM, Siddiqui, S, Patel, S, Staerkel, GA, Krishnamurthy, S. Critical Comparison of two techniques for cell block preparation: A study of 93 cases, 2010. e-Pub 2010.
96. Dhillon J, Gupta S, k A, Wallace M, Dawlett M, Lodhi A, Krishnamurthy, S. Relative utilization of interventional radiology guided fine needle aspiration biopsy and core needle biopsy for the investigation of renal masses, 2010. e-Pub 2010.
97. Payne, L, Wright, M, Lodhi, A, Narra, Umadevi, Ramirez, R, Patel, S, Staerkel, G, Krishnamurthy, S. Critical Comparison of Two Techniques for Cell Block Preparation: A Study of 117 Cases, 2010. e-Pub 2010.
98. Krishnamurthy S, Reuben J, Cristofanilli M, Lucci A. Detection of Disseminated Tumor Cells in Bone Marrow of Patients with Breast Cancer: Comparison of Two Enrichment Techniques. Modern Pathology 22(1):52A, 2009. e-Pub 2009.
99. Kundu UR, Hunt KK, Krishnamurthy S. Utility of Frozen Section for Intra-Operative Evaluation of Sentinel Lymph Nodes in Breast Cancer. Modern Pathology 22(1):52A, 2009. e-Pub 2009.
100. Krishnamurthy S, Singh B, Reuben J, Lodhi A, Cristofanilli M, Lucci A. Detection of Minimal Residual Disease in Blood and Bone Marrow in Early Breast Cancer. Modern Pathology 22(1):51A, 2009. e-Pub 2009.
101. Krishnamurthy, S, Tang, Wang S, X, Sahin, Lucci A, A, Kuerer, HM, Babiera, G, Bedrosian, I, Hunt, KK, Meric-Bernstam, F. Utility of one step nucleic acid amplification (OSNA) assay for comprehensive examination of axillary lymph nodes in breast cancer, 2009. e-Pub 2009.
102. Krishnamurthy, S. Steroid Hormone Receptors in fibroadenoma with and without neoplasia of human breast, 2009. e-Pub 2009.
103. Krishnamurthy, S. Spindle cell lesions of the breast, 2009. e-Pub 2009.
104. Bartholomeusz C, Krishnamurthy S, Yuan L, Yamasaki F, Kazansky A, Zhang D, Francisco E, Hortobagyi G, Ueno N. PEA-15 inhibits tumorigenesis in a breast cancer xenograft model by inhibiting tumor cell proliferation through increased cytoplasmic localization of activated ERK. AACR, 2009. e-Pub 2009.
105. Krishnamurthy, S. Emerging role of fine needle aspiration of satellite lesions in the management of patients with breast cancer, 2009. e-Pub 2009.
106. Krishnamurthy, S, Singh, Reuben B, J, Lodhi, Ashutosh, Cristofanilli, M, Lucci, Anthony. Detection of Minimal residual disease in Blood and Bone Marrow in Early Breast Cancer, 2009. e-Pub 2009.
107. Krishnamurthy, S, Fackler, MJ, Sukumar, S, Hayes, K, Hunt, KK, Kuerer, HM. Intraductal fluid cytology: Emerging insights in the use of ancillary tests, 2009. e-Pub 2009.
108. McCalip, Reading B, C, Krishnamurthy, S. Immunoexpression of PAX-5 in fine-needle aspirates of small carcinoma of the lung, 2009. e-Pub 2009.
109. Jack A, Kologinczak T, Liu C, Krishnamurthy S. Immediate Clinical Significance of a Positive HPV High Risk Test With Negative Surepath Cervico-Vaginal Preparation: A Study of 159 Patients. Cancer 114(5):372, 2008. e-Pub 2008.
110. Krishnaurthy S, Hynek I, Vasquez S, Mutyala B, Patel S. Performance of ProExC Using Papanicolaou-stained SurePath Cervico-Vaginal Specimens: A Study of 122 Specimens. Cancer 114(5):383, 2008. e-Pub 2008.
111. Krishnamurthy S, Hynek I, Hunt K, Yang W. Utility of Ultrasound-Guided Fine Needle Aspiration Of Indeterminate And Suspicious Axillary Lymph Nodes In The Management Of Patients With Early Breast Cancer: A Study Of 278 Patients. Cancer 114(5):350, 2008. e-Pub 2008.
112. Krishnamurthy S, Cristofanilli M, Reuben J, Lucci A. Evaluation of Disseminated Tumor Cells in Bone Marrow in Operable Breast Cancer. Modern Pathology 21(1):78A, 2008. e-Pub 2008.
113. Lucci A, Krishnamurthy S, Mosalpuria K, Bedrosian I, Meri-Berastan F, Reuben JM Sungh B, Woodward WA, Cristofanilli M. Global evaluation of minimal residual disease in primary breast cancer patients. Proceedings of the American Society of Clinical Oncology 26 15S, 2008. e-Pub 2008.
114. Krishnamurthy S. Nipple aspirate fluid: scope of molecular and proteomic studies. Susan Love Breast Cancer Foundation, 2007. e-Pub 2007.
115. Mutyala B, Honig M, Patel S, Sneige N, Guo M, Krishnamurthy S. Performance of a novel immunocytochemical study to topoisomerase II alpha and minichromo some maintenance protien 2 expression in Papanicolaou stained sure path cervico-vaginal specimens. Cancer Cytopathol 111(371), 2007. e-Pub 2007.
116. Honig M, Krishnamurthy S. Utility of monoclonal antibody MOC-31 as an immunomarker for detecting metastatic adenocarcinoma in effusion cytology. A study of 215 cases. Cancer Cytopathol 111(378), 2007. e-Pub 2007.
117. Reuben JM, Lee BN, Li C, Broglio KR, Valero V, Jackson S, Ueno NT, Krishnamurthy S, Hortobagyi GN, Cristofanilli M. Genomic of circulating tumor cells in metastatic breast cancer. Journal of Clinical Oncology, 2007. e-Pub 2007.
118. McCalip B, Reading C, Krishnamurthy S. Immunoempression of PAX-5 in fine needle aspirate of small cell carcinoma of the lung. Cancer Cytopathol 111(409), 2007. e-Pub 2007.
119. McCalip B, Reading C, Krishnamurthy S. Diagnosing small cell carcinoma of teh lung on fine needle aspiration samples. Cancer Cytopath 111(411), 2007. e-Pub 2007.
120. Bedi DG, Krishnamurthy R, Krishnamurthy S, Edeiken B, Le-Petross H, Hunt KK, Feig BW, Singletary SE, Ross MI, Amer FC, Bedroscan I, Meric F, Kuerer HM, Fornage BD. Cortical morphology of axillary lymph nodes as a predictor of metastatic disease in breast cancer: and in-vitro ultrasound study. American Journal of, 2007. e-Pub 2007.
121. Rourke LL, Lang JE, Mosalpuria K, Yi M, Cristofanilli M, Krishnamurthy S, Singh B, Bedrosian I, Meric-Bernstam F, Lucci A. Impact of Neoadjuvant chemotherapy on presence of circulating tumor cells and disseminated tumor cells in operable breast cancer. American Society of Breast Surgeons, 2007. e-Pub 2007.
122. Lang JE, Mosalpuria K, Cristofanilli M, Krishnamurthy S, Reuben J, Singh B, Bedrosian I, meric-Bernstam F, Lucci A. Primary tumor characteristics and lymph node status fail to predict presence of circulating tumor cells in patients with operable breast cancer. Society of Surgical Oncology (SSO), 2007. e-Pub 2007.
123. Lucci A, Krishnamurthy S, Cristofanilli M, Broglio K, Bedrosian I, Meric-Bernstam F, Singh B, Reuben J, Mosalpuria K. Primary tumor charactersistics assosiated with blood and marrow micrometastases. Breast Cancer Research and Treatment, 2006. e-Pub 2006.
124. Fulkerson K, Gutierrez L, Dachsangvorn O, Alapat C, Krishnamurthy S. Significance of a diagnosis of ASC-H in pap smears: A MDACC study. Cancer Cytopath(108;392), 2006. e-Pub 2006.
125. Krishnamurthy S, Cristofanilli M, Reuben J, Lucci A. Evaluation of bone marrow minimal residual tumor in breat cancer: A cytomorphological and immunocytochemical study. Cancer Cytopath(108;354), 2006. e-Pub 2006.
126. Cristofanilli M, Guarreri V, Valero V, Fritsche H, Broglio K, Reuben JM, Krishnamurthy S, lara J, Jecam R, McCormack RT, LWMM T, Hortoborgyi GN. Circulating tumor cells (CTCS) in metastatic breast cancer: Biological value beyond tumor burden. American Society of Clinical Oncology, 2006. e-Pub 2006.
127. Kawamoto T, Thomas M, Tarco E, Trivedi S, Wistnba II, Krishnamurthy S. Amplification of HER2/neu (crB2) gene expression in gall bladder (GBC) and in bile duct cancer. American Society of Clinical Oncology, 2006. e-Pub 2006.
128. Cristofanilli M, Yand DJ, Ibrahim N, Booser D, Giordano S, Krishnamurthy S, Isis GW, Bryant J, Hortobagyi GN, Kim EE. 99m Tc-EC-ANNEXIN-V: a novel technique for imaging of primary breast cancer (PBC) and early detection of treatment-induced apoptosis in patients receiving induction chemotherapy (IC). American Assosiation of Cancer Research, 2006. e-Pub 2006.
129. Cristofanilli M, Krishnamurthy S, Guerra L, Bisotooni K, Arun B, Walters R, Booser D, Green MC, Kau SW, Menander K, Hood JV, Valero V, Hortobagyi GN. Advexin (Ad5CMV-p53) combined with docetaxel (T) and doxorubicin (D) as induction chemotherapy(IC): High efficiancy of a novel gene-therapy approach for patients with locally advanced breast cancer (LABC). San Antonio Breast Cancer Symposium, 2006. e-Pub 2006.
130. Timothy M, Fritsche H, Coombes KR, Xiao L, Krishnamurthy S, Hunt K, Pusztai L, Chen JN, Clarke CH, Arun B, Hung MC, Kerer HM. Proteomics of NAF. San Antonio Breast Cancer Symposium, 2006. e-Pub 2006.
131. Hennessy BT, Krishnamurthy S, Valero V, Hortobagyi GN. 5 year outcome of patients with squamos cell carcinoma of the breast: The University of Texas M.D. Anderson Center Experience. San Antonio Breast Center Symposium, 2006. e-Pub 2006.
132. Cristofanilli M, Guaraeri V, Valero V, Frtsche MA, Broglio RR, Reuben JM, Sara J, Krishnamurthy S, Hertobagyi GN. Circulating tumor cells (CTCS) in metastatic breast cancer. Biological value beyond tumor burden. Proceedings of the America Society of Clinical Oncology 24(31S), 2006. e-Pub 2006.
133. Cristofanilli M, Valero V, Buzdan AU, Gonzalez-Angulo AM, Kau SW, Broglio KR, Islam R, Sneige N, Krishnamurthy S, Veron T, Hunt KK, Kuerer HM, Buchholz TA Simpletary SE, Hertobagyi GN. Imflamatory breast cancer: Patterning recurrence and micrometastatic homing. Breast Cancer and Treatment 101 1(S155), 2006. e-Pub 2006.
134. Lucci A, Krishnamurthy S, Cristofanilli M, Broglio K, Bedrosian I, Meri-Berastan F, Singh B, Reuben J. Primary tumor characteristics associated with blood and bone marrow micrometastasis. Breast Cancer Research and Treatment 100 1(S215), 2006. e-Pub 2006.
135. Krishnamurthy S, Fackler MJ, Sukumar S, Hunt KK, Kuerer HM. Utility of quantitative methylation specific PCR for categorization of epitelial cells in nipple aspirate fluid: A preliminary feasibility study. Cancer Cytopath(105;335), 2005. e-Pub 2005.
136. Suraiyya S, Sniege N, Krishnamurthy S. Use of a collodien bag technique for collection of cells from fine-needle aspiration biopsy samples with low cellularity. Cancer Cytopath(108;392), 2005. e-Pub 2005.
137. Krishnamurthy S, Guerra L, Valero V, Cristofanilli M. Pathologic Changes Following Adrenoviral 53 Gene (Advexin) Therapy for Loacallly Advanced Breast Cancer. United States and Canadian Academy of Pathology, Mod Pathol 18(39A), 2005. e-Pub 2005.
138. Krishnamurthy S, Guerra L, Valero V, Cristofanilli M. Utility of Fine Needle Aspiration biopsy in measuring the gene transfer efficiency of adenoviral P53 (Advexin) gene therapy in patients with locally advanced breast cancer. United States and Canadian Academy of Pathology Meeting, Mod Pathol 18(69A), 2005. e-Pub 2005.
139. Dimashkieh H, Krishnamurthy S. Ultrasound guided fine needle aspiration of Parathyroid lesions. United States and Canadian Academy of Pathology, Mod Pathol, 18(63A), 2005. e-Pub 2005.
140. Kuruvilla S, Liu J, Zander D, Krishnamurthy S. Hep-Parl and MOC31 for distinguishing moderatly and poorly differentiated hepatocellular carcinoma from adenocarcinoma in the liver. Texas Society of Pathology, 2005. e-Pub 2005.
141. Krishnamurthy S, Facler MJ, Sukumar S, Hayes K, Hunt KK, Kuerer HM. Emerging insights in the usage of ancillary molecular test with nipple aspiration fluid cytology. International Academy of Cytology. Paris,France, 2005. e-Pub 2005.
142. Assad, L, Krishnamurthy S, Fanning T. Fine Needle Aspiration Cytomorphology of Primary, Recurrent and Metastatic Chordomas. American Society of Cytopathology 52nd Annual Scientific Meeting, Acta Cytologica 48(748), 2004. e-Pub 2004.
143. Krishnamurthy S, Zhao L, Hayes K, Glassman AB, Cristofanilli M, Singletary SE, Hunt KK, Kuerer HM, Sneige N. Feasibility and Utility of Using Chromosomal Aneusomy to Further Define the Cytologic Categories in Nipple Aspirate Fluid Specimens: A Preliminary Study. American Society of Cytopathology 52nd Annual Scientific Meeting, Chicago, Acta Cytologica 48(730), 2004. e-Pub 2004.
144. Jalali, M, Krishnamurthy S. Comparison of immunomarkers for the identification of adrenocortical cells in cytology specimens. The United States and Canadian Academy of Pathology Annual Meeting, Mod Pathol 17(70A), 2004. e-Pub 2004.
145. Cristofanilli M, Krishnamurthy S, Guerra L, Arum B, Walters R, Booser D, Aneen M, Kau SW, Menander K, Hood JVW, Valero V, Hertobagyi GN. Adenexin (ad5CMVp53) combined docetaxel and doxorubicin as induction chemotherapy: significant efficacy of a novel gene-therapy approach for patients with locally advanced breast cancer. Breast Cancer Research and Treatment 88(S61), 2004. e-Pub 2004.
146. Barkan, G, Barkan A, Krishnamurthy S. Comparison of Fine Needle Aspiration of Solid Renal Masses with Concurrent Core Biopsy and Follow Up Surgical Excision. United States and Canadian Academy of Pathology, Mod Pathol 16(88A), 2003. e-Pub 2003.
147. Krishnamurthy S, Sneige N, Hunt KK, Marey S, Babiera GV, Cristofanilli M, Singletary SE, Kuerer HM. Cytology of nipple aspiration fluid (NAF) from breasts in wormen at high risk of developing breast carcinoma: A report of 88 cases. 51st Annual Meeting, Acta Cytologica 47(862), 2003. e-Pub 2003.
148. Cormier, JN, Xing Y, Krishnamurthy S, Meric-Bernstam F, Cantor SB, Ross MI, Babiera G, Duerer HM, Singletary SE, Hunt KK. Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost-effective?. American Society of Clinical Oncology, 2003. e-Pub 2003.
149. Gonzalez-Anulo, AM, Krishnamurthy S, Yamamura Y, Pusztai L, Buzdar AA, Hortobagyi GN, Esteva FJ. Correlation between response to neoadjuvant chemotherapy (NCT) with taxanes and HER2 gene amplification in patients (pts) with breast carcinoma (BC). European Association of Oncology, 2003. e-Pub 2003.
150. Krishnamurthy S, Sahin A, Middleton LP, Symmans FW, Gilcrease MG, Sneige N, Singletary ES, Kuerer HM, Ross MI, Hunt KK. Intraoperative Imprint Cytology for Evaluation of Axillary Sentinel Lymph Nodes in Breast Cancer. United States and Canadian Academy of Pathology, Mod Pathol 16(37A), 2003. e-Pub 2003.
151. Sun W, Bedi D, Dempsey P, Krishnamurthy S. Ultrasound guided fine needles aspiration biopsy of indeterminate and suspicious axillary lymph nodes in the management of breast carcinoma. Mod Pathol 16(84A), 2003. e-Pub 2003.
152. Chedid, S, Booser D, Krishnamurthy S, Reuben JM, Green M, Arun B, Valero V, Royce M, Sison M, Frye D, Hortobagyi GN, Murgo A, Cristofanilli M. Imatinib mesylate (STI-571) for metastatic breast cancer (MBC) that overexpresses PDGFRß and/or c-kit: Minimal clinical benefit in pretreated disease. American Association of Cancer Research, 2003. e-Pub 2003.
153. Shen, J, Hunt KK, Mirza NQ, Krishnamurthy S, Singletary SE, Kuerer HM, Meric-Bernstam F, Feig B, Ross MI, Babiera GV. Intramammary lymph node metastases are an independent predictor in breast cancer outcomes. American Society of Clincial Oncology, 2003. e-Pub 2003.
154. Krishnamurthy S, Sneige N, Hunt KK, March S, Babiera GV, Cristofanilli M, Singletary SE, Kuerer HM. Cytology of Nipple Aspiration Fluid (NAF) from Breasts in Women at High Risk of Developing Breast carcinoma: Report of 88 Cases. American Society of Cytopathology, 2003. e-Pub 2003.
155. Gong Y, Symmans WF, Krishnamurthy S, Patel S, Sneige N. Optimal fixation condition for immunocytochemical analysing estrogen receptor (ER) in cytology. Specimens of breast cancer. Mod Pathol 16(66A), 2003. e-Pub 2003.
156. Recine, M, Gong Y, Sun W, Kaw M, Evans D, Sneige N, Krishnamurthy S. Fine Needle Aspiration Cytology of Mucinous Tumors of Pancreas. United States and Canadian Academy of Pathology, Mod Pathol 16(79A), 2003. e-Pub 2003.
157. Cristofanilli M, Yamanura Y, Kau SW, Vevero TB, Ss S, patarga MG, Lm H, Krishnamurthy S, Hertobagyi GN. Thyroid hormones and breast cancer: Binary hypothyroidism in associated with a reduced incidence of primary breast cancer. Proceedings on the American Association of Cancer Research 44(66), 2003. e-Pub 2003.
158. Wang S, Bevers TB, Krishnamurthy S. Changes in Cervicovaginal Smears of Women Receiving Tamoxifen for Chemoprevention of Breast Cancer Compared with Those of Women Taking Placebo. Modern Pathology, 2002. e-Pub 2002.
159. Wallace, MJ, Krishnamurthy S, Gupta S, Ahrar K, Jr MJ, Hicks ME. CT-guided percutaneous biopsy of small (< 1cm) pulmonary lesions. Radiology 225(3):823-8, 2002. e-Pub 2002.
160. Krishnamurthy, Dimashkieh H, Patel S, Sneige N. Comparison of Immunocytochemical Techniques for the Evaluation of Estrogen Receptor (ER) on fine needle aspirate (FNA) smears of breast carcinoma. American Society of Cytopathology, 2002. e-Pub 2002.
161. Wu, SL, Biddle DA, Ordonez NG, Krishnamurthy S, Ayala AG, Ro JY. Oncocytic Adrenal Cortical Neoplasms: A clinical pathologic and immunohistochemical study of 7 cases. Mod Pathol 15(1):121A, 2002. e-Pub 2002.
162. Chagpar, A, Evelegh M, Fritche H, Krishnamurthy S, Hunt K, Kuerer HM. Prospective Evaluation of a Novel Quantitative Galactose Oxidase-Schiff Reaction in Nipple Aspirate Fluid from Women with Invasive Breast Carcinoma. American Association of Cancer Research, 2002. e-Pub 2002.
163. Cabioglu, N, Krishnamurthy S, Kuerer HM, Hunt K, Singletary SE, Meric F, Feig B, Ross M, Ames F, Babiera GV. The Role of Breast Conserving Surgery in Women with Breast Cancer Presenting with Nipple Discharge. American Society of Surgery, 2002. e-Pub 2002.
164. Cristofanilli, M, Yamamura Y, Kau S, Bevers T, Strom S, Krishnamurthy S, Hortobagyi GN. Thyroid Hormones and Breast Cancer: Primary Hypothyroidism is Associated with a Reduced Incidence of Primary Breast Cancer. American Association of Cancer Research, 2002. e-Pub 2002.
165. Cristofanilli, M, Krishnamurthy S, Guerra L, Bisotooni K, Arun B, Walters R, Booser D, Coffee K, Valero V, Hortobagyi GN. Advexin® (Ad5CMV-p53) Combined with Docetaxel (T) and Doxorubicin (D) as Induction Chemotherapy (IC) for Patients with Locally Advanced Breast Cancer (LABC): Preliminary Report for Safety and Efficacy. American Society of Clinical Oncology, 2002. e-Pub 2002.
166. Lin, T, Dalton H, Alapat C, Krishnamurthy S. Use of MOC 31 as a marker of metastatic adenocarcinoma in effusion. American Society of Cytopathology, 2002. e-Pub 2002.
167. Krishnamurthy S, Sneige N, Hunt KK, Thompson P, Marcy S, Singletary SE, Kuerer HM. Cytology of paired nipple aspiration fluid (NAF) from affected and contralateral breast in women with unilateral breast carcinoma – Report of 27 cases. Acta Cytologica, 2001. e-Pub 2001.
168. Lee, A, Hunt KK, Kuerer HM, Ross M, Amer F, Singletary E, Tucker S, Sahin A, Krishnamurthy S. Predictors of non-sentinel lymph node metastasis in breast carcinoma. Mod Pathol 14(1):30A, 2001. e-Pub 2001.
169. Krishnamurthy S, Tarco E, Hunt KK, Kuerer H, Ross M, Ames F, Singletary E, Sneige N. Utility of imprint cytology and rapid cytokeratin immunostaining for the intraoperative evaluation of axillary sentinel lymph nodes in breast cancer. Mod Pathol 14(1):29A, 2001. e-Pub 2001.
170. Poniecka A, Sneige N, Krishnamurthy S. Stability of estrogen receptor expression in the progression of breast cancer. Mod Pathol 14(1):34A, 2001. e-Pub 2001.
171. Krishnamurthy S, Katz R, Shumate A, Strolein K, Khanna A, Tucker S, Rajman I, Laholi S. DNA image analysis combined with routine cytology improves diagnostic sensitivity of common bile duct brushings. Cancer Cytopathol 93(3):229-235, 2001. e-Pub 2001.
172. Sur, N, Krishnamurthy S, Staerkel G, Fanning TV, Sneige N, Weber D. Alexanian Subcutaneous fat aspiration for detecting AL amyloid in hematologic malignancies. Mod Pathol 13, 2000. e-Pub 2000.
173. Krishnamurthy R, Bedi D, Krishnamurthy S, Edieken B, Fornage, B, Hunt KK. Cortical morphology as a predictor of metastatic axillary nodal disease in breast cancer – an in-vitro ultrasound study. Radiology, 2000. e-Pub 2000.
174. Lee A, Krishnamurthy S, Reuben J, Lucio L, Siddiqui S, Hunt KK, Sneige N. Intraoperative sentinel lymph node touch imprint cytology combined with anti cytokeratin CAM5.2 FITC and histology. A Comparative Study. Acta Cytologica:882, 2000. e-Pub 2000.
175. Massimo, Cristofanilli, Yand DJ, Ibrahim N, Booser D, MGiordano S, Krishnamurthy S, Isis GW, Bryant J, Hortobagyi GN, Kim EE. 99mTc-EC-ANNEXIN-V: A novel technique for imaging of primary breast cancer (PBC) and early detection of treatment-induced apoptosis in patients receiving induction chemotherapy (IC). American Association of Cancer Research, 2000. e-Pub 2000.
176. Krishnamurthy S, Bedi D, Caraway NP. Ultrasound guided fine needle aspiration of thyroid bed. Mod Pathol 13, 2000. e-Pub 2000.
177. Wu, S, Biddle D, Ordonez N, Krishnamurthy S, Ayala A, Ro J. Oncocytic Adrenocortical Neoplasms: . A Clinicopathologic and Immunohistochemical Study of Seven Cases, 2000. e-Pub 2000.
178. Pawlik, Timothy MMD, MPH, Fritsche H, PhD, RCoombes K, PhD, Xiao L, MS, Krishnamurthy S, MD, KHunt K, MD, Pusztai L, MD, PhD, Chen J, PhD, HClarke C, PhD, Arun B, MD, Hung M, PhD, MKuerer H, MD, PhD. Proteomics of NAF. San Antonio Breast Cancer Symposium, 2000. e-Pub 2000.
179. Massimo, Cristofanilli, Krishnamurthy S, Guerra L, Bisotooni K, Arun B, Walters R, Booser D, Green MC, Kau S, Menander K, Wart Hood JV, Valero V, Hortobagyi GN. Advexin Ò (Ad5CMV-p53) combined with docetaxel (T) and doxorubicin (D) as induction chemotherapy (IC): High efficacy of a novel gene-therapy approach for patients with locally advanced breast cancer (LABC). San Antonio Breast Cancer Symposium, 2000. e-Pub 2000.
180. Merchant, S, Lazo A, Krishnamurthy S. Steroid Hormone Receptors in Fibroadenoma with and without Neoplasia of Human Breast. Modern Pathology, 2000. e-Pub 2000.
181. Hennessy BT, Krishnamurthy S, Valero V, Hortobagyi GN. 5 year outcome of patients with squamous cell carcinoma of the breast. The University of Texas M. D. Anderson Cancer Center experience. San Antonio Breast Cancer Symposium, 2000. e-Pub 2000.
182. Krishnamurthy S, Sneige N, Kuerer H, Fornage B. Diagnostic Accuracy of Ultrasound-Guided Fine-Needle Aspiration of Axillary Lymph Nodes in the Preliminary Clinical Staging of Breast Cancer. Acta Cytologica:852, 2000. e-Pub 2000.
183. Krishnamurthy S, Sneige N, Bedi D, Fornage B. Diagnostic accuracy of ultrasound guided fine needle aspiration of non-palpable axillary lymph nodes in breast cancer. Acta Cytologica, 2000. e-Pub 2000.
184. Kuerer, HM, Thompson P, Krishnamurthy S, Sneige N, Singletary ES, Hunt KK. HER2/neu in nipple aspirate fluid. Am J Surg Oncol, 2000. e-Pub 2000.
185. Krishnamurthy S, Shin HJ, Sneige N. Distinction of Phyllodes tumor from Fibroadenoma on FNA. Mod Pathol, 1999. e-Pub 1999.
186. Soriano CA, Almaraz-Klippel D, Tinnirello A, Brown C, Krishnamurthy S. Prospective Study to Evaluate the Feasibility of Whole Slide Imaging for Rapid Evaluation of Image-guided Fine Needle Aspiration Biopsy from Different Body Sites. United States and Canadian Academy of Pathology.
187. Ibrahim E, Hegazy S, Gong Y, Krishnamurthy S, Meis J, Yu W. Metastatic Sarcomas to Pleural Effusion: A Referral Cancer Center Experience. United States and Canadian Academy of Pathology.
188. Wang L, Chen H, Fei A, Zhang YH, Middleton L, Krishnamurthy S, Huo L, Sahin A, Ding Q. GATA3 and TRPS1 Expression in Follicular Dendritic Cell Sarcoma. United States and Canadian Academy of Pathology.
189. Grinwald M, Schnitt S, Vincent-Salomon A, Krishnamurthy S, Provenzano E, Canas-Marques R, Shearon E, Borkowski P, Chandra P, Welch D, Cates J, Tommaso LD, Silva V, Etoz S, Mallel G, Vecsler M, Sandbank J. Differentiation Between HER2 Ultra-low and HER2 Null Breast Cancers Using an AI Support Tool: A Multi-Site Study. United States and Canadian Academy of Pathology.
190. Ali H, Ijaz K, Fei A, Wang H, Krishnamurthy S, Gan Q. Characteristic Cytomorphologic Features of Pancreatic Serous Cystadenoma That Has Been Overlooked on Fine-Needle Aspiration Specimen. United States and Canadian Academy of Pathology.
191. Yoon EC, Wang G, Parkinson B, Huo L, Peng Y, Wang J, Salisbury T, Wu Y, Chen H, Albarracin CT, Resetkova E, Middleton LP, Krishnamurthy S, Gan Q, Sun H, Huang X, Shen T, Chen W, Parwani AV, Sahin AA, Li Z, Ding Q. Expression of TRPS1, SOX10 and GATA3 in Triple Negative Invasive Ductal and Lobular Carcinomas. United States and Canadian Academy of Pathology.

Book Chapters

1. Mody DR, Krishnamurthy S, Divatia MK. Bone - neoplasms. In: Diagnostic Pathology Cytopathology. 1. Amirsys, 4:33, 2014.
2. Krishnamurthy S. Ancillary testing. In: Diagnostic Pathology Cytopathology. 1. Amirsys, 2:9, 2014.
3. Krishnamurthy S. Breast - benign neoplasms. In: Diagnostic Pathology Cytopathology. 1. Amirsys, 18:31, 2014.
4. Krishnamurthy S. Breast - malignant neoplasms. In: Diagnostic Pathology Cytopathology. 1. Amirsys, 32:51, 2014.
5. Krishnamurthy S. Breast - nipple discharge. In: Diagnostic Pathology Cytopathology. 1. Amirsys, 52:53, 2014.
6. Kunda U, Landon G, Krishnamurthy S. Pancreas-neoplasms. In: Diagnostic Pathology Cytopathology. 1. Amirsys, 8:27, 2014.
7. Krishnamurthy S. Evaluation of Sentinel lymph nodes in Breast Cancer. In: Breast Diseases, 2014.
8. Krishnamurthy S. Pathologic evaluation of Tissue obtained by Interventional Radiology techniques. In: Interventional Radiology, 2014.
9. Krishnamurthy S. Breast - overview. In: Diagnostic Pathology Cytopathology. 1. Amirsys, 2:3, 2014.
10. Krishnamurthy S. Breast - benign breast lesions. In: Diagnostic Pathology Cytopathology. 1. Amirsys, 4:17, 2014.
11. Krishnamurthy S. Role of Fine Needle Aspiration in the Management of Patients With Breast Cancer. In: Textbook of Surgical Oncology. McGraw Hill, 2009.
12. Singletary E, Krishnamurthy S. Breast Cancer Staging Role of Fine Needle Aspiration in the Management of Patients With Breast Cancer. In:. In: Textbook of Surgical Oncology. Ed(s) Kuerer H. McGraw Hill, 2009.
13. Katz R, Krishnamurthy S. Kidneys, Adrenals, and Retroperitoneum. In: Textbook of Cytopathology, 2007.
14. Whitman G, Huynh P, Patel P, Wilson J, Cantu A, Krishnamurthy S. Sonography of Invasive Lobular Carcinoma. In: Ultrasound Clinics. 4. Elsevier Saunders, 645:660, 2006.
15. Whitman, Erguvan-Dogan B, Yang WT, Wilson J, Patel P, Krishnamurthy S. Ultrasound-Guided Breast Biopies. In: Breast Ultrasound. 4. Elsevier, Inc, 603:616, 2006.
16. Krishnamurthy S. Sarcoma of the Breast. In: Advanced Therapy of Breast Disease, 2004.
17. Krishnamurthy S. Pathology of Lymph Nodes In Breast Cancer. In: Breast Cancer, 2003.
18. Krishnamurthy S, Dayal Y. Pathology of the gastrointestinal tract. In: Textbook of Pathology, 1996.

Letters to the Editor

1. Krishnamurthy S, Lucci A. Reply to detection of minimal residual disease in blood and bone marrow in early stage breast cancer. Cancer, 2011.
2. Krishnamurthy S, Lucci A. Anti-cytokeratin CAM5.2 (BD Sciences) and CK8 Give No Remarkable Advantages to the Pancytokeratin Cocktail of Antibodies (AE1/AE3, CAM5.2, MNF116, CK8, and CK18) in Detecting Disseminated Tumor Cells in Biologic Subtypes of Stage I-III Breast Cancer Patients. Ann Surg Oncol, 2010.